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ABSTRACT 
 
 
NATHAN WILLIAM RIGEL: Characterization of the SecA2 Protein Export Pathway of 
Mycobacteria 
(Under the direction of Miriam Braunstein) 
 
 
 
Nearly one-third of the world’s population is infected with Mycobacterium 
tuberculosis, the bacterium that causes tuberculosis.  To establish and maintain infection, M. 
tuberculosis uses surface and secreted proteins to modulate the host immune response.  There 
are several dedicated export machines that transport surface and secreted proteins from their 
site of synthesis in the cytoplasm across the bacterial cytoplasmic membrane.  The bulk of 
protein export across the cytoplasmic membrane is carried out by the Sec pathway.  Energy 
for Sec-dependent protein export is provided by the essential ATPase SecA.  Recently, a 
small subset of Gram positive bacteria and mycobacteria were found to possess two SecA 
homologs, SecA1 and SecA2.  In M. tuberculosis and the non-pathogenic model 
mycobacterium M. smegmatis, SecA1 is essential for general protein export and is the 
presumed “housekeeping” SecA, while SecA2 is an accessory SecA specific for a subset of 
exported proteins.  In this work, we describe our initial attempts to characterize the 
mechanism behind SecA2-mediated protein export in mycobacteria.  We began by 
comparing similarities and differences between SecA1 and SecA2.  One striking difference 
we discovered was that SecA1 and SecA2 localize to different cellular compartments.  By 
comparing a structural prediction of SecA2 to the published crystal structure of SecA1, we 
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identified putative structural differences between the two SecAs.  Both SecA1 and SecA2 
have predicted ATP binding sites.  We showed that M. tuberculosis SecA1 and SecA2 bind 
and hydrolyze ATP in vitro.  By constructing a secA2 mutant that encodes a protein defective 
in ATP binding, we also demonstrated that ATP binding is required for normal SecA2 
function in vivo.  Upon subsequent analysis, we found that SecA2 mutants unable to bind 
ATP were dominant negative.  We used this dominant negative phenotype as a tool to study 
SecA2 by performing a suppressor screen.  We isolated intragenic suppressors and used them 
to identify structural subdomains of SecA2 that are important for function.  While we have 
not yet identified the extragenic suppressors, we believe they represent a powerful tool for 
identifying SecA2-interacting proteins.  Identifying SecA2-interacting proteins will be 
crucial to fully understand the accessory SecA2 protein export pathway of mycobacteria.  
Finally, we show for the first time in any bacterium with two SecA proteins that the 
canonical SecA1 protein is also required to export SecA2-dependent substrates.  By 
developing a better understanding of the SecA2 pathway, we hope to increase our knowledge 
of mycobacterial physiology to enable the design of new anti-tuberculosis therapies. 
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Chapter 1 
INTRODUCTION 
 
Tuberculosis (TB) is caused by the acid-fast bacillus Mycobacterium tuberculosis.  
By current estimates, up to one-third of the world’s population is infected with M. 
tuberculosis (71).  In 2006, 1.7 million people died from TB while an additional 9.2 million 
new cases of TB were reported.  TB is the leading cause of death from a bacterial disease 
(72).  TB is also a leading cause of death of HIV positive individuals (71).  As with other 
infectious diseases, the burden of TB is highest in developing countries, especially in Africa 
and Eastern Asia. 
Spread of M. tuberculosis and development of TB disease.  While public health 
strategies have been implemented in many countries to control the spread of TB, a new threat 
has surfaced with the rise of multidrug-resistant (MDR-TB) and extensively drug-resistant 
(XDR-TB) M. tuberculosis strains (45, 71).  MDR-TB strains are resistant to the standard 
treatment with first-line antibiotics isoniazid and rifampicin.  Treatment is still possible with 
less effective second-line antibiotics.  However, if not treated properly, MDR-TB strains can 
acquire additional antibiotic resistance.  This has led to the appearance of XDR-TB strains.  
These strains are resistant to the first-line antibiotics, any fluoroquinolone, and any of the 
second-line antibiotics.  Depending on the drug resistance profile, some XDR-TB strains are 
untreatable.  
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As of February 2008, 45 countries, including the US, reported confirmed cases of 
XDR-TB (70).  40,000 new cases of XDR-TB are expected to emerge each year, 
underscoring the urgent need to devise new anti-TB treatments. 
M. tuberculosis is spread person to person via aerosols that are expelled when a 
person with an active case of TB coughs or sneezes.  M. tuberculosis is contained within 
these aerosols, which are then inhaled into the alveolar space of the lung.  The bacteria are 
then phagocytosed by macrophages.  M. tuberculosis is an intracellular pathogen, and as 
such, it has developed the means to survive inside host cells.  The mechanism by which M. 
tuberculosis survives inside macrophages is complex and is a matter of active investigation 
(35, 55). 
For individuals with a healthy immune system, primary infection with M. 
tuberculosis is usually controlled and TB disease does not immediately develop.  During the 
onset of the cell-mediate immune response, M. tuberculosis-infected macrophages become 
surrounded by other immune cells (macrophages and T cells) and are effectively walled-off 
from the rest of the lung (37).  This network of cells is termed a granuloma, one of the 
hallmarks of TB infection (20, 56).  The metabolic state of M. tuberculosis inside a 
granuloma is not well understood.  The most common description is that M. tuberculosis 
enters a dormant state, awaiting conditions that are more favorable for the bacterium to 
reactivate.  In 10% of all individuals infected with M. tuberculosis, the bacilli reactivate later 
in life resulting in active infectious TB disease (29).  The signals that trigger reactivation are 
not clear but do seem linked to the immune status of the infected individual.  This has 
become particularly important with the advent of the HIV epidemic since TB is the leading 
cause of death among HIV patients (26).       
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Identification of the molecular mechanisms that M. tuberculosis uses to gain a 
foothold in the host is an active area of research.  Protein export systems of M. tuberculosis 
are of particular interest given the importance of such systems to virulence in numerous and 
diverse bacterial pathogens (28, 40).  Exported proteins are defined as any protein located 
beyond the cytoplasmic membrane and includes proteins attached to the bacterial cell surface 
or secreted into the extracellular environment.  The extracytoplasmic location of exported 
proteins makes them ideally positioned to interact with host cells.  Consequently, exported 
proteins and the requisite systems for exporting them often play important roles in bacterial 
pathogenesis.   
The general Sec system of protein export.  In bacteria, the bulk of protein export 
from the cytoplasm across the cytoplasmic membrane is carried out by the universally 
conserved general secretion (Sec) pathway (Figure 1.1) (22, 47).  The Sec pathway is 
essential in all organisms tested.  Much of the detailed characterization of the Sec pathway 
was performed using the model organisms E. coli and B. subtilis  (22, 50).   
The central component of the Sec apparatus is the membrane-bound channel called 
the Sec translocase.  The translocase is composed of the integral membrane proteins SecY, 
SecE, and SecG (12).  Together, these three proteins form a complex that spans the 
cytoplasmic membrane and serves as the channel through which pre-proteins are translocated 
in an unfolded state.  Another key player in the Sec pathway is the multifunctional SecA 
ATPase (23).  SecA can directly bind precursor pre-proteins destined for export through the 
SecYEG translocase (49).  SecA can also interact with cytoplasmic chaperones, such as 
GroEL and SecB (8, 27).  SecB recognizes a subset of pre-proteins, keeps them in an 
unfolded export-competent state, and binds directly to SecA to deliver them for export (33, 
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53).  SecA also binds with low affinity to acidic phospholipids in the cytoplasmic membrane 
and with high affinity to SecYEG (34).  SecA is an ATPase and the energy from ATP 
hydrolysis is required for Sec export (46).  With each cycle of ATP binding and hydrolysis, 
SecA undergoes conformational changes that allow it to feed nascent pre-proteins through 
the SecYEG translocase, 20 amino acids at a time (58).  Given the essential roles SecA plays 
in protein export, it is no surprise that in all cases tested SecA is essential for viability. 
ATP binding and ATPase activity are essential for SecA function (46).  SecA 
contains ATP-binding Walker Box motifs, a structural feature found in many ATPases (69).  
Mutations in the Walker Box motifs of E. coli SecA destroy the ability of SecA to bind ATP 
(46).  Furthermore, mutations in the SecA Walker Box are nonfunctional as shown by the 
inability to complement temperature sensitive secA mutants.  SecA Walker Box mutants are 
also nonfunctional for in vitro pre-protein translocation assays.  Additionally, disruption of 
ATPase activity interferes with the ability of SecA to cycle between the cytoplasmic 
membrane and the cytoplasm (25).  Normally, SecA is found evenly distributed between the 
cytoplasmic membrane and cytoplasm (14).  However, a mutated Walker Box results in a 
SecA that is predominantly cell membrane-associated (46).  In fact, treatment with carbonate 
is unable to dissociate Walker Box mutant SecA from the cytoplasmic membrane, indicating 
that this protein is permanently lodged in the membrane and unable to cycle upon ATP 
binding and hydrolysis.  This fixed localization helps explain why a SecA Walker Box 
mutant is unable to complement temperature sensitive secA mutants. 
The Sec pathway exports proteins that are synthesized as pre-proteins with an N-
terminal sorting signal, called a signal sequence.  Sec signal sequences are tripartite; they 
consist of a positively charged N domain, a hydrophobic H domain, and a polar C domain 
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that contains a cleavage site (22).  During the process of export, a periplasmic signal 
peptidase, either LepB or LspA, cleaves the signal sequence to release the exported mature 
protein (66, 67, 77).    LepB cleaves standard signal sequences while LspA specifically 
cleaves signal sequences of lipoproteins by recognizing a specific lipobox motif (L-A/S-G/A-
C+1). 
The Sec pathway also participates in delivering integral membrane proteins to the 
cytoplasmic membrane (22, 76).  This class of proteins is delivered to the SecYEG 
translocase cotranslationally with the aid of the Signal Recognition Particle (SRP).  SRP is a 
ribonucleoprotein composed of a 4.5S RNA and a GTPase Ffh (fifty-four homolog).  As a 
newly synthesized pre-protein emerges from the ribosome, SRP recognizes the signal 
sequence or transmembrane domains of the nascent polypeptide chain.  This complex then 
interacts with FtsY, which in turn interacts with both anionic phospholipids and the SecYEG 
translocase.  Upon GTP hydrolysis, SRP and FtsY are released from the membrane, leaving 
the pre-protein associated with the SecYEG translocase. 
The Sec pathway also plays a role in delivery of integral membrane protein into the 
cytoplasmic membrane (22, 76).  SecA delivers some, but not all transmembrane proteins to 
the SecYEG translocase.  Once inserted into the SecYEG pore, hydrophobic transmembrane 
domains are believed to exit the translocase through a lateral gate.  The precise mechanism 
behind lateral exit and integration of transmembrane proteins into the cytoplasmic membrane 
is not fully understood.  Furthermore, insertion of a subset of transmembrane proteins 
requires the membrane protein YidC in addition to the Sec pathway (16).  YidC can associate 
with SecYEG and catalyze insertion of newly translocated membrane proteins.  In addition, 
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YidC can function independently of the Sec pathway and directly insert transmembrane 
domains into the cytoplasmic membrane (76). 
Specialized protein secretion systems have roles in bacterial pathogenesis.  In 
addition to the universally conserved Sec pathway, many bacterial pathogens use specialized 
secretion systems to transport virulence factors (28).  There are now six named specialized 
secretion systems in Gram negative bacteria (30).  Some of these pathways export proteins in 
two steps.  Such proteins first cross the cytoplasmic membrane through the Sec system and 
are then secreted across the Gram negative outer membrane by a separate export apparatus.  
Other pathways secrete proteins in one-step by a process that is completely independent of 
the Sec pathway.  One of the best-characterized specialized secretion systems is the Type III 
secretion system (T3SS) found in bacteria including Salmonella and Yersinia (38).  The 
T3SS spans the entire bacterial cell envelope (comprised of the cytoplasmic membrane and 
the cell wall) and forms a needle complex that extends beyond the bacterial cell surface.  The 
T3SS directly injects proteins synthesized in the bacterial cytoplasm through the needle 
complex and into host cells.  Once inside the host, these bacterial effector proteins can 
function in a wide variety of ways to mediate bacterial infection.   
While there are a plethora of specialized secretion systems in Gram negative bacteria, 
only recently have specialized export systems been described in Gram positive bacteria.  One 
such example is the ESX-1 system (1).  In M. tuberculosis, the ESX-1 system is required for 
virulence (43).  This system was first identified in mycobacteria as being required to export 
the small virulence factors CFP-10 and ESAT-6.  Both of these proteins lack predicted Sec 
signal sequences, suggesting an alternate secretion pathway is required for their export.  
Subsequent analysis shows the genes adjacent to esat-6 and cfp-10 encode proteins that 
 7 
constitute a specialized secretion system (11).  Several Gram positive bacteria encode ESX 
secretion systems including Staphylococcus aureus, Corynebacterium diphtheriae, and 
Listeria monocytogenes (1, 62). 
Another example of specialized protein secretion in Gram positive bacteria is the 
cytolysin-mediated translocation pathway.  Examples of this pathway are found in 
Streptococcus pyogenes and Listeria monocytogenes (44, 52).  In this system, a soluble 
cytolysin released from the bacterium forms a large oligomer within the membrane of a 
eukaryotic host cell.  Once this pore is formed, other effector proteins exported from the 
bacterial cytoplasm can directly enter the host cell cytoplasm.  In the S. pyogenes example, 
streptolysin O (SLO) forms a pore in membrane of human keratinocytes (44).  Then, SPN (S. 
pyogenes NAD-glycohydrolase) translocates into the host cytoplasm.  The combined activity 
of SLO and SPN is required for full cytotoxicity. 
Accessory SecA2 protein export systems.  It was long thought that all bacteria 
possess a single and essential SecA (24).  Recently, mycobacteria and a small subset of Gram 
positive bacteria were found to encode two SecA homologs (5, 9, 10, 15, 18, 42, 54, 59).  
Included in this list are pathogens (M. tuberculosis, Listeria monocytogenes, Streptococcus 
gordonii, Streptococcus parasanguinis, Staphylococcus aureus, and Bacillus anthracis) and 
nonpathogens (M. smegmatis, L. innocua, and Corynebacterium glutamicum).  In these 
bacteria, the SecA with highest homology to the essential SecA of B. subtilis is called SecA 
or SecA1 (Table 1.1).  The other SecA is called SecA2.  Bacteria with an accessory SecA2 
can be divided into two groups: those that also possess an accessory SecY2 protein 
(SecA2/Y2) and those that do not (SecA2-only) (Figure 1.2).   
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The accessory SecA2/Y2 systems of S. gordonii and S. parasanguinis.  The best-
studied SecA2/SecY2 systems are those of S. gordonii and S. parasanguinis, two organisms 
found in the oral cavity (5, 18).  The components and the mechanism of the accessory 
SecA2/SecY2 systems in these two bacteria are very similar.  In both cases, the secA2 and 
secY2 genes are encoded in a locus that additionally possesses a suite of similarly arranged 
genes that include a SecA2-exported substrate and proteins involved in glycosylation and 
export of this substrate (Figure 1.3).  In S. gordonii, the SecA2 system exports the serine-rich 
glycoprotein GspB (5).  After crossing the cytoplasmic membrane, GspB becomes anchored 
to the cell wall where the protein is implicated in platelet binding.  Platelet binding by S. 
gordonii is believed important to development of endocarditis (3).  Similarly, the SecA2 
system of S. parasanguinis exports a serine-rich glycoprotein called Fap1 to the cell wall 
(18).  Fap1 forms fimbriae that are needed for attachment of S. parasanguinis to the surface 
of teeth and subsequent accumulation of dental plaque leading to periodontal disease (74).  It 
seems highly likely that the proper export of these serine-rich glycoproteins by SecA2 is 
important to development of disease. 
The accessory SecA2/SecY2 systems in S. gordonii and S. parasanguinis share many 
of the same components, including an accessory secY2 homolog that encodes a protein with 
predicted transmembrane domains.  In S. gordonii, Asp1-3 (Accessory secretory protein) are 
all required for GspB export (64).  Asp2 is a predicted transmembrane protein.  It is possible 
that Asp2 and SecY2 form a membrane-embedded translocase.  The function of Asp1 and 
Asp3 is not clear as both proteins lack predicted transmembrane domains. The homologous 
proteins in S. parasanguinis are named Gap1-3 (Glycosylation associated protein).  The 
function of these proteins appears to differ slightly from the Asp proteins.  For example, in 
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the absence of Gap3, Fap1 is still exported but the pattern of glycosylation is different (51).  
The significance of the difference between Gap3 and Asp3 function is unclear.  There are 
other differences between the SecA2/SecY2 systems of S. gordonii and S. parasanguinis.  In 
S. gordonii, asp4 and asp5 encode proteins with homology to B. subtilis SecE (52% 
similarity) and SecG (55% similarity), respectively (65).  Both proteins are required for 
GspB export.  However, there are no obvious Asp4 or Asp5 homologs in S. parasanguinis.  
The significance of the slight differences between S. gordonii and S. parasanguinis is not 
clear.   
Both GspB and Fap1 are heavily glycosylated proteins.  In both the S. gordonii and S. 
parasanguinis secA2/Y2 loci there are multiple genes encoding proteins with roles in 
glycosylation of the exported serine-rich proteins (13, 63, 73).  Downstream of secA2 are gtf 
genes required for glycosylation of GspB and Fap1.  Although the genomic organization is 
slightly different, both S. gordonii and S. parasanguinis secA2/Y2 loci also encode additional 
genes with homology to glycosyltransferase (gly) and nucleotide sugar synthetase (nss).  Gly 
and Nss specify the types of carbohydrate linkages that are added to GspB.  S. parasanguinis 
encodes two additional glycosylation factors, GalT1 and GalT2.  GalT2 is required for full 
glycosylation of Fap1 (75). 
There is evidence that GspB and Fap1 are glycosylated prior to export.  While GspB 
export is blocked in S. gordonii secA2 and secY2 mutants, the GspB that is retained in the 
cytoplasm is still glycosylated (2).  In S. parasanguinis cytoplasmic fractions, Fap1 is 
detected with both anti-peptide and anti-glycan antibodies, suggesting glycosylation occurs 
prior to export (18).  This finding is unique because the known glycoproteins in M. 
tuberculosis and Campylobacter jejuni are glycosylated after export across the cytoplasmic 
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membrane (48, 68).  It is possible that the accessory SecA2 system is important for exporting 
proteins with post-translational modifications. 
However, data from both S. gordonii and S. parasanguinis indicates glycosylation is 
not required for SecA2-mediated export.  Fap1 is still exported in a S. parasanguinis gtf1 
mutant although it lacks any detectable carbohydrate modifications, and unglycosylated 
GspB is still exported in S. gordonii gtf mutants (6, 73).  Interestingly, glycosylation status 
partially explains why the GspB and Fap1 are not exported by the canonical Sec pathway.  In 
S. gordonii gtf mutants, GspB is not glycosylated but is still exported, and this export is 
reduced in a gtf secA2 double mutant.  One demonstration of the effect of glycosylation 
comes from experiments showing more GspB is exported by a gtf secA2 double mutant than 
a secA2 single mutant (6).  This difference is attributed to export of unglycosylated GspB via 
the canonical Sec pathway.  In support of this idea, treatment with azide, a known SecA 
inhibitor, diminishes the residual GspB export in the double mutant.  Thus, it appears that 
glycosylation can block GspB export by the canonical Sec pathway.  Perhaps, fully 
glycosylated GspB is too large for export through the SecYEG translocase.  These findings 
also suggest that the accessory SecA2/Y2 systems are adapted to export proteins that are 
modified post-translationally. 
In addition to glycosylation, the signal sequence is also important for directing GspB 
and Fap1 export (4, 6, 17).  Both GspB and Fap1 have atypically long N-terminal signal 
sequences required for export.  In S. gordonii, three key glycine residues (G3) are required 
for export of fully glycosylated GspB (4).  The G3 residues serve a dual function by 
promoting export by SecA2 and by blocking export by the canonical Sec pathway.  The Fap1 
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signal sequence does not have G3 residues, but there may be other features that specify 
export via SecA2.  
SecA1 is the essential housekeeping SecA protein of mycobacteria.  Genomic 
analysis shows that M. tuberculosis encodes all of the essential proteins of the Sec pathway, 
including the ATPase SecA1 and the translocase components SecY, SecE, and SecG (19).  
Notably, SecB is not encoded by any mycobacteria.  The SecB chaperone is not required for 
export of all Sec-dependent proteins, even in E. coli.  In mycobacteria, there is ample 
evidence that SecA1 functions as the housekeeping secretion factor, analogous to E. coli 
SecA.  SecA1 is essential for growth in M. tuberculosis and M. smegmatis; secA1 cannot be 
deleted from the M. smegmatis chromosome unless a copy of secA1 is expressed from a 
plasmid (9, 57).  Also in M. smegmatis, depletion of SecA1 leads to a loss of viability and 
prevents export of the MspA porin, which possesses a predicted Sec signal sequence (32).  In 
contrast, the secA2 gene is not essential as ∆secA2 mutants have been constructed in M. 
tuberculosis and M. smegmatis (9, 10). 
SecA2 is part of a specialized protein export system in mycobacteria.  The 
accessory SecA2 system of mycobacteria appears unrelated to the accessory SecA2/SecY2 
systems found in some Gram positive bacteria.  However, the accessory secA2 locus is highly 
conserved in Mycobacterium species.  The genomic organization of the accessory SecA2 
system in M. tuberculosis and M. smegmatis is significantly different from the SecA2/SecY2 
systems found in Gram positive bacteria (54).  One major difference is that there is no extra 
SecY2 in mycobacteria.  Of the genes that surround secA2 in mycobacteria, none is predicted 
to encode proteins involved in glycosylation.  Furthermore, there are no homologs of the asp 
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or gap genes found in S. gordonii and S. parasanguinis, respectively.  Additionally, there is 
no known SecA2 substrate encoded in the accessory secA2 locus of mycobacteria. 
On the other hand, the accessory SecA2 locus contains similar genes organized in the 
same way across all species of mycobacteria.  Sequence alignments show that the proteins 
encoded by the genes in the secA2 locus of M. smegmatis are >70% similar to the homologs 
encoded in the M. tuberculosis secA2 locus.  This degree of similarity is comparable for any 
protein conserved between these two organisms.  Three genes downstream of secA2 in both 
M. smegmatis and M. tuberculosis encode proteins with predicted transmembrane domains 
(Table 1.2), but the function of these proteins has not yet been determined.  One possibility is 
that these proteins form a membrane-embedded translocase to export SecA2-dependent pre-
proteins. 
The gene immediately downstream of secA2 encodes PgsA2, a 
phosphatidylglycerolphosphate homolog predicted to function in acidic phospholipid 
synthesis (21, 39).  Since E. coli SecA interacts with acidic phospholipids, perhaps PgsA2 
synthesizes phospholipids that specifically interact with SecA2.  In M. tuberculosis, but not 
M. smegmatis, the gene immediately upstream of secA2 encodes IlvG, a probable 
acetolactate synthase, a key enzyme for biosynthesis of branched chain amino acids.  
Upstream of ilvG is Rv1819c, a predicted ABC (ATP binding cassette) transporter that has a 
homolog in M. smegmatis (Msmeg3655).  ABC transporters are transmembrane proteins that 
use energy from ATP hydrolysis to transport molecules across the cytoplasmic membrane 
(7).  PgsA2, IlvG, and Rv1819c/Msmeg3655 have not been studied in detail so their 
contribution to SecA2-dependent protein export remains unknown.  The mechanism of 
SecA2-mediated protein export is probably very similar among different mycobacterial 
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species, including both pathogens and nonpathogens alike.  However, genomic analysis does 
not support the idea of the mycobacterial SecA2 systems functioning similarly to the 
accessory SecA2/SecY2 systems in Gram positive bacteria.     
 Mycobacterial proteins dependent on SecA2 for export.  In M. smegmatis, two 
proteins that require SecA2 for export to the cell wall were identified by 2D-PAGE.  
Msmeg1704 and Msmeg1712 (YtfQ) are encoded by genes in a putative operon, and possess 
N-terminal signal sequences (31).  Unlike the SecA2-dependent proteins of S. gordonii and S. 
parasanguinis, both Msmeg1704 and Msmeg1712 are predicted lipoproteins and have 
homology to periplasmic sugar binding proteins.  These proteins appear to be genuine 
lipoproteins, as both proteins are enriched by Triton X-114 extraction, a method used to 
isolate lipoproteins.  Additionally, processing of these proteins is inhibited by treatment with 
globomycin, an inhibitor of the lipoprotein signal peptidase (31).  It is worth noting that the 
effect of SecA2 on these lipoproteins is specific; other mycobacterial lipoproteins do not 
require SecA2 for their export.  There are no homologs of Msmeg1704 or Msmeg1712 in M. 
tuberculosis.  However, Msmeg1704 is not correctly processed when expressed in a M. 
tuberculosis ∆secA2 mutant.  This result indicates that the SecA2 systems are functionally 
conserved among mycobacterial species. 
 In M. tuberculosis, SecA2 substrates were discovered by comparing proteins secreted 
into the culture medium from cultures of wild-type and ∆secA2 mutant bacteria (10).  Three 
exported proteins are underrepresented in the ∆secA2 mutant culture filtrate: SodA 
(superoxide dismutase), HspX (Acr, alpha-crystallin), and Rv0390 (protein of unknown 
function).  Unlike the previously identified SecA2-dependent proteins, all three of these 
proteins lack N-terminal signal sequences.  Of these three proteins, SodA was characterized 
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further.  In the absence of SecA2, the amount of SodA exported into the culture medium is 
greatly reduced as shown by immunoblot and enzymatic activity assays (10, 36).  
Additionally, SodA accumulates in the cytoplasm of a ∆secA2 mutant as expected of a true 
SecA2-dependent protein.  KatG (catalase-peroxidase) is also exported into the culture 
medium by M. tuberculosis.  Immunoblot assays show that KatG export depends on SecA2.  
Both SodA and KatG are antioxidant enzymes and could be important for protecting 
intracellular M. tuberculosis from the oxidative burst of macrophages.  Taken together, the 
data obtained from studies of both M. tuberculosis and M. smegmatis consistently shows that 
SecA2 plays a role in exporting a select subset of proteins. 
 It is unclear why the SecA2-dependent proteins identified in M. smegmatis have 
signal sequences and the proteins identified in M. tuberculosis do not.  One possibility is that 
proteins recognized by SecA2 include examples with and without signal sequences.  
Alternatively, SecA2 could recognize features of the mature protein, thereby eliminating the 
need for a signal sequence.  It is also possible that role of SecA2 in exporting unconventional 
exported proteins like SodA is indirect.  In this case, SecA2 exports proteins (not yet 
identified) that constitute a specialized secretion system that specifically recognizes proteins 
without signal sequences like SodA.  An example of this indirect effect is found in the T3SS 
of Yersinia pestis.  YscJ is a Sec-dependent lipoprotein that is part of the needle complex.  
Disruption of YscJ prevents export of Type III effector proteins, none of which has Sec-
dependent signal sequences (60).  To distinguish between these proposed models of SecA2 
function, it is important to identify all the proteins that interact with SecA2 and require 
SecA2 for export out of the cytoplasm. 
 15 
 Role of SecA2 in pathogenesis of M. tuberculosis.  SecA2 is important for virulence 
of M. tuberculosis in both mouse and macrophage infection models.  Mice infected with the 
M. tuberculosis ∆secA2 mutant survive longer than mice infected with wild-type M. 
tuberculosis (10, 41).  Specifically, the ∆secA2 mutant has a growth defect during the early 
part of infection, prior to establishment of the cell-mediated immune response.  Eventually, 
growth of the ∆secA2 mutant plateaus and the bacteria persist for the duration of the 
infection.  The bacterial burden of the ∆secA2 mutant in lungs is lower than that of wild-type 
M. tuberculosis.  During the early phase of infection when the ∆secA2 mutant exhibits a 
defect in mice, M. tuberculosis is growing in macrophages.  In macrophage cell culture, the 
∆secA2 mutant is defective for intracellular growth in comparison to wild-type M. 
tuberculosis (41).  We hypothesize that the role of SecA2 is to promote export of proteins 
important to growth in macrophages.  As mentioned above, the ∆secA2 mutant is defective in 
exporting antioxidant enzymes.  This export defect might partially account for the observed 
macrophage growth defect.  However, the ∆secA2 mutant also has a growth defect in 
macrophages that do not generate an oxidative burst (41).  Therefore, SecA2 must export 
other proteins important for surviving inside host cells.  Since macrophage infected with the 
∆secA2 mutant release more proinflammatory cytokines, one role of SecA2 may be to export 
proteins that modulate the host immune system in response to infection.   
 Interestingly, the ∆secA2 mutant elicits better protective immunity in mice and guinea 
pigs than the vaccine strain M. bovis BCG (36).  The enhanced protection was attributed to 
an increased CD8+ T cell response.  This result further reveals the importance of SecA2 for 
evading protective immune responses of the host. 
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Summary.  It is clear that the mycobacterial accessory SecA2 system is responsible 
for exporting a select subset of proteins and it plays a role in the virulence of M. tuberculosis.  
Nevertheless, little is known about the mechanism of SecA2-dependent protein export in 
mycobacteria.  A better understanding of the SecA2 protein export system has the potential 
to reveal new drug targets or vaccine strategies to combat infection with M. tuberculosis. 
In this work, we undertook experiments to characterize the mechanism of SecA2-
mediated protein export in mycobacteria.  In the following chapters, we discuss biochemical 
and genetic analyses of the accessory SecA2 pathway of M. tuberculosis and M. smegmatis.  
In Chapter 2, we explore similarities and differences between the essential SecA1 protein and 
the accessory SecA2 protein.  We demonstrate that SecA2 is an ATPase, and that ATP 
binding is required for normal SecA2 function in vivo (Chapter 3 and 4).  Using a dominant 
negative secA2 allele, we perform a suppressor screen in M. smegmatis and identify 
important functional domains of SecA2 (Chapter 3).  We also uncover a role for SecA1 in 
exporting SecA2-dependent proteins (Chapter 5).  We conclude with a discussion of our 
initial attempts undertaken to identify SecA2 interacting proteins (Chapter 6).  Taken 
together, these studies represent an important first step for understanding the mechanism of 
SecA2-mediated protein export.  As the SecA2 protein export system is found in several 
mycobacterial pathogens, we hope our studies will help in the search for new treatments for 
mycobacterial disease. 
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Protein sequences were obtained from TIGR and NCBI and 
aligned using ClustalW. 
 
 
Table 1.1  Percent amino acid similarity to B. subtilis SecA 
 
 SecA/SecA1 SecA2 
B. subtilis 100 N/A 
E. coli 65 N/A 
S. gordonii 74 59 
S. parasanguinis 73 60 
S. aureus 78 58 
M. tuberculosis 63 52 
M. smegmatis 66 53 
L. monocytogenes 81 65 
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Table 1.2  Homologous proteins encoded by the accessory SecA2 locus of 
mycobacteria 
 
M. tuberculosis M. smegmatis % similarity TM domain 
Rv1819c Msmeg3655 77 yes 
IlvG N/A N/A no 
SecA2 SecA2 90 no 
PgsA2 PgsA2 82 no 
Rv1823 Msmeg3651 71 yes 
Rv1824 Msmeg3650 94 yes 
Rv1825 Msmeg3649 78 yes 
Protein sequences were obtained from TIGR and NCBI. 
Alignments were performed using ClustalW. 
Transmembrane (TM) domains were predicted using TMHMM (61).  
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Figure 1.1.  The general Sec pathway.  The Sec pathway exports unfolded pre-proteins 
(dark blue ribbon) across the bacterial cytoplasmic membrane.  Pre-proteins are targeted to 
the Sec pathway by an N-terminal signal sequence (yellow box), which is cleaved upon 
export by a signal peptidase (SP, orange) located in the periplasm.  Through repeated cycles 
of ATP binding and hydrolysis, SecA (light blue) undergoes conformational changes and 
powers export of pre-proteins through the membrane-embedded SecYEG translocase (green). 
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Figure 1.2.  Evolutionary relationships of SecA2 proteins.  The phylogenetic tree was 
generated in MEGA4 using the neighbor-joining method.  The length of the branches reflects 
the number of amino acid changes between different SecA2s, as indicated by the bar.  
Bootstrap values are shown at the junctions.  SecA2 sequences were obtained by searching 
all bacterial genome and protein databases available from NCBI and TIGR (as of April 2008) 
for the term SecA.  For organisms with two SecA sequences, the one least like B. subtilis 
SecA was defined as SecA2 and used to build the tree.  For simplicity, only one species of 
Lactobacillus with a SecA2 is included on the tree.  Organisms in red possess two SecY 
homologs. 
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Figure 1.3.  Organization of the genes encoding the accessory SecA2 system.  Similar 
coloring indicates encoded proteins with homology or similar properties.  Genes encoding 
SecA2-dependent substrates are in blue, glycosyltransferases in green, accessory Sec proteins 
in red, accessory SecA2-dependent secretion factors in orange, and biosynthetic enzymes in 
yellow.  Any gene that does not fit in the above categories is white.  Genes encoding proteins 
with predicted transmembrane domains are hatched. 
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 The Sec-dependent translocation pathway is used to export most proteins across the 
cytoplasmic membrane.  Recently, several bacteria, including the pathogen Mycobacterium 
tuberculosis and the non-pathogen M. smegmatis, were shown to possess two SecA 
homologs, SecA1 and SecA2.  SecA1 is essential for general protein export. SecA2 is 
specific for a subset of exported proteins and is important for M. tuberculosis virulence.  The 
mechanism for SecA2-dependent protein export via the accessory Sec system remains poorly 
defined.  We also began to examine differences between SecA1 and SecA2.  Using the 
experimentally determined crystal structure of SecA1 as a guide, we created a computer-
generated homology model of the structure of SecA2, and identified two regions present in 
SecA1 that are absent in SecA2.  We also used differential ultracentrifugation to create 
subcellular fractions of M .smegmatis and determine which compartments contain SecA1 and 
SecA2.  SecA1 was found evenly distributed between cell envelope and cytoplasmic 
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fractions, while SecA2 was predominantly in the cytoplasmic fraction.  Here, we used M. 
smegmatis as a model to characterize the accessory Sec system of mycobacteria.  We 
redesigned a ∆secA2 mutant of M. smegmatis for use in further genetic and biochemical 
analyses.  This mutant had a larger in-frame, unmarked deletion and had the same 
phenotypes as the previously published ∆secA2 mutant.  These results are the first step in 
understanding the unique functions of the two SecA proteins of mycobacteria. 
 
Introduction 
In all bacteria, the general Sec pathway is used to export the bulk of proteins from the 
cytoplasm across the cytoplasmic membrane (15, 42).  Given the substantial role the Sec 
pathway plays in exporting proteins to their proper location, it is not surprising that the Sec 
pathway is essential in all bacteria in which it has been tested.  
Proteins destined for export via the Sec pathway are synthesized as pre-proteins with 
a characteristic N-terminal sorting signal, called a signal sequence.  Signal sequences have a 
tripartite structure: a positively charged N domain, a hydrophobic H domain, and a polar C 
domain (15).  The signal sequence is cleaved off by one of two periplasmic signal peptidases 
(LepB or LspA) during or immediately after transport across the cytoplasmic membrane (62, 
64, 72). Only unfolded pre-proteins are compatible with the Sec pathway.   
The Sec machinery is comprised of a Sec translocase embedded in the cytoplasmic 
membrane.  The Sec translocase is composed of the integral membrane proteins SecY, SecE, 
and SecG (6, 16, 70).  These proteins form a channel through which exported proteins may 
pass.  The SecA ATPase is another protein required for export via the Sec pathway.  As is the 
Sec pathway itself, SecA is essential in bacteria (17).  Through repeated cycles of ATP 
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binding and hydrolysis, SecA ratchets pre-proteins through the SecYEG pore (19, 58).  
Subcellular localization experiments show that SecA is evenly distributed between the cell 
envelope (comprised of membrane and cell wall) and the cytoplasm (7, 18).  This reflects the 
dynamic nature of SecA function in protein export.  SecA interacts with lipids and the Sec 
translocase at the membrane (20, 28).  It also interacts with chaperones, such as SecB, and 
newly synthesized pre-proteins in the cytoplasm (21, 22, 48).  Thus, the presence of SecA in 
both membrane and cytosolic containing fractions is not surprising.  In E. coli, mutations that 
destroy ATPase activity in SecA are unable to complement temperature sensitive secA 
mutants (41).  This demonstrates ATPase activity is required for normal SecA function.  
Further, the SecA ATPase mutant proteins become stably associated with the cell envelope 
(18, 31, 41).  These findings support the idea that ATP binding and hydrolysis is necessary 
for SecA to reversibly associate with the Sec translocase in its role of translocating a protein 
across the membrane.  
Recently, some Gram positive bacteria and mycobacteria were discovered to possess 
two non-redundant SecA homologs (1, 3, 4, 8, 9, 38, 55, 60).  All mycobacteria examined, 
including pathogens and nonpathogens, possess two SecA homologs.  In bacteria with two 
SecAs, the SecA with higher sequence similarity to the canonical SecA of E. coli and B. 
subtilis is called SecA or SecA1.  The other SecA homolog is called the accessory SecA or 
SecA2.  SecA1 of M. tuberculosis is 63% similar to the well-characterized SecA of B. 
subtilis, and SecA1 of M. smegmatis is 66% similar to the canonical SecA protein.  This 
sequence similarity is spread across the length of the protein, including the well-
characterized Walker A and Walker B ATP binding motifs.  Walker box motifs are 
characteristic of ATPases, and conserved among SecA proteins in all bacteria (15, 55, 69).  
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In both M. smegmatis and M. tuberculosis secA1 cannot be deleted, indicating that secA1 is 
an essential gene (3, 4).  Additionally, depletion of SecA1 in M. smegmatis prevents the 
export of the Sec signal sequence-containing protein MspA (26).  Taken together, these 
findings support the notion that in mycobacteria, SecA1 functions as the housekeeping export 
factor similar to SecA of E. coli. 
 SecA2 from M. tuberculosis and M. smegmatis are 52% and 53% similar to B. subtilis 
SecA, respectively.  Notably, the ATP-binding Walker A and Walker B motifs are conserved 
in SecA2 (55).  SecA2 is smaller than SecA1, partially due to a truncation at the C-terminus.  
The first characterization of any SecA2 protein was conducted in M. smegmatis, a fast-
growing saprophytic organism often used as a model to study mycobacterial physiology (3).   
In both M. tuberculosis and M. smegmatis, SecA2 is not essential as in-frame, 
unmarked ∆secA2 deletion mutants have been constructed in both organisms (3, 4).  In both 
species, a deletion in secA2 is associated with several phenotypes.  All of these phenotypes 
can be complemented by introduction of wild-type secA2, which shows the phenotypes of 
∆secA2 mutants are due to absence of SecA2.  The ∆secA2 mutant of M. tuberculosis is 
attenuated for virulence in murine and macrophage infection models, and is defective in 
secreting a small subset of proteins (4, 37).  The M. tuberculosis ∆secA2 mutant also has a 
colony morphology phenotype.  When grown on minimal agar plates containing Tween 80 
detergent, colonies of the ∆secA2 mutant appear smooth and glossy compared to the dull and 
rough colonies of the wild-type parental strain (36).  The ∆secA2 mutant of M. smegmatis 
exhibits a growth defect on rich agar, is hypersensitive to azide and, like the M. tuberculosis 
∆secA2 mutant, is defective in exporting a small subset of proteins (3, 24).  Together, these 
 33 
phenotypic analyses show SecA2 is functional in mycobacteria with a role in exporting a 
specific subset of proteins.   
Interestingly, overexpression of SecA1 does not compensate for a lack of SecA2.  
Conversely, overexpression of SecA2 does not allow construction of a ∆secA1 deletion 
mutant (3).  This shows that SecA1 and SecA2 are not functionally redundant and each has 
distinct roles in mycobacterial protein export. 
In this chapter we discuss experiments designed to begin identifying properties that 
distinguish SecA1 and SecA2.  They reveal similarities and differences that will serve as a 
guide for building and testing a model that describes how SecA1 and SecA2 function in 
protein export.  Many of our experiments to characterize the mechanism of SecA2-mediated 
protein export in mycobacteria used the fast growing non-pathogen M. smegmatis as a model 
system.  M. smegmatis is more convenient to manipulate experimentally than the slow-
growing pathogen M. tuberculosis and it is often used to study basic biological processes of 
mycobacteria(54).  To validate M. smegmatis as a legitimate experimental system for SecA2 
export, we showed that expression of M. smegmatis secA2 restores the ability of the M. 
tuberculosis ∆secA2 mutant to grow in macrophages.  Expression of M. smegmatis SecA2 
also complements the colony morphology of a M. tuberculosis ∆secA2 mutant.  Furthermore, 
expression of M. tuberculosis SecA2 complements the rich agar growth defect and azide 
hypersensitivity of the M. smegmatis ∆secA2 mutant.  Taken together, the results of these 
cross-species complementation experiments show that SecA2 function is conserved between 
M. smegmatis and M. tuberculosis.  These results validate using M. smegmatis as a model 
mycobacterium to study accessory SecA2 protein export. 
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The originally published M. smegmatis ∆secA2 mutant (mc22522) is an in-frame, 
unmarked deletion of approximately one-third of the secA2 gene (3).  The deletion removes 
the predicted Walker B motif of the ATP binding site and it was therefore predicted to 
produce a nonfunctional protein.  As stated above, several phenotypes are reported for 
mc22522, all of which are complemented by introduction of wild-type secA2 into the mutant.  
This supports the notion that this mutant behaves like a null.  However, because mc22522 
should synthesize a truncated protein species, we still worried that the remaining two-thirds 
of SecA2 might complicate analysis of experiments using this ∆secA2 mutant.  To avoid any 
such problems, we constructed a new improved in-frame unmarked deletion mutant of M. 
smegmatis secA2 where only three codons of the original open reading frame (ORF) 
remained.  In this Chapter, we also describe our detailed analysis of this new M. smegmatis 
∆secA2 mutant (NR116) which is used in all subsequent work in this dissertation. 
Our comparative analysis of SecA1 and SecA2 began by comparing the expression 
levels of each protein in M. smegmatis and M. tuberculosis.  So far, this has not been 
performed for any organism possessing two SecA proteins.  Using antibodies specific for 
SecA1 and SecA2, we performed quantitative immunoblots on whole-cell protein lysates 
from wild-type M. smegmatis and M. tuberculosis.  In both cases, we found that the average 
number of moles of SecA2 and SecA1 per mg of protein was nearly equivalent.  This 
indicates that the different functions of SecA1 and SecA2 are not due to a difference in 
expression level. 
Next, we determined the subcellular localization pattern of SecA1 and SecA2 in M. 
smegmatis.  In E. coli, SecA is evenly distributed between cell envelope and cytoplasmic 
fractions.  We generated subcellular fractions of M. smegmatis and performed immunoblot 
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analysis to determine the location of SecA1 and SecA2.  SecA1 was equally distributed 
between cell envelope and cytoplasmic fractions, further supporting the notion that SecA1 is 
the canonical SecA of mycobacteria.  In contrast, SecA2 was found predominantly in the 
cytoplasmic fraction.  These results reveal a distinguishing feature of SecA1 and SecA2, and 
it also provides a useful assay for future studies of SecA2 in mycobacteria. 
Finally, we performed a comparison of the sequences and structures of SecA1 and 
SecA2.  Sequence alignments show a high degree of similarity (~50%) between SecA1 and 
SecA2, even though SecA2 is 20 kDa smaller than SecA1.  The crystal structure of M. 
tuberculosis SecA1 is solved (59), but the structure of M. tuberculosis SecA2 has not been 
determined.  Using a computer-generated homology model of SecA2, built on to the crystal 
structure of SecA1, we identified potential structural differences between these two proteins.  
While strikingly similar across most of the structure, two regions present in SecA1 are 
notably absent in SecA2.  We believe this model will be a useful tool in designing future 
experiments to characterize the accessory SecA2 protein of mycobacteria. 
 
Materials and Methods 
Bacterial strains and culture conditions.  Middlebrook 7H9, 7H10, 7H11, and Mueller 
Hinton media (BD Biosciences) were used for growing M. smegmatis.  For M. smegmatis, 
the growth medium was supplemented with 0.2% (w/v) glucose, 0.5% (w/v) glycerol, and 
0.1% (w/v) Tween 80 (Fisher).  For growing M. tuberculosis, 7H9 or 7H10 supplemented 
with 0.5% (w/v) glycerol and 1X ADS (0.5% (w/v) bovine serum albumin, 0.2% (w/v) 
dextrose, and 0.85% (w/v) NaCl) was used.  When needed, kanamycin (Acros Chemicals) or 
hygromycin (Roche) was added to medium at 20 µg/ml or 50 µg/ml, respectively.  LB was 
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used to grow E. coli cultures.  When needed, kanamycin or hygromycin was added at 40 
µg/ml or 150 µg/ml, respectively.  The identity of all vectors used in this study was 
confirmed by DNA sequencing (UNC-CH automated DNA sequencing facility and Eton 
Biosciences). 
Macrophage infections. Bone marrow macrophages were elicited from femurs of C57BL/6 
mice, as described previously (37, 40), and 2.5 x 105 macrophages were seeded into wells of 
8-well-chamber slides 24 h prior to infection.  The M. tuberculosis strains were grown to 
mid-exponential phase, washed with phosphate-buffered saline containing 0.05% (w/v) 
Tween 80, diluted in tissue culture medium (Dulbecco’s modified Eagle’s medium 
supplemented with 10% heat-inactivated fetal calf serum, 2 mM glutamine, and 1X 
nonessential amino acids [Gibco]) and added to the macrophage monolayer to achieve a 
multiplicity of infection of 1.0.  Macrophage monolayers were infected with M. tuberculosis 
strains for 4 h at 37°C in 5% CO2.  On days 0, 1, and 5 post-infection, the contents of 
triplicate wells for each infection were washed to remove extracellular bacilli and then lysed 
with 0.05% (w/v) Tween 80.  The resulting lysates were diluted and plated on Middlebrook 
7H10 agar to enumerate intracellular bacteria during the course of infection. 
Homology model of M. tuberculosis SecA2.  To generate a structural model of SecA2, we 
entered the protein sequence of M. tuberculosis SecA2 into the 3D-PSSM server (33).  This 
web tool compares the input sequence against a library of experimentally determined 
structures and scores compatibility between sequence and structure.  The result was an 
alignment of SecA2 with M. tuberculosis SecA1 (PDB accession 1NKT (resolution 2.6 Å)) 
(59).  Included in this alignment is a prediction of secondary structure for the input sequence 
(SecA2) along with the actual secondary structure for SecA1.  Using this alignment, as well 
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as a raw sequence alignment generated using ClustalW, we determined where several 
insertions and deletions in SecA2 should be placed.  This was achieved by comparing the 
sequence alignments versus the local environment of the SecA1 amino acids in the crystal 
structure.  By examining the side chains of the amino acids that flank an insertion or deletion, 
we decided whether the position of a given insertion/deletion made structural sense.  We then 
generated the homology model using Insight II (Accelrys, Inc.).  To assess the validity of the 
model, we used the Profiles3D/verify function in Insight II to determine self-compatibility 
scores. 
Subcellular fractionation.  Cell envelope and soluble fractions were prepared by differential 
ultracentrifugation as described previously (24).  Briefly, 100 ml cultures of M. smegmatis 
grown in Mueller Hinton were harvested by centrifugation at 3,000 x g.  Cell pellets were 
resuspended in 4 ml of breaking buffer (PBS, 0.6 µg/ml each of DNase and RNase, and a 
cocktail of protease inhibitors (2 µg/ml each of aprotinin, E-64, leupeptin, and pepstatin A 
and 100 µg/ml Pefabloc SC) and then lysed by five passages in a French pressure cell.  
Unbroken cells were pelleted at 3,000 x g for 20 min to generate a clarified whole cell lysate, 
which was centrifuged at 100,000 x g for 2 h to separate the cell envelope (pellet) fraction 
from the soluble fraction (supernatant).  The cell envelope fraction was washed once and 
then resuspended in PBS.   
Immunoblot conditions.  The anti-SecA2, anti-GroEL (HAT5/IT-64 from the World Health 
Organization collection), anti-MspA (gift from Michael Niederweis, (45)), and anti-HA 
(Covance) antibodies were used at 1:20,000 dilutions.  The anti-SecA1 antibody was used at 
a 1:50,000 dilution.  For most experiments, secondary antibodies conjugated to HRP (Biorad) 
were used along with ECL (Perkin Elmer) and film (Denville) to visualize blots.  For 
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quantitative immunoblots, whole-cell lysates of exponential phase M. tuberculosis cultures 
grown in Middlebrook 7H9 medium were prepared following fixation in an equal volume of 
10% (w/v) formalin for 1 h.  Fixed cells were pelleted by centrifugation, resuspended in 
extraction buffer, and lysed by bead beating.  For quantitative SecA1 and SecA2 Western 
blot analysis, 100 µg of formalin-fixed whole-cell lysates were electrophoresed on a 12% 
sodium dodecyl sulfate (SDS)-polyacrylamide gel alongside known amounts of purified 
SecA1 or SecA2 protein (29).  Proteins were transferred to nitrocellulose membranes and 
probed with rabbit polyclonal anti-SecA1 (1:50,000 dilution) or anti-SecA2 (1:20,000 
dilution) antibody.  The secondary antibody was goat anti-rabbit conjugated to alkaline 
phosphatase (1:20,000 dilution), and detection of the fluorescence from ECF (Amersham/GE 
Healthcare) was done with a PhosphorImager (Molecular Dynamics).  The signal intensity 
values from six independently prepared whole-cell lysates were quantified by comparison 
with standard curve values to determine the number of moles of SecA1 and SecA2 per mg of 
cellular protein. 
secA2 suicide plasmid pNR6.  Sequences immediately upstream and downstream of secA2 
were PCR amplified from M. smegmatis genomic DNA using primers 5’-
GTCGACCGACAGGTTCCAGCCGTAGAA-3’ / 5’-
GTCGACCACGGCGTCAGTTGTGCCTCG-3’ and 5’-
GTCGACTAGGCCCCAGCCATTAGGTTC-3’ / 5’-
TGATATCGAGCACCTCCCAGCCCCATTC-3’, respectively.  SalI restriction sites were 
added to the ends of the upstream PCR product which was then cloned into the vector pCC1 
using the Copy Control PCR cloning kit (Epicentre) to generate pNR3.  The 901 bp 
downstream PCR product was engineered to contain a 5’ SalI site, and was cloned into the 
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vector pCR2.1 (Invitrogen) to generate pNR4.  A 1087 bp SalI fragment of pNR3 was ligated 
into SalI-cut pNR4.  The resulting plasmid, pNR5, contained a 2385 bp deletion of secA2 
leaving only three codons.  A 1737 bp MscI-EcoRV fragment containing the secA2 deletion 
was cut from pNR5 and cloned into the EcoRV site of the counterselectable suicide plasmid 
pMP62, yielding vector pNR6.   
Two step allelic exchange.  The ∆secA2 mutant strain NR116 was constructed by two step 
allelic exchange as described previously (2, 50).  Wild-type M. smegmatis strain mc2155 was 
electroporated with pNR6, and hygromycin-resistant transformants were selected on 7H10 
plates.  Transformants were screened by Southern blot to identify a single-crossover 
integration of pNR6 at the chromosomal secA2 locus in strain SCO5.  To resolve the single 
crossover strain, a saturated culture (7H9 0.2% glucose, 0.5% glycerol, 0.1% Tween 80, 
hygromycin 50 µg/ml) of SCO5 was diluted 1:100 into 7H9 without hygromycin and grown 
overnight at 37˚C.  This culture was plated onto 7H10 supplemented with 4.5% (w/v) sucrose 
to select against the sacB marker encoded on the backbone of the suicide vector.  Sucrose-
resistant clones were screened for hygromycin sensitivity.  Then sucrose-resistant, 
hygromycin-sensitive clones were screened by PCR and Southern blot for evidence of a 
second recombination event leading to chromosomal deletion of secA2.  The resulting in-
frame, unmarked ∆secA2 deletion mutant derived from SCO5 was named NR116. 
Southern blot analysis of SCO5 and NR116.  Southern blot analysis was performed as 
previously described (56).  Briefly, genomic DNA was isolated from M. smegmatis strains 
and digested with BamHI.  The probe used was a 1093 bp PCR product containing the 
sequence immediately upstream of secA2.  The probe was labeled with [32P]dCTP using the 
Ready-to-Go labeling kit (Amersham). 
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Azide assay.  200 µl of saturated (OD600nm = 2.0) M. smegmatis culture was mixed with 3.5 
ml of molten 7H9 top agar, and then poured onto a 7H10 bottom agar plate.  After the top 
agar cooled, sterile 6 mm filter discs were placed onto the surface.  10 µl of 0.15 M sodium 
azide was then added to the disc.  The plates were inverted and incubated for 2 days at 37˚C.  
After incubation, any resulting zone of inhibition on the plate was measured.  Each strain was 
tested in triplicate, and untreated plates were included as a control. 
Agar plate growth assays.  All M. smegmatis strains were grown in 7H9 medium at 37˚C 
prior to plating.  Serial dilutions of each strain were made in 7H9 and then plated onto the 
appropriate agar medium.  All plates were incubated at 37˚C until colonies were visible. 
 
Results 
M. smegmatis is a valid model for studying the M. tuberculosis SecA2 system.  M. 
tuberculosis is difficult to manipulate experimentally because it is extremely slow growing 
and requires containment in a BSL3 laboratory.  As a result, the fast growing nonpathogen 
M. smegmatis is often used as a model mycobacterium (54).  Throughout this work, we take 
advantage of M. smegmatis as a convenient tool to study SecA2-mediated protein export in 
mycobacteria.  It is already known that expression of M. tuberculosis SecA2 can complement 
the rich agar growth defect and azide hypersensitivity phenotypes of the M. smegmatis 
∆secA2 mutant (3).  In order to validate using M. smegmatis as a model to study M. 
tuberculosis SecA2 export, we tested the ability of M. smegmatis secA2 to complement two 
phenotypes of the M. tuberculosis ∆secA2 mutant: a growth defect in macrophages and a 
smooth colony morphology when grown on plates containing Tween 80. 
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M. smegmatis secA2 complements the macrophage growth defect of a M. 
tuberculosis ∆secA2 mutant.  Unlike the wild-type M. tuberculosis H37Rv strain which can 
infect and grow inside macrophages over a period of several days, the ∆secA2 mutant is 
defective in intracellular growth (37).   A ∆secA2 mutant of M. tuberculosis is attenuated for 
growth in macrophages and in mice (4, 37).  Introduction of a wild-type copy of M. 
tuberculosis secA2 at the attB locus complements the mutant phenotype.  Here we tested if 
the M. smegmatis secA2 gene can also complement the M. tuberculosis ∆secA2 mutant 
phenotype.  Murine bone marrow-derived macrophages were infected with wild-type M. 
tuberculosis (H37Rv), ∆secA2 mutant mc23112 (∆secA2), the ∆secA2 mutant complemented 
with wild-type M. tuberculosis secA2 (∆secA2/Mtb secA2), or the ∆secA2 mutant expressing 
wild-type M. smegmatis secA2 (∆secA2/Msm secA2) (Figure 2.1A).  As shown previously 
(37), H37Rv and the ∆secA2 mutant complemented with M. tuberculosis secA2 grew 
similarly in macrophages over a 5-day period of infection while the ∆secA2 mutant failed to 
grow in these macrophages. Introduction of M. smegmatis secA2 in single copy at the 
chromosomal attB site in the mutant also fully restored the ability of the ∆secA2 mutant to 
grow in macrophages.  Western blot analysis confirmed that the ∆secA2 mutant strains 
carrying either M. tuberculosis or M. smegmatis secA2 expressed the corresponding SecA2 
protein at similar levels (data not shown).  These results indicated that M. smegmatis SecA2 
was able to promote growth of M. tuberculosis in macrophages, just like M. tuberculosis 
SecA2.    
Expression of M. smegmatis secA2 complements the smooth colony morphology 
of the M. tuberculosis ∆secA2 mutant.  The colony morphology of the M. tuberculosis 
∆secA2 mutant has been described previously (36).  In contrast to the dull, rough, irregularly 
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shaped colonies of wild-type M. tuberculosis, colonies of the ∆secA2 mutant are round and 
smooth with a glossy appearance.  This phenotype could indicate a difference in composition 
of the cell envelope between the two strains.  Notably, this difference is only detected when 
the bacteria are grown on media containing Tween 80.  When grown on 7H10 plates without 
Tween 80, wild-type and ∆secA2 mutant colonies are indistinguishable.  The rough colony 
morphology can be restored in the ∆secA2 mutant by expression of a wild-type copy of M. 
tuberculosis secA2. 
To further test the ability of M. smegmatis secA2 to complement the M. tuberculosis 
∆secA2 mutant, we grew the bacterial strains described in Figure 2.1A on 7H10 plates 
supplemented with 0.05% Tween 80.  After 3 weeks of growth, plates were removed from 
incubation and photographed.  As shown in Figure 2.1B, the ∆secA2 mutant is noticeably 
smoother than H37Rv.  Expression of M. tuberculosis secA2 is able to restore the rough 
colony morphology to the ∆secA2 mutant.  As expected, when M. smegmatis secA2 is 
expressed in the ∆secA2 mutant, the colonies appear rough (Figure 2.1B).  This provides 
further indication that M. smegmatis secA2 is able to function normally in M. tuberculosis.  
Together, these data showed that M. smegmatis SecA2 can substitute for M. tuberculosis 
SecA2 during growth in macrophages and under standard laboratory conditions.  We believe 
our findings show functional conservation between M. tuberculosis SecA2 and M. smegmatis 
SecA2; this provides strong justification for using M. smegmatis as a model to understand 
how SecA2 functions in protein export. 
Construction and characterization of a complete in-frame unmarked deletion of 
M. smegmatis secA2.  Previously, a 1296 bp ∆secA2 deletion mutant (mc22522) was 
constructed in M. smegmatis and used to assess the function of SecA2 (3).  The deletion in 
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this mutant spans the ATP binding site of SecA2 (Figure 2.2A).  Several in vitro phenotypes 
are reported for this mutant, including a growth defect on rich agar plates, hypersensitivity to 
sodium azide, and an export defect of the lipoproteins Msmeg1704 and Msmeg1712 (3, 24).  
Expression of a wild-type secA2 allele in trans complements these phenotypes, showing that 
the phenotypes are attributable to the deletion in secA2.   
Another phenotype observed in earlier studies is that while overexpression of SecA1 
has no effect on wild-type M. smegmatis, overexpression of SecA1 in mc22522 exacerbates 
the rich agar growth defect of the ∆secA2 mutant (3).  This synthetic phenotype suggests a 
relationship between SecA1 and SecA2 or their respective export pathways.  The ∆secA2 
deletion allele in mc22522 still encodes a protein of 366 amino acids, although no truncated 
SecA2 protein is observed by immunoblot (data not shown).  In other bacteria, SecA is 
capable of forming dimers (12, 14, 31, 46).  Thus, it is possible that the SecA proteins of 
mycobacteria also form dimers, perhaps even SecA1/SecA2 heterodimers.  We considered 
the possibility that a truncated SecA2 protein might have dominant effects through 
interfering with SecA1-protein complexes and thereby produce the observed phenotype.  To 
eliminate this potentially complicating factor, we constructed a new M. smegmatis ∆secA2 
mutant in which the secA2 gene is fully deleted and only three codons remain.  This strain, 
NR116, was then used for the remainder of this thesis work as an improved M. smegmatis 
∆secA2 mutant. 
 To construct the new ∆secA2 mutant, we performed allelic exchange using a two-step 
counterselectable system (50).  Wild-type M. smegmatis (mc2155) was electroporated with 
the suicide plasmid pNR6 (Figure 2.2B).  This plasmid lacks a mycobacterial origin of 
replication, and contains markers for hygromycin resistance (hygR) and sucrose sensitivity 
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(sacB).  Hygromycin-resistant transformants were selected on 7H10 plates and then analyzed 
by Southern blot to confirm recombination of the deletion allele into the secA2 chromosomal 
locus, yielding the single-crossover strain SCO5 (Figure 2.2D).  Upon counterselection for 
sucrose resistance, the integrated suicide vector will undergo a second recombination event, 
either yielding a ∆secA2 deletion mutant (Figure 2.2E) or regenerating the starting wild-type 
secA2 allele (Figure 2.2C) without the intervening suicide vector backbone.  Sucrose resistant 
colonies were screened for hygromycin sensitivity, which reports on loss of the vector 
backbone.  SucR HygS clones were analyzed by PCR and Southern blot until we identified 
NR116 as a ∆secA2 deletion mutant (Figure 2.2F). 
After constructing NR116, immunoblot analysis of whole cell lysates confirmed that 
SecA2 is no longer present in this new ∆secA2 mutant.  As expected, deletion of SecA2 in 
NR116 had no effect on expression of SecA1 (Figure 2.3A).  NR116 was then tested for all 
the previously reported phenotypes of mc22522 (3, 24).  When grown on rich Mueller Hinton 
agar, NR116 colonies were smaller than colonies of wild-type M. smegmatis.  The phenotype 
of NR116 was indistinguishable from that of the original ∆secA2 mutant mc22522 on rich 
agar (Figure 2.3B).  As reported previously, neither secA2 mutant exhibited a mutant 
phenotype when growing on minimal 7H10 agar media (3).  We also tested NR116 for 
sensitivity to sodium azide.  Sodium azide is known to target ATPases.  In bacteria, the major 
target of azide is SecA (23).  NR116 was more sensitive to azide than wild-type M. 
smegmatis; again the phenotypes of the ∆secA2 mutants NR116 and mc22522 were 
indistinguishable from each other (Figure 2.3C).  All these phenotypes associated with 
NR116 could be complemented by expressing a wild-type copy of M. smegmatis secA2 on a 
plasmid vector.   
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We were particularly interested in retesting the exacerbated phenotype resulting from 
SecA1 overexpression in NR116.  The results with NR116 were the same as shown 
previously with mc22522 (3); overexpression of SecA1 exacerbated the rich agar and azide 
hypersensitivity phenotypes of both secA2 mutants.  Since the same phenotype is observed 
when SecA1 is overexpressed in NR116, it eliminates the possibility that a truncated SecA2 
protein in the original mutant mc22522 was responsible for the phenotype (Figure 2.4).  This 
overexpression of SecA1 shows the inability of SecA1 to suppress secA2 mutant phenotypes, 
and it also reveals a synthetic phenotype between high level SecA1 expression and absence 
of SecA2.  We think this synthetic phenotype reflects a relationship between SecA2 and 
SecA1 or the general Sec Pathway.   
New ∆secA2 mutant phenotypes in M. smegmatis.  During the course of these 
experiments, we attempted to narrow down the property or component of rich agar that 
accounts for the M. smegmatis ∆secA2 mutant growth defect.  We considered the possibility 
that the salt concentration in Mueller Hinton agar is higher than in 7H10 minimal agar and 
that the ∆secA2 mutant might be more sensitive to media with a higher salt concentration.  
Mueller Hinton is a complex medium that includes digested casein and beef extract; thus, the 
exact chemical composition of this medium is not known.  7H10 is a defined medium; the 
identity and proportion of each chemical component is known.  Given the colony phenotype 
displayed by the M. tuberculosis ∆secA2 mutant and the growth defect exhibited by the M. 
smegmatis ∆secA2 mutant on rich agar, we hypothesized that SecA2 might be important for 
assembling the protective cell envelope of the bacteria.  One possible consequence of 
defective cell envelope assembly in the ∆secA2 mutant could be sensitivity to high salt.  To 
test this possibility, we supplemented standard 7H10 agar with 0.5 M NaCl.  Normally, 7H10 
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does not contain any NaCl.  Wild-type, the ∆secA2 mutant NR116, and a complemented 
mutant strain were plated onto this high salt medium (Figure 2.5).  Compared to standard 
7H10 plates, all strains grew substantially slower on the salt-containing plates.  In 
comparison to wild-type and the complemented strain, the ∆secA2 mutant showed a growth 
defect on 7H10 salt plates.  Normally, when grown on standard 7H10 plates there is no 
difference in growth between wild-type and ∆secA2 mutant M. smegmatis.  Thus, it seems 
the salt concentration of agar media has an impact on the rate of growth of the ∆secA2 
mutant. 
7H11 is a commonly used mycobacterial growth medium.  The composition of this 
medium is very similar to 7H10, with the notable addition of digested casein.  Digest of 
casein is also a component of Mueller Hinton.  M. smegmatis strains were plated onto 
Mueller Hinton, 7H11, or 7H10 supplemented with casein and incubated at 37˚C for 4 days.  
As shown in Figure 2.5, colonies of the ∆secA2 mutant are slightly smaller than colonies of 
wild-type M. smegmatis when grown on media containing casein.  Thus, casein digest is at 
least part of the explanation for why the ∆secA2 mutant exhibits a growth defect on Mueller 
Hinton agar.   
The ∆secA2 mutant might be sensitive to a specific component of casein digest that 
slows its rate of growth on agar.  Casein digest is rich in amino acids and other metabolic 
precursors, possibly including a high concentration of salt.  Another possibility is that the 
rich agar growth defect of the secA2 mutant is a consequence of growth rate.  Wild-type M. 
smegmatis colonies appear one day earlier on rich media than on minimal media.  When 
growing faster, a modest defect of the ∆secA2 mutant may become more evident.  If the 
∆secA2 mutant is compromised in cell envelope assembly or some other essential process, it 
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might take longer for colonies to form on rich agar.  In any case, more work is required to 
determine the true cause of the rich agar growth defect. 
SecA1 and SecA2 proteins are present in equivalent amounts in mycobacteria.  
The identification of bacteria that possess two SecA proteins is a relatively new discovery 
(55).  Unlike SecA1, the SecA2 protein of mycobacteria has a limited role in exporting a 
select subset of proteins (4, 24).  As a starting point to understanding the different roles of 
each SecA protein, we determined the relative amounts of SecA1 and SecA2 inside the 
bacterial cell. Quantitative immunoblot analysis was performed with whole-cell lysates 
prepared from the virulent M. tuberculosis strain H37Rv or wild-type M. smegmatis mc2155, 
using antibodies specific to each SecA protein. These antibodies were raised against peptides 
specific for SecA1 or SecA2, and they recognize only the respective protein.  By comparison 
to standard curves of purified M. tuberculosis SecA1 and SecA2 proteins (gift from Carol 
Teschke, University of Connecticut), quantitative immunoblots were used to determine the 
number of moles of SecA1 or SecA2 protein per mg of cellular protein.  The results, from an 
evaluation of six independent whole-cell lysates, revealed nearly equivalent amounts of each 
protein (29, Chapter 4). In M. tuberculosis, the ratio of the average number of moles per mg 
of protein of SecA2 (2.07 x 10-11) to that of SecA1 (2.25 x 10-11) across these experiments 
was 0.93 +/- 0.12 (standard error). In M. smegmatis, the ratio was again similar (1.13 +/- 0.07 
standard error).  This indicates that differences between SecA1 and SecA2 are not due to 
different levels of expression, at least under standard laboratory conditions.  Further, these 
data reveal similar results with M. tuberculosis and M. smegmatis SecA1 and SecA2 proteins.   
SecA1 is equally distributed between cell envelope and soluble fractions, while 
SecA2 is predominantly cytoplasmic.  Previous studies show SecA1 and SecA2 are not 
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functionally redundant; one SecA protein can not compensate for the absence of the other 
(3).  However, little is known about properties that distinguish SecA1 and SecA2 function 
inside the cell.  We generated cell envelope and soluble fractions of M. smegmatis and used 
SDS-PAGE and quantitative immunoblot analysis with anti-SecA1 and anti-SecA2 
antibodies to determine the subcellular localization of the respective proteins.  The cell 
envelope fraction contains cytoplasmic membrane and cell wall while a soluble fraction 
contains the cytosol.  The purity of each fraction was assessed by immunoblots for the cell 
wall protein MspA (Mycobacterium smegmatis porin A) and the soluble cytoplasmic 
chaperone GroEL.  As shown by quantitative anti-SecA1 immunoblots, SecA1 was found 
equally distributed between cell envelope (47 +/- 3%) and soluble (53 +/- 3%) fractions 
(Figure 2.6A and D).  This result is like that reported for E. coli SecA, where the single 
essential SecA is evenly distributed between cell envelope and soluble fractions (7).  This 
data is consistent with SecA1 being the “housekeeping” secretion factor of mycobacteria, 
analogous to SecA of E. coli. 
In contrast to SecA1, SecA2 was predominantly localized to the soluble fraction (80 
+/- 10%) instead of the cell envelope (20 +/- 10%) (Figure 2.6A and E).  The same 
subcellular fractionation was also performed on the ∆secA2 mutant NR116 (Figure 2.6B).  
As expected, no SecA2 is detected in that strain which demonstrates the anti-SecA2 antibody 
specificity.  Furthermore, we also found that the absence of SecA2 had no impact on 
expression or localization of SecA1.  In a ∆secA2 mutant strain complemented with a wild-
type copy of M. smegmatis secA2, localization of SecA1 and SecA2 was the same as in wild-
type M. smegmatis (56 +/- 5% soluble vs. 44 +/- 5% cell envelope) (Figure 2.6C-E).  This 
 49 
indicates that the complementation vector used in our study produces SecA2 protein that 
localizes normally.   
These results reveal an interesting difference between SecA1 and SecA2.  It indicates 
that SecA1 behaves like the canonical SecA in being equally distributed between cell 
envelope and soluble fractions.  In contrast, SecA2 is not equally distributed but, rather, 
enriched in the soluble fraction.  This suggests significant differences in the role played by 
SecA2 versus SecA1 in directing protein export.  Furthermore, by showing that the absence 
of SecA2 does not effect localization or expression of SecA1, it is clear that phenotypes of 
the ∆secA2 mutant are not due to an effect on SecA1 activity.   
Predicted structural differences between M. tuberculosis SecA1 and SecA2.  
Although the crystal structure of M. tuberculosis SecA1 has been solved (59), a crystal 
structure for SecA2 is not yet available.  In the absence of an experimentally determined 
structure, we built a computer-generated model of SecA2 based on homology to SecA1 
(Figure 2.7A).  The model we constructed was a monomer of SecA2 built on a monomer of 
SecA1.  To assess the validity of the model, we used the Profiles3D/verify function in Insight 
II to determine self-compatibility scores.  This function checks if the structure assigned to a 
particular stretch of amino acids in the model is physically able to form.  The score for the 
SecA2 model was 282.69; the expected score for a protein of this size is 330.86.  For proteins 
this large, a score of 148.88 or less indicates an incorrect model.  For comparison, we 
repeated the self-compatibility analysis for SecA1.  The score was 360.31.  For proteins of 
this size, the expected score is 376.61 and a score less than 169.47 is likely incorrect.   
 The crystal structure of M. tuberculosis SecA1 resembles the crystal structures of 
other SecA proteins (30, 47, 59, 65).  From the genetic and biochemical analyses done with 
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E. coli and B. subtilis, SecA proteins can be divided into two large domains, the N-domain 
and the C- domain.  Within these two domains, several structural subdomains that have been 
defined (15, 49, 67).  As shown in Figure 2.7, the N-domain of SecA1, also known as the 
DEAD motor, consists of two subdomains called NBD1 (nucleotide binding domain, dark 
blue) and IRA2 (intramolecular regulator of ATPase activity, cyan).  The highly conserved 
Walker A and Walker B motifs are found in the cleft formed between these two subdomains.  
ATP is bound within this cleft.  When separated from the C-domain, the N-domain of SecA 
is still able to bind and hydrolyze ATP (32, 51). 
The C-domain of SecA is divided into several substructures.  Several α-helixes are 
collectively known as the α-helical scaffold domain (HSD).  Included in this subdomain is 
the staple domain (SD, green) that joins the N-domain and C-domain together.  In the HSD 
are also two α-helixes that form the regulatory region IRA1 (yellow).  IRA1 modulates the 
ATPase activity of SecA (68).  Also in the C-domain are the pre-protein crosslinking domain 
(PPXD, pink), the α-helical wing domain and the C-terminal linker (HWD and CTL, 
respectively; red).  As expected from its name, SecA contacts pre-protein substrate via the 
PPXD (34, 43, 48).  However, it is important to note this has only been experimentally 
demonstrated for a single pre-protein, pro-OmpA in E. coli.  Activities that map to the CTL 
of E. coli include binding to phospholipids, binding to the chaperone protein SecB, and 
binding to a Zn2+ ion (5, 13, 21).  However, the corresponding CTL region of M. tuberculosis 
SecA1 does not contain residues for a Zn2+ binding motif.  The absence of the SecB/Zn2+ 
binding site is not surprising since there is no SecB homolog in M. tuberculosis (11).  The 
function of the HWD is not understood.  Taken together, the structural subdomains of M. 
tuberculosis SecA1 are organized equivalently to E. coli and B. subtilis SecA. 
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Comparing the homology model of SecA2 to SecA1 reveals similarities and 
differences.  The overall structures are highly similar.  The nucleotide binding domains are 
nearly identical between the two proteins and SecA2 shares most of the subdomains in the 
SecA1 C-terminus and each domain is similarly structured.  However, two regions are 
notably predicted as being absent in SecA2.  The model predicts that SecA2 lacks the so-
called Gram negative loop (orange) that is found within the IRA2 subdomain (25).  Sequence 
alignments show that this region is present in all Gram negative SecA proteins but absent 
from Gram positive SecAs.  This finding is interesting given that mycobacteria are neither 
Gram positive nor Gram negative.  The function of this loop is not known.  Part of the 
CTL/HWD is also missing in the SecA2 model.  Loss of the Gram negative loop and part of 
the HWD/CTL account for the 20 kDa size difference between SecA1 and SecA2.  The 
functional significance of the missing subdomains in SecA2 is not clear.  Perhaps these 
subdomains are import for substrate recognition and thus sort pre-proteins to the appropriate 
SecA protein.  Alternatively, these domains could be important for specifying interactions 
with different translocases.  Using the homology model as a guide, detailed studies of each 
SecA2 subdomain can now be performed to characterize the mechanism of SecA2 function. 
 
Discussion 
In this Chapter, we sought to characterize SecA1 and SecA2 by comparing the 
similarities and differences between these two proteins.  We started by asking basic questions 
about SecA1 and SecA2: Are they present in equal amounts?  Are they localized in the same 
subcellular compartments?  What accounts for the difference in size of each protein?  We 
identified some similar features but we also uncovered differences.  Also in this Chapter, we 
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performed experiments to justify the use of M. smegmatis as a model system, and developed 
new genetic and biochemical tools to use in our studies of the accessory SecA2 system of 
mycobacteria. 
M. smegmatis is a valid model for studying the accessory SecA2 system of 
mycobacteria.  In two separate assays, we showed that M. smegmatis SecA2 can substitute 
for M. tuberculosis SecA2.  The intracellular growth defect in macrophages and the colony 
morphology phenotype of the M. tuberculosis ∆secA2 mutant were both complemented by 
M. smegmatis secA2 expressed from a plasmid integrated into the chromosome in single-
copy.  These cross-species complementation experiments demonstrate M. smegmatis SecA2 
can fulfill the role of SecA2 in M. tuberculosis.  It supports our use of M. smegmatis as a 
model system to study SecA2-mediated protein export. 
A new in frame, unmarked deletion mutant of M. smegmatis secA2 has the same 
phenotypes as the original ∆secA2 mutant.  The initial secA2 mutant of M. smegmatis 
(mc22522) is an in-frame deletion mutant.  It was used to show SecA2 is not essential but is 
functional in M. smegmatis (3, 24).  The deletion in secA2 in mc22522 is not complete, but 
encompasses the ATP binding Walker B motif which is conserved in all SecA homologs.  By 
deleting this critical region, it was predicted the resulting ∆secA2 mutant would behave like a 
null mutant.  Successful complementation experiments in mc22522 confirmed this prediction.  
However, much of the SecA2 coding sequence remains in mc22522.  As subdomains of E. 
coli SecA are able to fully function alone, we worried that the truncated SecA2 species might 
interfere with SecA2-interacting protein complexes and complicate our subsequent genetic 
and biochemical analyses.  For this reason, this thesis work started with the construction of 
an improved in-frame, unmarked full deletion of M. smegmatis secA2 where only 3 codons 
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remained of the original ORF.  This mutant, NR116, was tested in a battery of phenotypic 
assays and in all cases exhibited phenotypes identical to those of the original ∆secA2 mutant.  
In Chapter 4, we further show that, like mc22522, NR116 is unable to export Msmeg1704 
and Msmeg1712.  Even though comparison of mc22522 and NR116 did not reveal any 
differences, we still chose to use NR116 in our subsequent studies.   
During the course of our analysis of NR116, we also discovered new phenotypes.  
When grown on minimal agar supplemented with excess sodium chloride, NR116 colonies 
are smaller compared to wild-type M. smegmatis.  The added osmotic pressure caused by 
high salt may be revealing a structural defect in the cell envelope of the ∆secA2 mutant.  One 
of the functions of the cell envelope is to act as a barrier to the external environment, and to 
provide structural integrity to the bacterial cell.  If SecA2 is involved in establishing the 
proper cell envelope architecture, then the ∆secA2 mutant may not be as effective at resisting 
stresses to the envelope like increased osmotic pressure.  There are many examples of cell 
envelope proteins that are required for growth under high salt conditions (35, 39, 66).  
Interestingly, Vibrio cholerae Type II secretion mutants have outer membrane defects and 
thus are more sensitive to a variety of compounds including bile salts (61). 
We also found that the ∆secA2 mutant has a growth defect on 7H11 agar.  One 
component found in 7H11 agar, but absent from 7H10 minimal agar, is digested casein.  
Casein is also a component of Mueller Hinton agar.  Accordingly, supplementation of 7H10 
agar with casein also resulted in a smaller colonies for ∆secA2 mutant NR116.  The ∆secA2 
mutant also has growth defect on LB agar (data not shown).  We do not understand why 
growth on a nutrient source rich in amino acids or high in salt is detrimental to the ∆secA2 
mutant.  One possibility is that some component of rich agar is toxic to ∆secA2 mutant.  In 
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this model, the ∆secA2 mutant is unable to export a factor required to metabolize this toxic 
component.  SecA2 might also export proteins that protect the cell from external stresses like 
increased osmotic pressure.  Another possibility is that by increasing the growth rate of M. 
smegmatis on rich agar, a minor subtle phenotype becomes apparent.  Without knowing the 
exact cause of the rich agar growth defect, it is difficult to distinguish between these 
possibilities.   It is worth mentioning that the growth defect of the ∆secA2 mutant in rich LB 
or Mueller Hinton is limited to agar media.  Growth curves fail to demonstrate a phenotype 
for the ∆secA2 mutant growing in any liquid media (data not shown).  We do not understand 
the basis of the rich media growth defect, or why the rich media growth defect is observed 
only on solid media, not liquid media. 
SecA1 and SecA2 are expressed at similar levels in mycobacteria.  We began our 
comparative analysis of SecA1 and SecA2 by determining that the expression level of both 
proteins was the same.  To the best of our knowledge, this has not been shown for any other 
organism with two SecA proteins.  Importantly, this result rules out the possibility that the 
difference between SecA1 and SecA2 is due to the abundance of each protein.  We also 
showed that the expression of each protein is the same in M. tuberculosis and M. smegmatis, 
supporting our use of M. smegmatis as a model for studying SecA2.     
SecA1 and SecA2 localize differently in M. smegmatis subcellular fractions.  
Previous studies show that SecA1 and SecA2 are not interchangeable (3); overexpression of 
secA1 does not compensate for the loss of secA2, and vice versa.  Here, we showed that the 
subcellular localization of SecA1 and SecA2 differs in M. smegmatis.  SecA1 partitioned 
equally between the cell envelope and soluble fractions, as is the case for the canonical SecA 
(7, 31), while SecA2 is predominantly in the soluble fraction.  Interestingly, it was recently 
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shown that the localization of the two SecA homologs of S. parasanguinis also differs (10).  
In S. parasanguinis, the canonical SecA protein is also found equally distributed in cell 
envelope and soluble fractions.  However, in this bacterium, SecA2 was predominantly 
associated with the cell envelope, which is opposite to our finding of SecA2 being 
predominantly localized to the cytosol in M. smegmatis.  Nonetheless, both studies 
demonstrate a difference in how SecA1 and SecA2 behave in the cell.  It also suggests that 
the SecA2 system of mycobacteria is functionally different from the SecA2/Y2 systems 
being studied in other bacteria. 
The essential nature of SecA1 in mycobacteria suggests it is the housekeeping SecA, 
like SecA of E. coli (3, 57).   In E. coli, SecA is shown to undergo repeated cycles of ATP 
binding and hydrolysis to drive export of pre-proteins through the SecYEG translocon (58, 
63).  In the process, SecA transiently associates with SecYEG and the cytoplasmic 
membrane while cycling back to the cytoplasm.  In keeping with our proposal that SecA1 is 
the housekeeping SecA, we found SecA1 to be evenly distributed between cell envelope and 
soluble/cytosolic fractions.  The localization profile of mycobacterial SecA2 is strikingly 
different and it suggests that SecA2 has a different mode of action than SecA1.  Perhaps the 
primary function of mycobacterial SecA2 is in delivery of substrates to a translocase.  In this 
regard, it may behave like a chaperone, such as SecB.  SecB functions as a chaperone by 
binding to a subset of pre-proteins, keeping them unfolded, and targeting them to the 
translocase-associated SecA (27, 53).  Like SecA2, only a subset of proteins is dependent on 
SecB for export.  Also, all mycobacteria lack a SecB homolog (11).  In this proposed model, 
SecA2 would function as a chaperone to recognize pre-proteins overlooked by SecA1, keep 
them competent for export, and then hand them off to a translocase.  It is possible that SecA2 
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could deliver select substrates to SecA1 and the general Sec translocase or to a unique 
translocase that has not yet been discovered.  While more experiments are needed to address 
this striking difference between SecA1 and SecA2, our findings provide a framework for 
future studies to determine the mechanistic differences between each SecA.  
M. tuberculosis SecA2 lacks two subdomains found in the crystal structure of 
SecA1.  Overall, the SecA2 model closely resembles the SecA1 crystal structure (59).  This 
is not surprising given the high amino acid sequence similarity (50%) shared by the two 
proteins.  Both proteins are comprised of two large domains, the N-domain and the C-
domain, typical of SecA proteins (15, 67).  The N-domain of both SecA1 and SecA2 has an 
ATP binding pocket in the cleft formed by the NBD1 and IRA2 subdomains.  Within this 
cleft are the well-described ATP-binding Walker box motifs (69).  These motifs are found in 
ATPases, including SecA proteins (71).  Our structural model is highly suggestive of SecA2 
being a functional ATPase.  In Chapter 4, we investigate the ATPase activity of both M. 
tuberculosis SecA1 and SecA2.  The N-domain is linked to the C-domain through a long 
helix called the staple domain (SD) in both SecA1 and SecA2.  With the exception of the two 
regions missing from SecA2, the C-domain of both proteins also exhibits a high level of 
similarity.  Both proteins appear to possess the important regulatory subdomain called IRA1.  
In E. coli, IRA1 is important for controlling the overall ATPase activity of SecA (68).  Both 
proteins also contain a domain with a proposed role in pre-preprotein recognition, PPXD.  
PPXD is exposed on the surface of SecA and thus could interact with many pre-proteins; 
however, such an interaction has only been experimentally proven for the model substrate 
pro-OmpA (34, 43, 48).  It remains possible that other subdomains of SecA are involved in 
pre-protein binding, even possibly regions found in SecA1 but missing in SecA2.  Since 
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SecA2 is important for exporting only a subset of proteins, it seems likely there will be some 
structural feature involved in routing pre-proteins to the appropriate SecA protein.  Studies of 
the PPXD subdomain could provide insight into how substrate recognition occurs.  With the 
identification of proteins that require SecA2 for their export, experiments will soon be 
feasible for determining where and how SecA2 interacts with pre-protein substrates. 
The structural modeling identified two candidate regions that distinguish M. 
tuberculosis SecA1 and SecA2.  Despite over 20 years of detailed biochemical and genetic 
analysis of E. coli SecA, the subdomains we found missing from SecA2 are among the least 
understood regions of this highly studied molecule.  One of the regions missing from M. 
tuberculosis SecA2 corresponds to the Gram negative loop, a region found in all Gram 
negative SecAs but absent from all Gram positive SecAs (25).  The function of this loop is 
completely unknown.  Since mycobacteria are neither Gram positive nor Gram negative, it is 
interesting to discover M. tuberculosis SecA1 has the Gram negative loop and that SecA2 
lacks it.  However, the significance of this domain as a distinguishing property of each SecA 
remains to be resolved. 
The other region missing from SecA2 is found in the helix wing domain/C-terminal 
linker (CTL).  In E. coli, the CTL has several roles, including binding to anionic 
phospholipids and the cytoplasmic chaperone SecB (5).  Additionally, the CTL also contains 
a Zn2+ binding motif that is required for SecB binding (13, 21).  Despite these seemingly 
important roles, the CTL is dispensable for SecA function at least in E. coli (52).  Notably, 
there is no SecB homolog in mycobacteria or any Gram positive bacteria (44). 
Instead of interacting with chaperone proteins, the role of HWD/CTL in SecA1 might 
be to interact with pre-proteins or the membrane-embedded translocase.  The domains of 
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SecA that are important for interacting with the SecYEG translocase are still poorly defined.  
Perhaps by deleting part of the HWD/CTL region, the specificity for pre-protein recognition 
is relaxed; in this case, pre-proteins normally rejected by SecA1 might now be recognized as 
competent for export by SecA2.  This possibility could be directly tested by making the 
corresponding deletions in SecA1.  Another possibility is that the missing regions are 
important for recognizing and binding to the appropriate translocase.  Without these regions, 
SecA2 might be restricted to function as a cytoplasmic chaperone like SecB instead of 
associating with the canonical Sec translocase like SecA.  Yet another possibility is that 
SecA2 uses the energy generated by ATP hydrolysis to power a unique membrane-embedded 
translocase.  More experiments are needed to test these possibilities.  Interestingly, sequence 
alignments of all known SecA2 proteins, including those from bacteria with an accessory 
SecY2, showed that SecA2 lacks part of the CTL due to a truncation at the C-terminus (data 
not shown).   
In summary, the experiments presented in this Chapter uncovered similarities and 
differences in some of the basic properties of SecA1 and SecA2.  Other experiments in this 
Chapter provide important justification for using M. smegmatis as a model for studying 
SecA2 export of mycobacteria and provide a foundation for further studies of the SecA 
proteins of mycobacteria presented throughout this work.  
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Figure 2.1.  SecA2 from M. tuberculosis and M. smegmatis both restore the macrophage 
growth defect and altered colony morphology of a M. tuberculosis ∆secA2 mutant.  (A) 
Murine bone marrow-derived macrophages were infected at a MOI of 1.0 with the following 
strains: wild-type H37Rv (H37Rv), ∆secA2 mutant (∆secA2), ∆secA2 mutant complemented 
with wild-type secA2 from M. tuberculosis (∆secA2/Mtb secA2), and the ∆secA2 mutant 
complemented with wild-type secA2 from M. smegmatis (∆secA2/Msmeg secA2).  CFU were 
determined by plating macrophage lysates at various times post-infection.  The infection was 
performed with triplicate wells for each strain per time point.  Error bars represent means +/- 
standard deviations for the triplicate wells.  Data are representative of two independent 
experiments.  *, (P<0.05)  (B) Colony phenotype of M. tuberculosis strains.  Wild-type 
(H37Rv), ∆secA2 mutant (mc23112), ∆secA2 mutant transformed with M. tuberculosis secA2 
(∆secA2/Mtb secA2) and ∆secA2 mutant transformed with M. smegmatis secA2 
(∆secA2/Msm secA2) were plated onto 7H10 agar plates containing 0.05% Tween 80.  
Images of individual colonies were obtained after 3 weeks of growth at 37˚C.  Scale bar = 1.0 
mm.
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Figure 2.2.  Construction of NR116, a new in-frame and unmarked M. smegmatis 
∆secA2 mutant.  (A) Cartoon representation of the subdomains of SecA2.  The deletion 
junction in each ∆secA2 mutant is indicated by arrows.  (B) Map of suicide plasmid pNR6 
used to construct NR116.  Diagram of M. smegmatis secA2 locus in (C) wild-type strain 
mc2155, (D) single crossover strain SCO5, and (E) ∆secA2 mutant strain NR116.  The bar 
below each line indicates site of probe hybridization.  (F) Southern blot of genomic DNA 
digested with BamHI.  BamHI restriction sites and predicted fragment sizes are indicated in 
A-C.  Lanes 1: mc2155, 2: SCO5, 3: NR116. 
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Figure 2.3.  Comparison of phenotypes of two ∆secA2 mutants: mc22522 and NR116.  
(A) Whole cell lysates prepared from mc2155 and NR116 were analyzed by SDS-PAGE and 
immunoblot using anti-SecA1 and anti-SecA2 antibodies.  (B) Colonies of M. smegmatis 
wild-type (mc2155), ∆secA2 mutant (mc22522 and NR116), and complemented ∆secA2 
mutant were grown on minimal (7H10, top) or rich (MH, bottom) agar at 37˚C.  (C) 
Sensitivity to sodium azide was assessed by measuring inhibition of growth surrounding a 
filter disc impregnated with 10 µl of 0.15 M sodium azide.  Each strain was assayed in 
triplicate.  Error bars represent +/- standard error of the mean.
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Figure 2.4.  Overexpression of SecA1 fails to complement and exacerbates phenotypes 
associated with ∆secA2 null mutant NR116.  NR116 was electroporated with pYUB544, a 
multicopy plasmid that expresses M. smegmatis SecA1.  The resulting strain was grown on 
minimal (7H10) or rich (MH) agar, and tested for sensitivity to sodium azide as described 
above.  Wild-type, ∆secA2 mutant NR116, and NR116 complemented with M. smegmatis 
secA2 are shown for comparison. 
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Figure 2.5.  Identification of new ∆secA2 mutant phenotypes.  Serial dilutions of the wild-
type, ∆secA2 mutant (NR116), and complement mutant (∆secA2/secA2) M. smegmatis strains 
were grown on 7H11 agar or 7H10 agar supplemented with casein or 0.5 M NaCl and 
incubated at 37˚C until visible colonies appeared.  Strains were also grown on minimal 
(7H10) and rich (MH) agar plates as a control. 
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Figure 2.6.  SecA1 is found equally distributed between cell envelope and soluble 
fractions, while SecA2 is found predominantly in the soluble fraction.  Cultures of M. 
smegmatis were grown in Mueller Hinton until an approximate OD600nm of 1.0.  Whole-cell 
lysates were generated using a French pressure cell, and subcellular fractions were made by 
differential ultracentrifugation as described in the Methods.  Protein derived from an equal 
number of cells was analyzed by quantitative immunoblot.  Anti-SecA1 (A) and anti-SecA2 
(B) antibodies were used at a 1:50,000 dilution and 1:20,000 dilution, respectively.  Goat 
anti-rabbit secondary antibodies conjugated to alkaline phosphatase (Amersham/GE 
Healthcare) were used according to the manufacturer.  Immune complexes were developed 
using ECF and visualized using a phosphorimager (Molecular Devices).  Data from 
quantitative anti-SecA1 (C) and anti-SecA2 (D) immunoblots are from three independent 
replicates.  Error bars indicate +/- standard error of the mean.
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Figure 2.7.  A computer-generated homology model of M. tuberculosis SecA2 is missing 
domains found in M. tuberculosis SecA1.  (A) The crystal structure of SecA1 (PDB 
accession 1NKT) was used to generated the model structure of SecA2.  The subdomains are 
named as in E. coli and B. subtilis SecA: NBD1 (Nucleotide Binding Domain, dark blue), 
IRA1 (Intramolecular Regulator of ATPase, yellow), IRA2 (cyan), PPXD (Preprotein 
Crosslinking Domain, pink), HSD (Helix Scaffold Domain, green), and HWD/CTL (Helix 
Wing Domain/C-Terminal Linker, red).  (B) A cartoon representation of the subdomains of 
SecA2. 
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The finding that two SecA homologs function in mycobacteria is a relatively recent 
discovery.  SecA1 is essential, and is thought to function like the well-characterized SecA 
protein of Escherichia coli.  SecA2 is not essential, but is required to export a subset of 
proteins.  The mechanism of SecA2-dependent protein export remains poorly defined.  Both 
SecA1 and SecA2 from Mycobacterium tuberculosis have been shown to possess ATPase 
activity, and this activity is required for normal function.  Sequence alignments between E. 
coli SecA and mycobacterial SecA proteins show a high degree of similarity between the 
high-affinity ATP-binding Walker box motifs.  Mutation of key residues in the Walker box 
of E. coli secA results in alleles that fail to complement temperature-sensitive secA mutants.  
We constructed Walker box mutant secA2 alleles and tested the ability of these alleles to 
complement phenotypes of M. tuberculosis and M. smegmatis ∆secA2 mutants.  We show 
that secA2 KR fails to complement and exacerbates ∆secA2 mutant phenotypes, and is a 
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dominant negative allele.  SecA2 KR cannot support export of SecA2-dependent substrates 
and localized to a different subcellular fraction than wild-type SecA2.  We isolated 
spontaneous intragenic and extragenic suppressors of secA2 KR, and subsequently identified 
important functional domains of SecA2.  These results shed light on the mechanism of 
SecA2-mediated protein export. 
 
Introduction 
 Protein export pathways are an important aspect of bacterial physiology.  Exported 
proteins, those proteins transported beyond the cytosol to the cell envelope or released into 
the extracellular environment, are important for establishing cell structure, acquiring 
nutrients, and sensing changes in the environment.  Exported proteins also have important 
roles in virulence because exported (secreted and surface-anchored) proteins are ideally 
positioned to interact with and modulate responses of host cells to invading bacterial 
pathogens (17).  Because of the important role played by extracytoplasmic proteins in 
virulence, it is not surprising that the requisite export systems are equally important to 
virulence.  Many bacterial pathogens use specialized systems to export virulence factors to 
the bacterial cell surface or release them into the extracellular environment (1, 19).  Thus, 
identifying exported proteins and understanding their underlying transport systems could 
yield new targets for antimicrobial therapies. 
In mycobacteria and a small subset of Gram positive bacteria, the accessory Sec 
pathway represents an example of a specialized protein export system (4, 8, 9, 11, 12, 33, 39, 
44).  The accessory Sec pathway is found in pathogens and non-pathogens alike.  It has been 
linked to virulence in several cases including Mycobacterium tuberculosis and Listeria 
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monocytogenes (9, 23, 31, 32).  The accessory Sec pathways studied so far are shown to 
export a select subset of proteins that include proven or predicted virulence factors (4, 9, 12, 
20, 32).  While the constituents of the accessory Sec pathway differs among bacterial species, 
one component they all share is the presence of an accessory SecA homolog called SecA2.  
SecA2 is homologous to the essential SecA (SecA1) that is part of the canonical essential Sec 
pathway found in all bacteria (13).  In E. coli, SecA guides transit of unfolded pre-protein 
substrates through a channel in the cytoplasmic membrane comprised of the SecYEG 
proteins (22, 36).  The power for this system is provided by the ATPase activity of SecA.  
SecA is essential, as is this ATPase activity (35).  Mutants defective in SecA ATP 
binding/hydrolysis are unable to complement temperature sensitive secA mutants in E. coli.  
Both SecA1 and SecA2 from M. tuberculosis and M. smegmatis have predicted ATP-binding 
Walker box motifs (8, 24, 39).  In Chapter 4, we show that M. tuberculosis SecA1 and SecA2 
are able to bind and hydrolyze ATP in vitro.  In this Chapter, we address the biological 
significance of SecA2 ATPase activity in M. tuberculosis and M. smegmatis.   
SecA1 is essential in mycobacteria (8, 41).  The secA1 gene cannot be deleted unless 
secA1 is present elsewhere on the chromosome or encoded on a plasmid.  In contrast, secA2 
is dispensable for growth in both M. tuberculosis and M. smegmatis.  Previous studies 
described construction and phenotypic characterization of ∆secA2 mutants in both species (8, 
9).  The ∆secA2 mutant of M. tuberculosis is attenuated in both mouse and macrophage 
models of infection (9, 31).  In addition, when grown on agar plates that contain the detergent 
Tween-80, colonies of the ∆secA2 mutant appear smooth and glossy compared to the rough 
and dull colonies of the wild-type strain H37Rv (30).  The ∆secA2 mutant of M. smegmatis 
exhibits several phenotypes, including growth defects on rich and high salt agar, and 
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hypersensitivity to sodium azide (Chapter 2) (8).  The basis of these plate phenotypes is 
unknown.  One possible explanation is that SecA2 is needed to export substrates that enable 
optimal growth under diverse conditions.  M. tuberculosis and M. smegmatis ∆secA2 mutants 
are both defective in exporting a small subset of proteins.  Comparative 2D-gel analysis of 
exported proteins from both organisms led to the identification of a small number of proteins 
that depend on SecA2 for export (9, 20, 23).  The phenotypes of mycobacterial ∆secA2 
mutants have proven useful for studying SecA2 function.   
In order to study the importance of ATPase activity for SecA2 function, we tested the 
effect of amino acid substitutions in the ATP-binding Walker Box of SecA2.  The Walker 
Box substitutions we engineered are in highly conserved positions and are predicted to 
prevent SecA2 from binding ATP.  In Chapter 4, we confirm that SecA2 with a mutated 
Walker Box is unable to bind ATP.  When tested in M. tuberculosis, we found that Walker 
box mutant secA2 alleles fail to function as judged by the inability to complement the 
macrophage growth defect or colony morphology phenotype of the M. tuberculosis ∆secA2 
mutant.  In M. smegmatis, we showed a Walker box mutation in SecA2 eliminates export of 
two SecA2-dependent lipoproteins, Msmeg1704 and Msmeg1712.  This indicates that in M. 
smegmatis ATP binding is also necessary for normal SecA2 function.  Furthermore, we 
discovered that in M. smegmatis the Walker box mutant secA2 alleles not only fail to 
complement, but actually exacerbate plate phenotypes associated with the ∆secA2 mutant.   
The bulk of our studies focused on a particular Walker box mutant of M. smegmatis 
SecA2 K129R.  We showed that this lysine to arginine amino acid substitution in the Walker 
Box of M. smegmatis SecA2 leads to dominant negative phenotypes.  Dominant negative 
mutations combined with suppressor analysis can be a powerful way to identify proteins that 
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work together in biological pathways (2).  The robust phenotypes associated with SecA2 
K129R expression enabled us to isolate spontaneous suppressors of the dominant negative 
phenotypes.  Both intragenic and extragenic suppressors were obtained.  Analysis of the 
intragenic suppressors identified domains required for SecA2 function in vivo.  Although the 
identity of the extragenic suppressors remains unknown, we are confident they will help to 
identify SecA2-interacting proteins.  This work represents the first mutational analysis of any 
SecA2 and it provides an important first step in understanding the basic mechanism of 
SecA2-mediated protein export pathways in mycobacteria.   
 
Materials and Methods 
Bacterial strains and culture conditions.  M. smegmatis was grown in Middlebrook 7H9 or 
on 7H10 (BD Biosciences) supplemented with 0.2% (w/v) glucose, 0.5% (w/v) glycerol, and 
0.1% (w/v) Tween 80 (Fisher); or Mueller Hinton (BD Biosciences) supplemented with 0.1% 
(w/v) Tween 80.  M. tuberculosis was grown in 7H9 or on 7H10 supplemented with 0.5% 
(w/v) glycerol and 1X ADS (0.5% (w/v) bovine serum albumin, 0.2% (w/v) dextrose, and 
0.85% (w/v) NaCl).  The antibiotics kanamycin (Acros Chemicals) or hygromycin (Roche) 
were added as needed at 20 µg/ml or 50 µg/ml, respectively.  LB was used to grow E. coli 
cultures.  When needed, kanamycin or hygromycin were added at 40 µg/ml or 150 µg/ml, 
respectively.  All vectors used in this study were verified by DNA sequencing (UNC-CH 
automated DNA sequencing facility and Eton Biosciences).  NR116 was used as the ∆secA2 
mutant of M. smegmatis, and mc23112 (9) was used as the ∆secA2 mutant of M. tuberculosis 
for all experiments. 
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Construction of secA2 Walker Box mutant plasmids pNR7, pNR8, pNR22, and pNR25.  
The DNA encoding the Walker boxes of secA2 was mutated using the Quikchange Site 
Directed mutagenesis kit (Stratagene).  The plasmid templates were pMB162 for M. 
tuberculosis secA2, pMB208 and pYA810 for M. smegmatis secA2 (8, 20).  pMB162 
contains M. tuberculosis secA2 under the control of the constitutive mycobacterial hsp60 
promoter and integrates in the attB site of the mycobacterial chromosome.  M. smegmatis 
secA2 is driven from the hsp60 promoter in both pMB208 and pYA810; the difference 
between these vectors is that pMB208 is episomal while pYA810 integrates at the 
chromosomal attB site.  The Walker A motif of M. tuberculosis SecA2 was mutated in 
plasmid pMB162 using the following primers: 5’-CGGTGAGGGCAGAACCCTTGCC-3’ 
and 5’-CGGCAAGGGTTCTGCCCTCACC-3’, and the Walker B motif was mutated using 
the primers: 5’-GACGTGGCTCTCATCAATGAAGCCGACTCCG-3’ and 5’-
CACGGAGTCGGCTTCATTGATGAGAGCCACG-3’.  The resulting mutant plasmids 
were pNR7 and pNR8, respectively. To create the Walker A mutation in M. smegmatis 
secA2, primers 5’-CGGGTGAGGGCAGGACGCTGGC-3’ and 5’-
GCCAGCGTCCTGCCCTCACCCG-3’ were used with pMB208 and pYA810 as the 
template to generate plasmids pNR22 and pNR25, respectively. 
Construction of inducible secA2 K129R plasmid pNR54.  Using pHSG86 as a template, 
we PCR amplified M. smegmatis secA2 with primers 5’-
AGGATCCATCCGGAGGAATCACTT-3’ and 5’-
AGGATCCCTAGTGGTGGTGGTGGTGGTGGCGGAACACACCCGGCAGG-3’.  The 
resulting PCR product was cloned into pCC1 to yield pNR52.  Next, a 2.4 kb BamHI 
fragment was cloned from pNR52 into similarly cut pMP715 (gift from Dr. Marty Pavelka, 
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University of Rochester) to give pNR53.  pMP715 contains the TetO sequence upstream of 
the BamHI site, as well as the TetR repressor.  TetR binds to the TetO sites and blocks gene 
expression (21).  In the presence of anhydrotetracycline (Atc), TetR dissociates from TetO 
and allows gene expression.  To mutate Walker box residue K129, pNR53 was subjected to 
site-directed mutagenesis as described.  The resulting plasmid pNR54 carries secA2 K129R 
under control of the Atc inducible promoter.  Induction of SecA2 K129R in M. smegmatis 
transformed with pNR54 was achieved by treating cultures with 300 ng/ml Atc for 21 hours 
at 37˚C. 
Construction of suicide plasmid pNR23.  Two-step allelic exchange was used to replace 
the ∆secA2 deletion in the chromosome of strain NR116 with a full-length copy of secA2 
containing the K129R Walker A mutation (7, 38).  First, pMB148 was digested with EcoRI to 
remove 1082 bp of extraneous vector sequence.  pMB148 contains M. smegmatis secA2 and 
additional upstream and downstream sequences.  The remaining 7793 bp was then self-
ligated to give a 7793 bp plasmid named pNR20.  Site-directed mutagenesis was performed 
on pNR20 as described above, to generate pNR21.  We used the same mutagenic primers on 
pNR20 that we used to make the secA2 Walker A K129R mutation in pNR25.  pNR21 
contains full-length secA2 K129R driven from the native secA2 promoter.  Finally, a 5059 bp 
AseI-EcoRV fragment from pNR21 was cloned into NdeI-EcoRV cut pMP62 to yield the 
counterselectable suicide vector pNR23.   
Construction of secA2 K129R strain NR179.  pNR23 was electroporated into ∆secA2 
mutant strain NR116, and hygromycin resistant transformants were selected on 7H10 plates.  
Strains where pNR23 integrated at the secA2 locus by homologous recombination were 
analyzed by Southern blot to identify the single-crossover strain NR155.  For the second 
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recombination event, NR155 was grown to saturation in 7H9 broth with 50 µg/ml 
hygromycin, diluted 1:100 in 7H9 without antibiotics, and grown overnight.  Dilutions of the 
overnight culture were plated on 7H10 plates that contained 4.5% (w/v) sucrose to select for 
sucrose resistant colonies.  Sucrose resistant, hygromycin sensitive clones were analyzed by 
colony PCR and Southern blot to identify strain NR179 as containing a full-length secA2 
K129R allele at the chromosomal locus. 
Southern blot analysis.  Genomic DNA was prepared from M. smegmatis strains as 
described and digested with BamHI (7).  The probe was a 592 bp BamHI-XmaI fragment 
from pMB156 that contained sequence homologous to the region immediately downstream 
of M. smegmatis secA2.  A Ready-to-Go labeling kit (Amersham) was used to label the probe 
with [32P]dCTP, and the resulting blot was developed by autoradiography. 
Azide assay.  200 µl of saturated (OD600nm = 2.0) M. smegmatis culture was mixed with 3.5 
ml of molten 7H9 top agar, and then poured onto a 7H10 bottom agar plate.  Sterile 6 mm 
filter discs were placed onto the surface of the cooled top agar.  10 µl of 0.15 M sodium azide 
was then added to the disc.  The plates were inverted and incubated for 2 days at 37˚C, and 
resulting zones of inhibition were measured.  Each strain was tested in triplicate, and 
untreated plates were included as a control. 
Agar plate growth assays.  All M. smegmatis strains were grown in 7H9 broth at 37˚C prior 
to plating except the ∆secA2 mutant expressing pNR25.  This strain was grown at 30˚C 
because of toxicity associated with expressing the secA2 K129R allele.  Serial dilutions of 
each strain were made in 7H9 and then plated onto the appropriate agar medium.  All M. 
tuberculosis strains were grown at 37˚C until saturation, diluted in 1X PBS with 0.05% (w/v) 
Tween 80, and plated onto 7H10.  Plates were incubated at 37˚C until colonies were visible. 
 83 
Export of Msmeg1704-HA and Msmeg1712-HA.  To monitor export of Msmeg1704 and 
Msmeg1712, both proteins were tagged with the HA epitope at the C-terminus.  pHSG51 and 
pHSG58 encode Msmeg1712-HA and Msmeg1704-HA under control of the constitutive 
hsp60 promoter.  Both of these plasmids are KanR and episomal.  To generate HygR 
derivatives of these plasmids, pHSG51 was cut with NheI and SpeI to generate a 4.2 kb 
fragment.  This fragment was end-filled using the Klenow fragment (New England Biolabs), 
and ligated to the HygR-containing 1.5 kb SmaI-EcoRV fragment from pYUB412 to generate 
pNR35.  pNR36 (Msmeg1704-HA) was constructed by digesting pHSG58 with NheI and 
SpeI yielding a 5.4 kb fragment.  The fragment was end-filled with Klenow and ligated to the 
HygR-containing SmaI-EcoRV fragment from pYUB412.  To monitor export of Msmeg1704-
HA and Msmeg1712-HA, pNR35 and pNR36 were transformed into M. smegmatis.  Strains 
were grown in Mueller Hinton broth until OD600nm = 1.0, and then lysed in a French pressure 
cell.  Lysates were fractionated by differential ultracentrifugation into cell wall (50,000 x g 
pellet), membrane (100,000 x g pellet), and soluble (100,000 x g supernatant) fractions (20).  
Protein derived from the same amount of starting cells for each fraction was analyzed by 
SDS-PAGE and western blots. 
Immunoblot conditions.  The anti-SecA2, anti-GroEL (HAT5, from the World Health 
Organization antibody collection), anti-MspA (gift from Dr. Michael Niederweis), and anti-
HA (Covance) antibodies were used at 1:20,000 dilutions.  The anti-SecA1 antibody was 
used at a 1:50,000 dilution.  For most experiments, secondary antibodies conjugated to HRP 
(Biorad) were used along with ECL (Perkin Elmer) to visualize blots.  For quantitative 
westerns, secondary antibodies conjugated to AP (Amersham/GE Healthcare) were used 
along with ECF.  Fluorescence was quantified using a phosphorimager (Molecular Devices). 
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Results 
ATP binding is required for SecA2 function in M. tuberculosis and M. smegmatis.  
Sequence alignments reveal the presence of conserved high-affinity ATP-binding Walker 
box motifs in SecA1 and SecA2 of mycobacteria (Figure 3.1A).  In Chapter 4, we will 
demonstrate that M. tuberculosis SecA1 and SecA2 both possess ATPase activity in vitro.  
While the requirement for ATPase activity of E. coli and Bacillus subtilis SecA in its role in 
protein export is well established (34, 35), it is not known if the biological function of any 
accessory SecA2 proteins requires ATPase activity.  To address this issue, we used a genetic 
approach.  We constructed secA2 Walker Box mutants predicted to prevent ATP binding 
(Figure 1A) and tested them for function by introducing the mutated alleles into ∆secA2 
mutants and assaying for complementation of ∆secA2 mutant phenotypes.  If ATPase activity 
is required for normal SecA2 function, then mutations that destroy ATPase activity should 
result in a secA2 allele that does not complement ∆secA2 mutant phenotypes.  We chose to 
mutate key lysine and aspartic acid residues in the Walker box motif of SecA2.  The side 
chains of these two amino acids function in nucleotide binding by interacting with the γ-
phosphate of ATP (49).  Indeed, mutations of the Walker Box lysine residue eliminates ATP 
binding of many diverse ATPases including E. coli SecA, the Type IV secretion protein 
DotB of Legionella pneumophila and type IV pilus protein PilQ of E. coli (35, 40, 43).  In 
this Chapter, we describe experiments conducted in M. tuberculosis and in M. smegmatis in 
which secA2 Walker box mutant alleles were tested for function.      
Using site-directed mutagenesis, we constructed two mutant alleles of M. tuberculosis 
secA2 with mutations in the sequence encoding the conserved Walker A or Walker B high-
affinity ATP binding motifs.  In plasmid pNR7, the lysine codon at residue 115 in the Walker 
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A motif was replaced with an arginine codon (SecA2 K115R).  In plasmid pNR8, the aspartic 
acid codon in the Walker B motif was changed to asparagine codon at residue 216 (SecA2 
D216N).  We also constructed plasmids pNR22 and pNR25, which carry M. smegmatis 
secA2 with a Walker A lysine to arginine substitution at amino acid 129 (SecA2 K129R), 
which correspond to K115 of M. tuberculosis SecA2.  In E. coli, the corresponding KR and 
DN Walker box mutations result in secA alleles that are unable to complement a temperature-
sensitive secA mutant (35).  The various expression constructs were transformed into the M. 
tuberculosis wild-type (H37Rv) and ∆secA2 mutant (mc23112) and the M. smegmatis wild-
type (mc2155) and ∆secA2 mutant (NR116).  For each construct, SecA2 expression was 
driven from a constitutive hsp60 promoter.  Based on the rationale described above, if 
ATPase activity is important for SecA2 function, then secA2 Walker box mutant alleles will 
fail to complement ∆secA2 mutant phenotypes.  Indeed, we found that none of the mutant 
alleles compensated for the absence of secA2.  These results indicated that ATPase activity is 
critical for normal SecA2 function.  Much to our surprise, in some assays these alleles not 
only failed to complement, but actually exacerbated the ∆secA2 mutant phenotypes and 
behaved as dominant negative mutations.   
Phenotypes of secA2 Walker Box mutant alleles expressed in M. tuberculosis.   
M. tuberculosis SecA2 K115R does not restore the ability of a M. tuberculosis 
∆secA2 mutant to grow in macrophages.  A ∆secA2 mutant of M. tuberculosis is attenuated 
for growth in macrophages and in mice (9, 31).  To test the idea that SecA2 functions as an 
ATPase in mycobacteria, we asked whether the intracellular phenotype of the ∆secA2 mutant 
of M. tuberculosis could be complemented by a M. tuberculosis secA2 allele that encodes a 
lysine to arginine (K115R) substitution at position 115 of the Walker box motif.  This secA2 
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K115R allele was electroporated into the ∆secA2 mutant mc23112 and integrated in single 
copy at the chromosomal attB site.  Introduction of a wild-type copy of secA2 at the attB 
locus was previously shown to complement the ∆secA2 mutant phenotype (31).  Murine bone 
marrow-derived macrophages were infected with wild-type M. tuberculosis (H37Rv), 
∆secA2 mutant mc23112 (∆secA2), the ∆secA2 mutant complemented with wild-type M. 
tuberculosis secA2 (∆secA2/secA2), or the ∆secA2 mutant expressing the secA2 K115R allele 
(∆secA2/secA2 KR) (Figure 3.1B). As shown previously, H37Rv and the secA2 
complemented strain grew similarly in macrophages over a 5-day period of infection while 
the ∆secA2 mutant failed to grow in these macrophages (31). Introduction of secA2 K115R 
did not restore the ability of the ∆secA2 mutant to grow intracellularly; the ∆secA2 mutant 
expressing SecA2 K115R failed to grow in macrophages.  Western blot analysis confirmed 
that the ∆secA2 mutant strains carrying wild-type secA2 or secA2 K115R expressed SecA2 
protein at similar levels (Figure 3.1C) ruling out the possibility that the lack of growth in 
macrophages was due to a problem with expression of secA2 K115R. The intracellular 
growth defect of the secA2 K115R expressing strain was also not a result of a general growth 
defect. The secA2 K115R strain had a mean generation time that was 1.07 +/- 0.06 times that 
of the wild-type strain when the two strains were grown in parallel in 7H9 liquid media. 
These results indicated that substitution of the conserved lysine in the Walker A motif 
renders SecA2 inactive in its biological role of promoting M. tuberculosis growth in 
macrophages.  
Expression of M. tuberculosis secA2 K115R does not complement the smooth 
colony phenotype of a ∆secA2 mutant.  In contrast to the dull, rough, irregularly shaped 
colonies of wild-type M. tuberculosis, colonies of the ∆secA2 mutant of M. tuberculosis are 
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round and smooth with a glossy appearance (30).  This phenotype could indicate a difference 
in composition of the cell envelope between the two strains.  Notably, this difference is only 
detected when the bacteria are grown on media containing Tween 80.  When grown on 7H10 
plates without Tween 80, wild-type and ∆secA2 mutant colonies are indistinguishable (data 
not shown).  The rough colony morphology can be restored in the ∆secA2 mutant by 
expression of a wild-type copy of secA2 (30).  To further test the Walker Box mutant secA2 
alleles, we grew the same set of M. tuberculosis strains tested in macrophages on 7H10 plates 
supplemented with 0.05% Tween 80.  After 3 weeks of growth, plates were removed from 
incubation and photographed.  As shown in Figure 3.2A, colonies of the ∆secA2 mutant 
appeared smooth in comparison to H37Rv.  Expression of wild-type secA2 restored the rough 
colony morphology to the ∆secA2 mutant.  In contrast, when the secA2 K115R mutant allele 
is expressed in the ∆secA2 mutant, the colonies remained smooth (Figure 3.2B).  This 
provided further indication that Walker Box mutant secA2 alleles are unable to function 
normally.  It is worth mentioning that expression of the secA2 K115R allele in H37Rv 
changed the rough appearance of these colonies to a smooth phenotype similar to that of the 
∆secA2 mutant.  This is consistent with secA2 K115R being a dominant negative allele.  
Further demonstration of secA2 Walker box alleles being dominant negative is presented 
later in this Chapter.   
Phenotypes of secA2 Walker box mutant alleles expressed in M. smegmatis.   
SecA2 K129R expressed from the native secA2 chromosomal locus causes 
∆secA2 mutant phenotypes with increased severity.  Two-step allelic exchange was used 
to create an M. smegmatis strain that expressed secA2 K129R at the native secA2 locus (7, 
38).  An advantage to this approach is that SecA2 K129R expression will be controlled by 
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the native SecA2 promoter, not the constitutive hsp60 promoter used on mycobacterial 
plasmid vectors.  Suicide vector pNR23 was constructed as described in Methods.  This 
construct encodes a full-length copy of M. smegmatis secA2 with a single point mutation to 
change the codon for lysine 129 in the Walker Box to arginine.  pNR23 was electroporated 
into ∆secA2 mutant (Figure 3.3A), and the resulting transformants were screened for a single 
crossover event; the desired strain was subsequently named NR155 (Figure 3.3B).  Upon 
counterselection, we performed Southern blot analysis to identify a strain carrying secA2 
K129R at the chromosomal locus and named this strain NR179 (Figure 3.3C and D).  
Expression of SecA2 K129R in NR179 was confirmed by immunoblot (Figure 3.3E).  Strain 
NR179 was then tested for ∆secA2 mutant phenotypes.  When compared to wild-type M. 
smegmatis strain, NR179 showed a growth defect on rich MH agar (Figure 3.3F).  NR179 
was also hypersensitive to azide treatment (data not shown).  These results demonstrated that 
ATP binding is important for the normal function of SecA2 in M. smegmatis.  Interestingly, 
the Mueller Hinton rich agar growth defect of NR179 was more severe than that of a ∆secA2 
mutant (compare colony size of ∆secA2 to NR179).  Thus, when SecA2 K129R is the only 
SecA2 expressed in a cell, a more severe growth defect is observed on rich agar plates than if 
no SecA2 is present.  The azide hypersensitivity displayed by the ∆secA2 mutant was also 
more severe in NR179 (data not shown).  As described below, increased severity of ∆secA2 
mutant phenotypes was a recurring theme with Walker Box secA2 mutants. 
Expression of M. tuberculosis Walker Box mutant secA2 K115R or D216N alleles 
do not complement and they exacerbate the phenotypes of a M. smegmatis ∆secA2 
mutant.  To continue our evaluation of the importance of ATP binding for SecA2 function, 
we tested the ability of M. tuberculosis secA2 Walker Box mutant alleles to function in M. 
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smegmatis.  Wild-type SecA2 from M. tuberculosis was previously shown to function in M. 
smegmatis by the ability to complement the rich agar growth defect and azide 
hypersensitivity phenotypes associated with a M. smegmatis ∆secA2 mutant (8).  M. 
smegmatis wild-type, ∆secA2 mutant (∆secA2), ∆secA2 mutant complemented with wild-
type M. tuberculosis secA2 (∆secA2/secA2), and ∆secA2 mutant complemented with M. 
tuberculosis secA2 K115R (∆secA2/secA2 K115R) or secA2 D216N (∆/secA2 D216N) 
cultures were grown in 7H9 broth at 37˚C and a series of dilutions were plated onto Mueller 
Hinton rich agar.  The plates were incubated at 37˚C for 3-4 days.  In comparison to wild-
type M. smegmatis colonies, ∆secA2 mutant colonies were smaller on rich agar (Figure 
3.4A).  The ∆secA2 mutant carrying pMB162, a plasmid that encodes wild-type M. 
tuberculosis SecA2, grew like wild-type.  However, plasmids derived from pMB162 that 
express M. tuberculosis secA2 K115R (pNR7) or D216N (pNR8) mutant alleles were unable 
to restore growth of the ∆secA2 mutant to wild-type levels.  The secA2 K115R and D216N 
alleles not only failed to complement, but they exacerbated the growth defect of the ∆secA2 
mutant on rich agar plates.   
We also assayed the Walker Box mutant secA2 alleles for the ability to complement 
the azide hypersensitivity phenotype (Figure 3.4B).  Saturated cultures of M. smegmatis were 
mixed with molten top agar and spread onto 7H10 bottom agar plates.  Sterile filter discs 
were placed in the middle of the top agar overlay and then impregnated with 10 µl of 0.15 M 
sodium azide.  The plates were inverted and incubated for two days until zones of clearing 
around the filter discs were measured.  As previously reported, the ∆secA2 mutant was more 
sensitive to azide than wild-type M. smegmatis, and this increased sensitivity was reversed by 
expression of a wild-type copy of M. tuberculosis secA2 (8).  As was seen with the growth 
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phenotype on rich agar, expression of the Walker Box mutant secA2 alleles in the ∆secA2 
mutant not only failed to complement the azide sensitivity phenotype but resulted in a more 
severe phenotype than the parental ∆secA2 mutant strain. 
Expression of M. smegmatis secA2 K129R fails to support export of SecA2-
dependent proteins in M. smegmatis.  We also tested the ability of SecA2 Walker Box 
mutants to function in M. smegmatis.  We started by testing the ability of M. smegmatis 
SecA2 K129R to export two SecA2-dependent lipoproteins, Msmeg1704 and Msmeg1712.  
Plasmid pNR25, expressing M. smegmatis secA2 K129R, was generated by performing site-
directed mutagenesis on wild-type secA2 carried on pYA810.  Wild-type and ∆secA2 mutant 
M. smegmatis strains were transformed with pNR25, and the transformants were tested for 
∆secA2 mutant phenotypes, starting with export of SecA2-dependent proteins.   
The M. smegmatis ∆secA2 mutant is defective in exporting Msmeg1704 and 
Msmeg1712 lipoproteins from the cytoplasm to the cell wall (20).  To directly test if ATPase 
activity is important for SecA2 function in promoting protein export, we tested if Walker box 
mutant secA2 alleles could support export of these two SecA2-dependent proteins of M. 
smegmatis.  To monitor export, each protein was tagged with the HA-epitope at the C-
terminus.  The tagged proteins were then expressed in wild-type (WT) M. smegmatis, ∆secA2 
mutant (∆), ∆secA2 mutant complemented with wild-type secA2 (∆/WT), or the ∆secA2 
mutant expressing the secA2 K129R allele (∆/KR) mutant and grown in Mueller Hinton broth 
at 37˚C.  Expression of SecA2 and SecA2 K129R in the complemented strains was 
confirmed by western blot (data not shown).  Cells were lysed in a French pressure cell and 
then fractionated into cell wall (CW), membrane (MEM), and soluble (SOL) fractions by 
differential ultracentrifugation.  Protein derived from an equivalent number of starting cells 
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was then analyzed for each fraction by SDS-PAGE and western blot with anti-HA antibodies 
(Figure 3.5).  As expected from published studies, the ∆secA2 mutant failed to export 
Msmeg1704-HA and Msmeg1712-HA to the cell wall fraction (20).  Moreover, both proteins 
accumulated in the soluble fraction of the ∆secA2 mutant which is consistent with an export 
defect of the proteins following synthesis in the cytoplasm.  Expression of wild-type secA2 in 
the ∆secA2 mutant complemented the export defect of Msmeg1704-HA and Msmeg1712-HA 
to the cell wall, indicating the export defect is due to the absence of secA2.  When secA2 
K129R was expressed in a ∆secA2 mutant, Msmeg1704-HA and Msmeg1712-HA failed to 
reach the cell wall, and accumulated in the soluble fraction.  Purity of each fraction was 
confirmed by immunoblots for the cell wall protein MspA and the cytoplasmic chaperone 
GroEL (data not shown).  These results indicated that SecA2 K129R is unable to function in 
exporting these two known M. smegmatis SecA2-dependent proteins.  
M. smegmatis secA2 K129R fails to complement and exacerbates the rich agar 
growth defect and azide hypersensitivity phenotypes associated with a M. smegmatis 
∆secA2 mutant.  As previously reported, colonies of the M. smegmatis ∆secA2 mutant have 
a growth defect on rich agar plates like Mueller Hinton when compared to wild-type bacteria 
(8).  This growth phenotype is restricted to plate media; no growth defect is observed when 
the ∆secA2 mutant is grown in rich broth.  The rich agar growth defect is complemented by 
wild-type secA2 from M. smegmatis, demonstrating that this phenotype is due to deletion of 
secA2.  We tested if SecA2 K129R expressed from the native secA2 chromosomal locus was 
functional by using the rich agar and azide assays.  By expressing SecA2 K129R from the 
native SecA2 promoter, we could avoid any artifacts associated with expression of SecA2 
K129R from the constitutive hsp60 promoter as is the case with pNR25.  As expected from 
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the earlier studies, M. smegmatis secA2 K129R failed to complement and exacerbated the 
rich agar growth defect (Figure 3.6A) and azide hypersensitivity (Figure 3.6B) of the ∆secA2 
mutant.   
We made an additional observation with this allele.  When secA2 K129R was 
expressed from plasmid pNR25 in wild-type M. smegmatis, ∆secA2 mutant phenotypes were 
observed.  This strain (wild-type/secA2 K129R) exhibited a rich agar growth defect and azide 
sensitivity phenotype that is comparable to that seen with the ∆secA2 mutant.  Since this 
strain carries wild-type secA2 at the chromosomal locus and secA2 K129R on a plasmid, this 
result suggested that M. smegmatis secA2 K129R is a dominant negative allele. 
M. smegmatis secA2 K129R is a dominant negative allele.  Dominant negative 
mutations produce a gene product that can interfere with the function of the normal gene 
product in merodiploids; the mutant phenotype is observed in the presence of a wild-type 
allele (2).  The net result for the cell is a loss of activity of the wild-type gene product.  
Dominant negative mutations usually occur when a mutant protein can still interact with the 
same proteins as the wild-type protein, but the mutation blocks its function such that only 
non-productive protein complexes form (40, 43).   
Dominant negative alleles are typically dosage dependent (2, 10, 46).  If expression of 
a dominant negative allele is increased, a stronger phenotype arises.  Therefore, we tested the 
effect of increasing expression of secA2 K129R in a wild-type strain.  Plasmid pNR25 is a 
single copy vector; it integrates at the attB site of the M. smegmatis chromosome.  To 
increase expression of secA2 K129R, we constructed a multi-copy episomal plasmid carrying 
secA2 K129R.  This plasmid, pNR22, was electroporated into wild-type and ∆secA2 M. 
smegmatis.  Despite repeated attempts, we were unable to obtain transformants in either 
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strain background (data not shown).  Control plasmids were successfully electroporated into 
M. smegmatis in parallel.  Although a negative result, the failure to obtain transformants 
suggested that high level secA2 K129R expression is toxic, which is consistent with there 
being a dosage dependent effect and the secA2 K129R Walker box allele being dominant 
negative. 
To better show the dosage-dependent dominant negative phenotype, we used an 
inducible promoter system recently shown to function in mycobacteria (14, 21).  By inducing 
expression of secA2 K129R after transformation into mycobacteria, we hoped to be able to 
first construct the strains and then test the effects of high-level expression in a controlled 
fashion.  The inducible system we used is based on the Tet operator (21).  We cloned secA2 
K129R downstream of two TetO sites on plasmid pMP715 thus generating pNR54.  Also 
encoded on pNR54 is the repressor protein TetR.  TetR binds to the TetO sites and blocks 
expression of secA2 K129R.  However, in the presence of the inducer molecule 
anhydrotetracycline (Atc), TetR dissociates from the TetO sites allowing expression of secA2 
K129R (Tet ON).  The level of secA2 K129R expression can be controlled by adjusting the 
concentration of Atc inducer. 
Wild-type and ∆secA2 mutant M. smegmatis strains were electroporated with pNR54, 
and the resulting transformants were grown in 7H9 in the absence of Atc at 37˚C.  Each 
strain was used to inoculate Mueller Hinton broth +/- Atc induction and growth was 
monitored by measuring optical density.  After 21 hours of induction, serial dilutions of each 
strain were plated onto Mueller Hinton plates +/- Atc supplementation (500 ng/ml) and 
incubated at 37˚C for 3-4 days.  As the concentration of inducer increased in the growth 
media, a corresponding increase in SecA2 K129R expression was observed by SecA2 
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immunoblots (data not shown).  High level expression of SecA2 K129R in both wild-type 
and ∆secA2 mutant strain backgrounds led to reduced growth in rich liquid media as revealed 
by growth curves (Figure 3.7A and C).  This is the first time we observed a phenotype in 
liquid media related to SecA2.  As expression of SecA2 K129R increased, the rich agar 
growth defect of both wild-type and ∆secA2 M. smegmatis also became more severe (Figure 
3.7B and D).  As a control, we also determined that overexpression of wild-type SecA2 does 
not exacerbate the rich agar growth defect of wild-type of ∆secA2 mutant M. smegmatis (data 
not shown).  These results confirmed that the rich agar growth defect associated with 
expression of SecA2 K129R is dosage dependent, and are consistent with secA2 K129R 
being a true dominant negative allele. 
A model to explain the exacerbated and dominant negative phenotypes caused 
by Walker box mutant secA2 alleles.  In the previous sections, we described a collection of 
experiments in M. tuberculosis and M. smegmatis in which secA2 Walker box mutants were 
tested.  The results are consistent across the various studies.  First, they clearly show that the 
Walker box is required for normal SecA2 function.  Second, they show that failure to express 
any secA2 is better than expressing a Walker box mutant secA2 allele.  Said another way, the 
phenotype associated with a Walker Box mutant secA2 allele is worse than a ∆secA2 deletion 
allele.  Third, they show secA2 Walker box mutants behave as dominant negative alleles.  A 
model to explain the secA2 Walker box mutant phenotype is as follows.  The Walker box 
mutations render SecA2 catalytically “dead”.  However, this “dead” protein may still interact 
with its normal binding partners, but due to the inability to hydrolyze ATP, remains in a 
locked complex.  In this way, the “dead” SecA2 Walker box molecules could titrate up 
interacting proteins.  If the SecA2-interacting proteins tied up in non-functional complexes 
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have additional and possibly essential functions in the cell, this would lead to exacerbated 
phenotypes like those we observed.  With this model in mind, as the levels of SecA2 K129R 
increase, the observed phenotypes would become more severe due to the increased 
production of non-functional complexes.  The translocase complex that functions with SecA2 
to promote export of a subset of proteins remains to be identified.  One strong possibility is 
that SecA2 works with the general Sec translocase.  With this possibility in mind, it is 
possible that the interacting proteins tied up by SecA2 K129R are components of the 
essential canonical Sec pathway (Figure 3.8).  The SecA2 Walker box mutants could bind 
irreversibly to the SecYEG translocase, thus compromising export of proteins in addition to 
Msmeg1704 and Msmeg1712.   
 The subcellular distribution of the dominant negative SecA2 K129R differs 
from the cytosolic distribution of wild-type SecA2.  As presented in Chapter 2, subcellular 
fractionation showed that M. smegmatis SecA2 is primarily localized to the cytoplasm of M. 
smegmatis, unlike M. smegmatis SecA1 and E. coli SecA (Figure 3.9A) (35).  As a way to 
understand phenotypes associated with the secA2 K129R allele, we tested the localization 
pattern of SecA2 K129R.  In fact, we found that SecA2 K129R is not enriched in the 
cytosolic/soluble fraction like wild-type SecA2 but, rather, is predominantly associated with 
the cell envelope that is comprised of cell membrane and cell wall (Figure 3.9D and E).   
This shift in localization suggested that the SecA2 K129R protein is trapped at the 
membrane (Figure 3.8).  This striking shift in subcellular localization is consistent with the 
model that SecA2 normally interacts transiently with a membrane-embedded channel to 
deliver proteins for export from the cytoplasm and that the Walker Box substitution in SecA2 
K129R causes the protein to become permanently associated with the membrane channel.  
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Permanent association of SecA2 K129R, due to a defect in ATPase activity, could 
compromise the efficiency of the translocase channel.  If this channel were essential, like the 
SecYEG translocase, the expected result would be impaired growth in a dosage-dependent 
manner, not unlike the phenotypes associated with the secA2 K129R allele. 
We also examined the localization of SecA1 in the presence of SecA2 K129R.  Of all 
the proteins in the canonical Sec pathway, we considered SecA1 a prime candidate for 
interacting with SecA2.  Although it remains controversial whether SecA functions as a 
dimer during the process of protein export, in other bacteria SecA is shown to form dimers.  
Thus, it seemed possible that SecA1 would form mixed dimers with SecA2.  If so, then 
SecA1 dimerization with SecA2 K129R would be expected to also shift SecA1 primarily to 
the cell envelope fraction.  In wild-type M. smegmatis, SecA1 is equally abundant in 
cytoplasmic and cell envelope fractions.  Examination of subcellular fractions of 
the ∆secA2/secA2 K129R strain revealed that localization of SecA1 is unaffected by the 
presence of SecA2 K129R (Figure 3.9D and E).  This result does not preclude the interaction 
of SecA2 with the canonical Sec pathway.  It does however suggest that the point of 
interaction is not SecA1. 
Isolation of spontaneous suppressors of the exacerbated rich agar growth defect 
caused by Walker Box mutant alleles.  Suppressor mutations can be useful in identifying 
functional domains of a protein (intragenic suppressors) or additional gene products involved 
in a biological process (extragenic suppressors) (2, 5, 16, 25, 28).  During initial experiments 
with the ∆secA2 M. smegmatis strains expressing M. tuberculosis secA2 K115R, M. 
tuberculosis secA2 D216N, or M. smegmatis secA2 K129R, spontaneous suppressors of the 
severe rich agar growth defect were observed (Figure 3.10A).  We therefore sought to 
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characterize suppressors of the dominant negative phenotype as a means of identifying 
SecA2 functional domains and SecA2-interacting proteins. 
Intragenic and extragenic suppressors of secA2 K115R.  As a starting point, we 
collected suppressors of the exacerbated rich agar growth defect caused by M. tuberculosis 
secA2 K115R (pNR7) expression in the M. smegmatis ∆secA2 mutant.  Suppressors were 
collected from independently grown cultures of the M. smegmatis ∆secA2 mutant carrying 
pNR7; this plasmid integrates in single copy into the attB site of the bacterial chromosome.  
Serial dilutions of each culture were plated onto Mueller Hinton agar to collect suppressors, 
and on 7H10 agar to obtain total CFU counts.  Using this method, we determined that the 
spontaneous suppressors arose at a relatively high frequency of 10-4.  All the suppressors we 
collected grew better than the starting strain (∆secA2/secA2 K115R) on Mueller Hinton agar.  
They did not, however, grow like wild-type M. smegmatis on rich agar.  Instead, they 
resembled the ∆secA2 mutant in exhibiting a minor growth defect on Mueller Hinton agar.  
As a first step to characterize the suppressors, we tested each for normal SecA2 expression 
by anti-SecA2 western blot.  Of the 11 suppressors we isolated, 9 still expressed full-length 
SecA2 at normal levels (data not shown). 
To determine whether these suppressors were intragenic or extragenic, we prepared 
genomic DNA from each of the SecA2-expressing suppressors.  We then PCR amplified 
secA2 K115R integrated at the chromosomal attB site and sequenced the entire gene.  One of 
the suppressor mutations mapped to the secA2 K115R allele.  One of these intragenic 
suppressors contained an in-frame, unmarked 8 amino acid deletion of residues 681-688 in 
the IRA1 subdomain (13, 48).  Each of the subdomains of SecA2, including IRA1, will be 
discussed in more detail below.   
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The remaining suppressors did not have mutations in secA2 K115R; this implies the 
suppressor mutation is elsewhere in the genome.  To confirm that the suppressor mutation is 
unlinked to the secA2 K129R allele, we used a technique to reintroduce a fresh Walker Box 
mutant secA2 K129R allele into the attB site (37).  In these suppressors, SecA2 K115R is 
encoded on a plasmid that is integrated into the chromosome based.  By electroporating a 
second copy of this integrating plasmid, the original resident vector (encoding SecA2 
K115R) is excised while the incoming vector integrates in the chromosome.  This technique 
allows replacement of the resident secA2 K115R allele with a fresh copy of secA2 K115R.  In 
all cases we tested, the final resulting strain still exhibited the suppressor phenotype, 
confirming that the suppressor is indeed extragenic (data not shown).  Together, these results 
demonstrated the feasibility of performing a suppressor screen in M. smegmatis to identify 
intragenic and extragenic suppressors of Walker Box secA2 mutant alleles.   
Comprehensive screen to identify suppressors of the ∆secA2 mutant rich agar 
growth defect exacerbated by expression of secA2 K129R.  To expand our search for 
suppressors, we isolated suppressors of the exacerbated rich agar growth defect using the M. 
smegmatis ∆secA2 mutant expressing M. smegmatis secA2 K129R from the chromosomal 
attB locus.  By choosing this starting strain, we hoped to avoid any possible complications 
that could arise from mixing bacterial systems as might occur by expressing M. tuberculosis 
secA2 K115R in a M. smegmatis ∆secA2 mutant.  Suppressors were isolated by plating serial 
dilutions of independently grown cultures onto Mueller Hinton agar plates.  As above, we 
also plated dilutions onto 7H10 agar to obtain total CFU counts and calculate how frequently 
suppressors arose.  Again, the frequency of recovering spontaneous suppressors was 10-4.  
Interestingly, we noticed some of the suppressors had a smaller (S) colony size than other 
 99 
larger colonies (B).  However, in further analysis, both S and B colony types displayed 
similar sized colonies on rich agar plates.  Like the suppressors of M. tuberculosis secA2 
K115R, the suppressors of M. smegmatis secA2 K129R did not exhibit the severe growth 
defect of the starting strain, and the suppressors again resembled ∆secA2 null mutants when 
grown on rich agar plates and when tested for sensitivity to sodium azide. 
In total, we collected 55 suppressors, 34 of which expressed full-length SecA2 at 
normal levels as determined by Western blot (data not shown).  As described above, we PCR 
amplified secA2 from genomic DNA isolated from each suppressor strain, and sequenced the 
entire secA2 K129R allele in the attB locus to determine if the suppressor were intragenic or 
extragenic.  We thus identified 9 suppressors with intragenic mutations (within secA2 
K129R), and 23 with no mutation in secA2 K129R, which presumably represent extragenic 
suppressors.  In the following sections, we describe the identity and analysis of the intragenic 
suppressors.  We have yet to identify the extragenic suppressors, but we outline a potential 
strategy for doing so.  
Intragenic suppressors of SecA2 K129R map to different subdomains of SecA2.  
The sequenced intragenic suppressor mutations are shown in Table 1.  These mutations fall 
into four subdomains of SecA2: NBD1, IRA1, IRA2, and PPXD (13, 47) (Table 1).  With the 
exception of the IRA2 suppressor, we identified at least two suppressor mutations within any 
given subdomain.  We mapped the location of each intragenic suppressor mutation onto the 
structural prediction model of SecA2.  When viewed as a space-filled image, the NBD1, 
IRA1, and PPXD mutations all appear to be surface exposed (Figure 3.10B and Figure 3.11).  
Since these suppressor mutations are restricted to the surface exposed regions of SecA2 
K129R, it is possible that the mechanism of suppression is similar.  These surface exposed 
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regions could be important for protein-protein interactions.  We discuss the possibility that 
the intragenic suppressors disrupt protein interactions in more detail below. 
To confirm that the suppressor phenotype was due to the sequenced mutation in 
secA2 K129R and not to a second site mutation, we reconstructed a representative suppressor 
of each subdomain.  Genomic DNA was prepared from suppressor mutants and used as 
templates to PCR amplify the secA2 K129R suppressor allele.  The resulting PCR products 
were subcloned into pCR2.1 and sequenced to verify that the secA2 gene still contained the 
K129R mutation, as well as the intragenic suppressor mutation.  The secA2 K129R 
suppressor allele was then subcloned into pMV306, the same vector originally used to 
integrate secA2 K129R into the attB site of the chromosome.  The resulting vectors were 
electroporated into ∆secA2 mutant M. smegmatis, and transformants were tested for rich agar 
growth defects and sensitivity to sodium azide.  For all intragenic suppressors tested, the 
suppressed phenotype was again seen when reintroduced into the ∆secA2 mutant strain.  All 
reconstructed suppressor mutants again exhibited a phenotype equivalent to a ∆secA2 mutant 
background as opposed to the exacerbated phenotype of the ∆secA2 mutant expressing secA2 
K129R (Figure 3.12).  This confirmed that the sequenced intragenic mutations are sufficient 
to account for suppression of the secA2 K129R phenotype. 
Three intragenic suppressors hit the same amino acids in NBD1 (nucleotide binding 
domain).  NBD1 and IRA2 together form the ATP-binding N-domain (13, 47).  In two 
independent isolates, we identified a deletion of residues 182-185 (STAD) and in another 
suppressor, a duplication of residues 182-185 (STADSTAD) was found.  NBD1 is 261 amino 
acids in length and it includes the Walker Boxes required for ATP binding.  However, it 
seems highly unlikely these mutants have any impact on ATP binding in SecA2 K129R.  The 
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NBD1 and IRA2 suppressor mutations are not found in the Walker Box motifs, and since the 
K129R substitution is intact in these suppressors as confirmed by DNA sequencing, we 
expect the intragenic suppressors remain defective for ATP binding. 
Another intragenic suppressor has an amino acid substitution mutation in the IRA2 
subdomain where threonine 459 is replaced with isoleucine (T459I).  As with the NBD1 
mutations, this IRA2 mutation is also far from the ATP binding site of SecA2 and seems 
unlikely to have any effect on ATP binding.  On one helix of the IRA1 subdomain, we found 
two independent 8 amino acid in-frame deletions of residues 732-739 or 734-741 of M. 
smegmatis SecA2 K129R.  With M. tuberculosis SecA2 K115R, we found an 8 amino acid 
in-frame deletion on the other helix composed of residues 681-688.  IRA1 forms two helices 
joined by a loop, and is important for regulating SecA ATPase activity (48).  Recently, a 
crystal structure of a SecY-SecA complex revealed a role for IRA1 in contacting the opening 
of the SecY pore as well as pre-proteins (15, 50).  Finally, we identified two independent 
mutations in pre-protein binding domain PPXD: a substitution of aspartic acid 326 to 
histidine (D326H), and an insertion of a glutamic acid residue at position 364.   
How do these intragenic suppressors function?  Our model to explain the exacerbated 
dominant negative phenotypes associated with SecA2 K129R is that disrupting the Walker 
Box motif renders SecA2 catalytically “dead” (Figure 3.13).  However, this “dead” protein 
can still interact with its normal binding partners, including some factors that are part of an 
essential process.  By titrating essential factors in non-functional complexes, the “dead” 
SecA2 K129R molecules could produce the exacerbated and dosage-dependent phenotypes 
we observed.  We hypothesize that surface exposed intragenic suppressor mutations might 
disrupt protein interaction domains.  In this case, SecA2 K129R is still “dead” because the 
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Walker Box is still mutated, but SecA2 K129R is no longer able to form non-functional 
complexes.  Such suppressors would effectively lack functional SecA2 protein.  The resulting 
phenotype of the suppressor then should resemble that of a ∆secA2 null mutant; indeed, all of 
the intragenic suppressors we isolated phenotypically resemble a ∆secA2 mutant.  Mutations 
that decrease the structural stability of SecA2 K129R could also lead to the suppressor 
phenotype.  However, all of our intragenic suppressors expressed SecA2 K129R normally 
with no evidence of protein degradation, which makes this explanation seem unlikely (data 
not shown).  One other possibility is that the suppressor mutations restore ATP binding to 
SecA2 K129R.  However, since the K129R substitution is maintained in each suppressor, and 
none of the suppressor mutations map in the immediate vicinity of the Walker box, this 
mechanism of suppression also seems an unlikely explanation. 
Localization of SecA1 and SecA2 differs in the intragenic suppressors.  Using our 
subcellular fractionation scheme, we determined the localization of SecA1 and SecA2 in the 
intragenic suppressor strains.  We determined previously that SecA1 is equally distributed 
between soluble and cell envelope fractions, wild-type SecA2 is predominantly cytoplasmic, 
and SecA2 K129R is found predominantly in the cell envelope fraction.  Earlier, we 
proposed that the altered localization of SecA2 K129R is linked to the dominant negative 
phenotype.  Based on the model we described above, if the intragenic suppressors disrupt 
interaction of SecA2 K129R with a membrane-associated protein, we predicted localization 
of SecA2 would change in the suppressor strains.  This turns out to be the case.  Figure 
3.14A shows that representative intragenic SecA2 K129R suppressors in IRA1, IRA2, and 
PPXD changed the localization of SecA2 K129R from primarily being membrane-associated 
to being enriched in the soluble fraction.  The localization change is not as dramatic in the 
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NBD1 suppressor, but there is still a significant shift to the soluble fraction.  The fact that 
suppressors of the secA2 K129R phenotype result in restoration of the normal SecA2 
localization profile provides strong support for our proposal that the entrapment of SecA2 
K129R at the membrane is critical to the dominant negative phenotype.  It is also consistent 
with our proposal that the intragenic suppressors we collected alleviate the growth defect of 
secA2 K129R allele by eliminating protein interactions with a membrane-associated complex. 
We also looked at the localization of SecA1 in the intragenic suppressor strains 
(Figure 3.14B).  In the IRA1 suppressor, SecA1 distribution was unaltered.  It remains 
equally divided between cell envelope and cytoplasm.  However, in the IRA2 and NBD1 
suppressors, the localization of SecA1 skewed toward the envelope fraction.  In the PPXD 
suppressor, the localization of SecA1 was skewed toward the soluble fraction.  There is no 
obvious explanation for the different effects the individual suppressors have on SecA1 
localization; however, this result was consistently reproduced when fractions were made 
from independent experiments.   
Intragenic suppressor mutations reveal residues important for SecA2 function.  
The residues mutated in our intragenic suppressors are not reported in any of the prior 
extensive mutational analyses of SecA proteins in other bacteria (5, 6, 16, 25, 26, 28, 48).  
However, ours is the first study directed at finding suppressors of a Walker Box mutant of 
any secA.  It is also the first suppressor analysis of any secA2 mutant.  We propose that the 
intragenic suppressor mutations we identified were able to suppress the phenotype associated 
with SecA2 K129R because they prevent SecA2 K129R from interacting with an essential 
SecA2-interacting protein complex.  If true, then these suppressor mutations would also be 
expected to disrupt wild-type SecA2 function even in the absence of the K129R substitution.  
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To test this prediction, we used site-directed mutagenesis to restore the Walker Box of three 
representative SecA2 K129R intragenic suppressors (IRA1 ∆734-741, IRA2 T459I, and 
NBD1 STADSTAD) back to the wild-type lysine residue.  The result was three new secA2 
mutant alleles, all of which have an intact Walker box capable of binding ATP.  The resulting 
plasmids were then electroporated into wild-type and ∆secA2 mutant M. smegmatis.  Each 
mutant was then tested for ∆secA2 mutant phenotypes.  All three of these mutant alleles 
failed to complement the azide hypersensitivity (Figure 3.15A) or the rich agar growth defect 
(Figure 3.15B and C) of a ∆secA2 mutant.  Expression of these allele in wild-type M. 
smegmatis had no effect.  Each protein was expressed normally as determined by anti-SecA2 
immunoblot (data not shown).  From these results, we conclude that the intragenic suppressor 
mutations generate recessive null alleles of secA2.  These results support the idea that 
intragenic suppressors of secA2 K129R alleviate the exacerbated plate phenotypes by 
rendering SecA2 K129R nonfunctional, probably by disrupting interactions between SecA2 
K129R and factors involved in the SecA2 export pathway.   
Efforts to identify extragenic suppressors of secA2 K129R.  After sequencing 
secA2 K129R, 23 suspected extragenic suppressors of the rich agar growth defect remained.  
Cloning the suppressor by standard molecular biology protocols has proved technically 
challenging and, to date, we have not identified the genetic locus of these extragenic 
suppressors.  Because we consider it a possibility that SecA2 interacts with components of 
the essential Sec pathway, we considered secA1 and secY attractive candidates for being the 
site of extragenic suppressor mutations.  However, direct sequencing showed no mutations 
mapped to these two genes in the extragenic suppressors (data not shown). 
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Currently, we are constructing genomic libraries to clone the suppressor by 
complementation.  The library needed depends on the nature of the suppressor mutation.  The 
first scenario is if the suppressor is recessive.  In this case, a merodiploid that contains the 
suppressor mutant allele and the parental wild-type allele will exhibit the severe rich agar 
growth defect of the starting ∆secA2/secA2 K129R strain.  A library made from wild-type 
genomic DNA will be electroporated into the suppressor strain.  The resulting transformants 
will be plated onto 7H10 minimal agar plates.  Next, we will screen the transformants for the 
severe growth defect on Mueller Hinton rich agar by patching.  Patches that grow poorly on 
rich agar should contain a vector carrying the wild-type parental suppressor allele. 
If the suppressor is dominant, however, the library needs to be constructed from each 
suppressor and transformed into the starting strain where the suppressors were isolated: the 
M. smegmatis ∆secA2 mutant expressing secA2 K129R.  In this case, the resulting 
transformants will be screened by patching to identify clones without the severe rich agar 
growth defect.  Said another way, vectors that carry a dominant suppressor allele will 
alleviate the rich agar growth defect associated with secA2 K129R.  Not knowing whether the 
suppressors are dominant or recessive is a complicating factor.  Another problem is the rate 
at which we initially obtained the suppressors.  The observed frequency of the spontaneous 
rich agar suppressors is 10-4, which precludes the use of libraries with small DNA inserts.  
Consequently, we want to use cosmid libraries in this project.  In addition, we wanted to use 
a single-copy cosmid library to avoid artifacts associated with multicopy suppression.  Since 
the attB site is occupied by secA2 K129R in all our suppressors, we could not use the existing 
integrating M. smegmatis genomic libraries.  Recently, we obtained a new cosmid vector that 
integrates elsewhere in the mycobacterial chromosome to use in construction of new M. 
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smegmatis libraries for this project (gift from Dr. William Jacobs, Albert Einstein College of 
Medicine). 
Localization of SecA1 and SecA2 differs in the extragenic suppressors.  As with 
the intragenic suppressors, we determined the localization profile of SecA1 and SecA2 in two 
candidate extragenic suppressors.  We chose two suppressors, 7S and 20B, which were 
isolated from independently grown cultures as having small and large colonies, respectively.  
Like all of the isolated suppressors, 7S and 20B suppress the rich agar growth defect to the 
level of a ∆secA2 mutant.  As observed with the intragenic suppressors, we found SecA2 
K129R to be released from the envelope fraction in extragenic suppressors 7S and 20B 
(Figure 3.16A).  This finding supports the idea that the extragenic suppressors alleviate the 
toxic phenotype of SecA2 K129R by eliminating the interaction between SecA2 K129R and 
the membrane-associated complex.  One way this could occur is if the 7S and 20B 
suppressors have mutations in components of the membrane-associated complex that prevent 
interaction with SecA2.  For this reason, we believe the extragenic suppressors have great 
potential to identify proteins that work with SecA2 in export.  
We also examined the localization of SecA1 in 7S and 20B.  In 7S, SecA1 was 
slightly more abundant in the envelope fraction; in wild-type M. smegmatis, SecA1 is evenly 
split between the envelope and the soluble fraction.  Strikingly, in 20B, SecA1 was found 
predominantly in the soluble fraction (Figure 3.16B).  The drastic change in localization 
pattern of SecA1 in 20B would be consistent with a suppressor mutation that maps to secA1.  
However, direct sequencing of secA1 in 20B showed this is not the case.  It is possible that 
the suppressor mutation is in another component of the Sec pathway and that this mutation 
alters the subcellular localization of SecA1.   
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Msmeg1712-HA is not exported to the cell wall in extragenic suppressor 7B and 
20S.  In an effort to link our extragenic suppressors to export of SecA2-dependent protein 
export, we examined the ability of two extragenic suppressors to export the Msmeg1712.  As 
shown previously, Msmeg1712 is exported to the cell wall of M. smegmatis in a SecA2-
dependent manner (20).  We transformed 7S and 20B with pNR35 which expresses 
Msmeg1712 tagged at the C-terminus with the HA epitope.  The resulting transformants were 
grown in Mueller Hinton broth and the cultures were fractionated as described above.  As 
shown in Figure 3.17, Msmeg1712-HA is exported to the cell wall only when wild-type 
SecA2 is present.  When SecA2 K129R is present, Msmeg1712-HA fails to reach the cell 
wall and accumulates in the cytoplasm.  In suppressor 7S and 20B, Msmeg1712-HA is 
similarly retained in the cytoplasm.  This indicates that the extragenic suppressor mutations 
in these two strains do not allow Msmeg1712-HA to bypass the requirement of SecA2 for 
export.  It also confirms our other data indicating that the extragenic suppressors behave like 
∆secA2 null mutations.   
Discussion 
 In this study, we showed that the Walker Box motif is required for normal SecA2 
function.  We exhaustively tested this by using different assays in both M. tuberculosis and 
M. smegmatis, and our results all lead to the same conclusion – SecA2 must bind ATP to 
function normally.  We also showed that mutations in the SecA2 Walker box region are 
dominant negative and change the normal subcellular localization of SecA2 from the 
cytoplasm to the membrane.  Dominant negative alleles can be extremely useful in 
identifying proteins that work together in a biological pathway.  Using a dominant negative 
secA2 K129R allele, we were able to isolate spontaneous suppressor mutations.  We believe 
 108 
our collection of intragenic and extragenic suppressors have great potential to uncover 
functional domains of SecA2 and identify proteins that work with SecA2 in protein export.    
 SecA2 must bind ATP to function in vivo.  Our other studies showed that SecA1 
and SecA2 of M. tuberculosis are functional ATPases in vitro (Chapter 4) (24).  Here we 
tested the biological significance of ATP binding by evaluating mutants with an amino acid 
substitution in the ATP binding site of SecA2.  Mutations in the Walker A (K108R) and 
Walker B (D209N) motifs of E. coli SecA destroy ATP binding and render SecA 
nonfunctional in a variety of in vitro and in vivo assays (27, 35).  In E. coli SecA, these 
Walker Box mutations also alter the subcellular localization of SecA by preventing its 
dissociation from the membrane as a consequence of failing to cycle between ATP binding 
and hydrolysis.  Here, we constructed the corresponding Walker Box mutations in M. 
tuberculosis (K115R and D216N) and M. smegmatis (K129R) SecA2 and tested each for 
function in vivo.  This is the first study of ATPase activity in any accessory SecA2 protein. 
The K115R Walker Box substitution prevented SecA2 from carrying out its function 
in promoting growth of M. tuberculosis in macrophages.  The same K115R mutation also 
failed to complement the smooth colony morphology phenotype of the ∆secA2 mutant of M. 
tuberculosis (30).  These two results indicated that normal SecA2 function in M. tuberculosis 
requires ATP binding.  While the explanation for the intracellular growth defect and smooth 
colony morphology of the ∆secA2 mutant is not yet known, we believe both phenotypes 
result from the inability of the ∆secA2 mutant to export proteins that rely on the accessory 
SecA2 system.  In regards to the altered colony morphology of the ∆secA2 mutant, often 
such changes are due to alterations to the cell surface.  This could arise from the ∆secA2 
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mutant failing to export cell wall biosynthetic enzymes.  Interestingly, a ∆secA2 mutant of 
Listeria monocytogenes also has altered colony morphology (33). 
We also directly tested the ability of SecA2 K129R to support protein export in M. 
smegmatis.  Previous studies in our laboratory identified Msmeg1704 and Msmeg1712 as M. 
smegmatis lipoproteins that require SecA2 for export from the cytoplasm to the cell wall 
(20).  We found SecA2 K129R was incapable of exporting these two SecA2-dependent 
lipoproteins.  This result directly demonstrates the requirement for the ATPase activity of 
SecA2 in promoting export of its select substrates.   
 Walker Box mutant secA2 alleles are dominant negative.  Early on we were 
surprised to discover Walker Box mutant alleles were not only non-functional, as shown by 
the failure to complement ∆secA2 mutant phenotypes, but in several assays the phenotypes 
associated with the Walker Box secA2 alleles were actually worse than that of a ∆secA2 null 
mutant.  This type of result is common for dominant negative mutations (10, 40, 43, 46).  In 
other experiments, we noticed expression of mutant Walker Box secA2 alleles in wild-type 
mycobacteria resulted in dominant negative ∆secA2 mutant phenotypes.   Expression of 
Walker Box mutant secA2 alleles (secA2 K115R, secA2 D215N, and secA2 K129R) in wild-
type M. tuberculosis resulted in smooth colonies like those exhibited by the ∆secA2 mutant.  
Expression of M. smegmatis SecA2 K129R in wild-type M. smegmatis also resulted in 
dominant negative phenotypes as assessed by rich agar plating and azide sensitivity.  Often, 
dominant negative mutations exhibit dosage dependent effects (2).  By using multicopy and 
inducible secA2 K129R alleles expressed in wild-type M. smegmatis, we observed that 
severity of the phenotypes associated with SecA2 K129R was indeed dosage dependent.  
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Together our data convincingly show substitutions in the Walker Box of SecA2 to be 
dominant negative. 
 There is a precedent for Walker Box mutations being dominant negative.  As 
mentioned above, the E. coli SecA K108R mutant was instrumental in demonstrating the 
importance of ATPase activity for the canonical SecA (35).  SecA K108R inhibits proOmpA 
export in vitro in the presence of wild-type SecA.  While not specifically mentioned, this 
phenotype is consistent with a dominant negative.  The DotB ATPase is part of a Type IV 
secretion system of Legionella pneumophila that is required for growth of this pathogen in 
host cells (43).  A DotB K162Q Walker Box mutant fails to support bacterial growth of a 
∆dotB mutant inside host cells.  Furthermore, a dotB/dotB K162Q merodiploid fails to grow 
intracellularly.  DotB K162Q forms mixed multimers with wild-type DotB, effectively 
disrupting the Type IV secretion system.  Finally, Walker box mutants of the PilQ subunit of 
E. coli type IV pili are also dominant negative (40).  In the presence of wild-type PilQ, PilQ 
K238Q inhibits pilus formation.  These diverse studies demonstrate the ability of Walker Box 
mutations to poison the processes with which they are involved.  
Figure 3.13 shows a model to explain the phenotypes associated with SecA2 K129R.  
In a wild-type cell, SecA2 interacts with a membrane-embedded translocase to promote its 
export of a select subset of proteins.  Because expression of SecA2 K129R causes 
phenotypes more severe than when there is no SecA2 present and because high level 
expression of SecA2 K129R prevents growth, we propose that SecA2 K129R interferes with 
an essential process.  For this reason, we consider components of the essential Sec pathway 
to be attractive candidates for SecA2-interactors tied up by SecA2 K129R.  The primary 
function of SecA2 may be to deliver proteins to the translocase.  Such a role would help 
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explain the largely cytosolic location of wild-type SecA2, in comparison to SecA1.  
Alternatively, the role of SecA2 may be to provide energy to drive a select subset of proteins 
through the membrane-embedded translocase.  In either case, when the Walker Box of 
SecA2 is mutated, SecA2 K129R is no longer able to bind and hydrolyze ATP like wild-type 
SecA2 (24).  Accordingly, SecA2 K129R would be unable to undergo conformational 
changes associated with ATP hydrolysis.  As a result, SecA2 K129R could become 
irreversibly locked to a component of the SecYEG translocon.  This proposal is consistent 
with our observation of altered SecA2 K129R localization.  Since the canonical Sec pathway 
is essential, locking SecA2 K129R to the translocase would effectively poison the cell by 
disrupting export of other proteins via the general Sec pathway.   
The azide hypersensitivity phenotype further supports the possibility of an interaction 
between SecA2 and the essential Sec pathway (8).  Azide is an inhibitor of ATPases, and in 
mycobacteria, SecA1 is the major target of azide (18).  The azide hypersensitivity associated 
with the M. smegmatis ∆secA2 mutant could reflect a role for SecA2 in assisting SecA1 to 
export essential proteins.  Furthermore, inhibiting SecA1 by azide treatment coupled with 
expression of SecA2 K129R would then greatly impair the essential Sec pathway.  In fact, 
the exacerbated azide hypersensitivity observed in a secA2 K129R strain supports this model.     
In the model above, we propose the toxicity associated with expression of SecA2 
K129R, is due to formation of non-functional complexes between SecA2 and components of 
the essential Sec translocase.  However, it is also possible that SecA2 interacts with an 
unidentified membrane-embedded translocase to export pre-proteins out of the cytoplasm.  
Based on the exacerbated phenotypes associated with SecA2 K129R, we believe that this 
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mystery translocase would have to either export essential factors or itself be essential for 
some other reason.   
 Spontaneous suppressors of secA2 129R arise frequently.  Isolating suppressors of 
secretion defects in E. coli led to the discovery of several components of the essential Sec 
pathway (6, 16, 25). We hypothesized a similar approach would be useful for identifying 
components of the accessory SecA2 pathway in M. smegmatis.  Although numerous 
suppressors of various protein export defects in E. coli have been studied in the past, 
suppressors of Walker Box mutant secA alleles have never before been collected.  Such a 
screen would be possible because the E. coli SecA K108R Walker box mutant displays a 
dominant negative phenotype (35).  Adding SecA K108R inhibits translocation of proOmpA 
in vitro in the presence of wild-type SecA.   
Intragenic suppressors.  We identified seven different intragenic suppressors of M. 
smegmatis secA2 K129R and one intragenic suppressor of M. tuberculosis secA2 K115R.  All 
of the intragenic suppressors behaved like ∆secA2 null mutations in several different assays.  
With the model we proposed (Figure 13), it follows that a suppressor mutation that prevents 
binding between SecA2 K129R and a SecA2-interacting protein would be expected to 
behave like a null mutations.  Indeed, when the intragenic suppressors were retested in the 
context of a corrected (wild-type) Walker box, they behaved like nulls.  We grouped the 
possible mechanisms of suppression into three broad categories: 1) disrupting protein 
interaction domains, 2) destabilizing the structural integrity of SecA2 K129R, and 3) 
restoring ATPase activity.  Although more experiments are required to determine the 
mechanistic basis of suppression, we think the most likely explanation is that the intragenic 
suppressor mutations disrupt protein interaction domains, thereby preventing SecA2 K129R 
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from interfering with an essential membrane-associated complex.  All suppressors expressed 
equal levels of SecA2 K129R protein as the starting mutant strain and there was no evidence 
of protein degradation (data not shown).   Moreover, since each suppressor still contains the 
K129R substitution, and none of the suppressors map directly to the Walker Box amino 
acids, we find it unlikely ATP binding and ATPase activity could be restored in the 
intragenic suppressors. 
As stated earlier, the exact mutations we identified as intragenic suppressors have not 
previously been hit in any of the prior extensive mutational analyses conducted on E. coli 
SecA (16, 25, 28, 48).  The resulting amino acid substitutions do map to structurally and 
functionally defined domains of E. coli SecA (13, 47).  However, it is important to 
emphasize that all these domains are large regions that remain to be fully characterized and 
might possess functions in addition to those currently known.  Furthermore, there could be 
novel functions associated with these domains in accessory SecA2 proteins.  Therefore, 
caution is required when attempting to interpret the significance of the intragenic suppressors 
of SecA2 K129R uncovered in our studies. 
We mapped each suppressor mutation onto a structural homology model of SecA2.  
Ideally, we hope to identify suppressor mutations in protein interaction domains of SecA2.  
Unfortunately, the domains of SecA2 that are most relevant to our model of how the 
intragenic suppressors might function (i.e. those domains that participate in or stabilize 
SecYEG interactions) are only just starting to be defined even for E. coli SecA.   
The intragenic suppressor mutations we identified have not been picked up in any of 
the prior extensive studies of E. coli SecA.  Most of the intragenic suppressor mutations we 
identified were surface exposed and thus positioned at sites that could possibly participate in 
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interactions with other proteins.  Two intragenic mutations mapped to the PPXD subdomain, 
which in E. coli is important for interaction with pre-protein substrates (36).  Two 
substructures within PPXD, Stem and Bulb, are involved in binding the signal sequence and 
the mature domain of a pre-protein substrate (36).  However, it is important to emphasize that 
this has only been shown for one native SecA substrate, proOmpA.  The D326H mutation we 
discovered in SecA2 is just 3 amino acids upstream of two residues important for normal E. 
coli SecA function: Y326 and I327 (Figure 3.11) (28, 29).  Site-directed mutagenesis studies 
have shown that Y326 is critical for E. coli SecA to interact with pre-protein substrates, but 
not for interactions with SecYEG or the membrane.  The affinity of SecA I327S for pre-
proteins was also predicted to be reduced.   
Elsewhere in PPXD, we obtained an insertion mutation at residue 364 of SecA2.  This 
mutation is near the E. coli secA suppressor allele prlD5 (A373V).  The prlD5 mutant was 
isolated as a suppressor that rescued export of a mutant maltose-binding protein with a 
defective signal sequence (16).  The prlD5 suppressor mutation reveals a role for the PPXD 
domain of SecA in pre-protein interaction.  Interestingly, NMR structural studies showed that 
residue A373 is found on the surface of the Stem substructure (36).  We have not tested the 
affinity of our PPXD mutants for pre-proteins, but such an experiment could help us 
understand the function of the PPXD domain in SecA2. 
One explanation for how the PPXD suppressors alleviate the phenotypes associated 
with SecA2 K129R is that the mutations in PPXD prevent interactions between SecA2 
K129R and the membrane-embedded translocase.  A recent crystal structure of a SecA-SecY 
complex from Thermotoga maritima shows that PPXD makes substantial contacts with SecY 
(50).  In fact, the two IRA1 helices are inserted into the entrance of the SecY channel.  
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Crosslinking studies show that IRA1 can also interact with pre-proteins and feed them into 
the translocase (15).  This suggests a plausible mechanism for how mutations in IRA1 can 
suppress the SecA2 K129R mutant.  Since IRA1 is important for SecA-SecY interactions, 
mutations in IRA1 could prevent occupation of the SecY channel by SecA2 K129R.  
Mutations in IRA1 could also prevent SecA2 K129R from binding and sequestering essential 
pre-proteins substrates.  It will be important to identify the translocase channel used by 
SecA2 to distinguish between these possible models. Furthermore, some mutations in SecA 
PPXD prevent stable interactions with SecY.   
 In E. coli SecA, the IRA1 subdomain is important for coupling ATPase activity to the 
process of protein translocation (48).  Directed mutagenesis studies of the SecA IRA1 
domain have helped to dissect the regulatory functions of this subdomain (Figure 3.11).  One 
of these mutants, F811A, is found in the region where we found a deletion in SecA2 IRA1; in 
E. coli, secA F811A was able to complement a temperature sensitive secA mutant, although 
not as efficiently as wild-type secA and when tested for in vitro translocation SecA F811A 
protein exhibits a protein export defect.   
Another explanation for how the secA2 K129R suppressors in PPXD could function is 
that one role of SecA2 is to assist SecA1 to export a subset of proteins needed for normal 
growth on rich agar.  In the absence of SecA2, export of such proteins is still possible, but 
much less efficient.  The result would be the rich agar growth defect observed with the 
∆secA2 mutant.  Perhaps SecA2 K129R irreversibly binds to these pre-proteins and delivers 
them to the translocase, but by failing to release them as a result of the ATPase defect, 
prevents their export altogether.  This would lead to the exacerbated rich agar growth defect 
that is characteristic of the ∆secA2 mutant expressing secA2 K129R.  If mutations in the 
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PPXD of SecA2 relax interactions with pre-proteins, perhaps the pre-proteins can now be 
exported as in a ∆secA2 mutant.  Regardless of the mechanism, the phenotype of a SecA2 
K129R suppressor in PPXD is equivalent to a ∆secA2 mutant. 
Some of the SecA2 K129R suppressor mutations are in close proximity to 
characterized SecA mutations.  For example, temperature-sensitive mutations in SecA NBD1 
have been identified as A169D and Y170D.  When grown at the non-permissive temperature, 
both secA A169D and secA Y170D mutants have a defect in exporting OmpA and MalE 
proteins (28, 42).  Both substitutions result in amino acids with significantly different 
properties, and are predicted to destabilize SecA structure.  It follows then that both of these 
SecA proteins cannot support protein export at high temperatures. 
According to our proposed model, the intragenic suppressor mutations we identified 
suppress SecA2 K129R by rendering it inactive.  If this is true, when the Walker Box 
mutation is repaired by changing residue 129 back to lysine, the suppressor mutations should 
still be nonfunctional.  We performed this experiment on intragenic suppressor alleles from 
three different subdomains (NBD1, IRA1, and IRA2).  As expected, the resulting alleles 
could not complement the rich agar growth defect and azide hypersensitivity phenotype 
displayed by the ∆secA2 mutant.  In addition, these alleles were recessive to wild-type secA2, 
as shown by the absence of any effect on wild-type M. smegmatis.  This analysis allowed us 
to identify new secA2 null alleles, and demonstrate the importance of each subdomain for 
normal SecA2 function in vivo. 
Extragenic suppressors.  Suppressor analysis has a long history of being used to 
identify interacting proteins and proteins that work together in a pathway.  Notably, 
suppressor analysis has been used in studies of the E. coli Sec pathway(5, 6, 45).  In E. coli, 
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prl alleles are dominant suppressors that were identified because they allow export of 
proteins with defective signal sequences.  The Prl mutations map to components of the 
canonical Sec pathway including SecA (PrlD), SecY (PrlA), and SecE (PrlG), and are 
thought to support protein export because of a diminished specificity for aberrant signal 
sequences.  Combinations of some prlA and prlG alleles lead to synthetic phenotypes; these 
allele-specific phenotypes are indicative of contact sites between SecY and SecE (3).  We 
hope that by identifying extragenic suppressors of SecA2 K129R, it will similarly help 
identify components involved in SecA2-mediated protein export.   
Both the intragenic and extragenic suppressors we identified exhibited the remarkable 
property of shifting the localization of SecA2 K129R away from the cell envelope to a 
predominantly soluble location, like that exhibited by wild-type SecA2.  We believe this 
result to have functional significance.  First, it supports our proposal that the membrane 
localization of SecA2 K129R is relevant to the dominant negative phenotype.  Second, it 
argues strongly for the suppressor mutations acting by alleviating non-functional interactions 
with a membrane complex.  Particularly, for the extragenic suppressors 7S and 20B the shift 
in SecA2 K129R localization suggests that the mutation in these strains eliminates an 
interaction with a component of the SecA2 protein export pathway as opposed to some 
indirect effect alleviating the dominant negative phenotype.  As stated previously, one 
possibility is that the suppressor mutations in 7S and 20B are themselves in a component of 
the membrane-embedded translocase.  Although it is not obvious why the intragenic and 
extragenic suppressors of SecA2 K129R alter the localization of SecA1, it is suggestive of a 
relationship between SecA2 and SecA1 and/or other components of the general Sec pathway.  
For these reasons, we are particularly interested in identifying the mutations in these strains.  
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We are currently using two approaches to locate the suppressor lesion in 7S and 20B by 
screening cosmid libraries (described in Results) and by sequencing the genome of the 
suppressor strains.  
Summary.  This study represents an important step in understanding how the 
accessory SecA2 protein export system of mycobacteria functions.  By mutating the Walker 
Box of SecA2, we showed that this ATP binding motif is absolutely required for normal 
SecA2 function in both M. tuberculosis and M. smegmatis.  We took advantage of the 
dominant negative properties of the Walker Box mutant SecA2 protein as a tool to study 
protein export.  The shifted localization of SecA2 K129R from the cytosol to the cell 
envelope reveals a role for SecA2 at the membrane.  Presumably, SecA2 associates with the 
membrane during delivery of pre-proteins to a membrane-embedded translocase.  Such an 
association, particularly if the membrane-embedded translocase is essential like SecYEG, 
could also explain the exacerbated phenotypes associated with expression of SecA2 K129R 
in a ∆secA2 mutant.  We collected intragenic and extragenic suppressors of the exacerbated 
rich agar growth defect.  Our analysis of the intragenic suppressors identified several key 
regions that are required for normal SecA2 function.  While we have not yet identified any of 
the extragenic suppressors, we believe that doing so has the potential to reveal SecA2-
interacting proteins.  It is our hope that a thorough understanding of all the factors involved 
in SecA2-mediated protein export will aid in the identification of new targets for anti-
mycobacterial therapies.  
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Table 3.1. Intragenic suppressors of M. smegmatis secA2 K129R 
and M. tuberculosis secA2 K115R 
 
isolate 
number 
subdomain 
location 
sequence details 
 
6S, 9S 
 
NBD1 
 
deletion of residues 182-185  
23S* NBD1 duplication of residues 182-185 
34S* IRA2 Thr 459 → Ile 
2S PPXD Asp 326 → His 
25S* PPXD Glu insertion at residue 364 
21B* IRA1 deletion of residues 734-741 
38S IRA1 deletion of residues 732-739 
SSW† IRA1 deletion of residues 681-688 
* indicates suppressors were subcloned and retested in M. smegmatis. 
†
  indicates suppressor of M. tuberculosis secA2 K115R.
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Figure 3.1.  The M. tuberculosis secA2 (K115R) allele does not complement the M. 
tuberculosis ∆secA2 mutant phenotype in macrophages.  (A) ClustalW sequence 
alignment of mycobacterial SecA2 proteins with E. coli and B. subtilis SecA.  The ATP-
binding Walker A lysine and Walker B aspartic acid are indicated in red.  (B) Murine bone 
marrow-derived macrophages were infected at a MOI of 1.0 with H37Rv, ∆secA2 mutant, 
∆secA2 mutant complemented with wild-type secA2, (∆secA2/secA2), and ∆secA2 mutant 
complemented with secA2 K115R (∆secA2/secA2 KR). CFU were determined by plating 
macrophage lysates at various times post-infection. The infection was performed with 
triplicate wells for each strain per time point, and the error bars represent means +/- standard 
deviations. Symbols for H37Rv and the complemented strain are overlapping in most time 
points in the graph presented. Data are representative of three independent experiments.  *,  
(P<0.05).  (C) Expression of SecA1 and SecA2 in strains with different secA2 alleles.  Equal 
amounts of formalin-fixed whole-cell lysates of the wild-type H37Rv, ∆secA2 mutant, 
∆secA2 mutant complemented with wild-type secA2, and ∆secA2 mutant complemented with 
secA2 K115R were run on SDS-polyacrylamide gels and subjected to Western blot analysis 
with anti-SecA1 or anti-SecA2 antibodies.  The top panel shows SecA1 protein and the lower 
panel shows SecA2 protein.  MW, molecular weight (in thousands).
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Figure 3.2.  SecA2 Walker box mutants fail to restore the rough colony morphology in 
∆secA2 M. tuberculosis.  (A) Wild-type (H37Rv) and ∆secA2 mutant (mc23112) M. 
tuberculosis strains were transformed with empty vector or wild-type M. tuberculosis secA2 
(Mtb secA2).   (B) Wild-type and ∆secA2 M. tuberculosis strains were transformed with a 
Walker Box mutant secA2 allele from M. tuberculosis (secA2 K115R).  All transformants 
were plated onto 7H10 agar plates containing 0.05% Tween 80.  Images of individual 
colonies were obtained after 3 weeks of growth at 37˚C.  Scale bar = 1.0 mm.
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Figure 3.3.  Construction and analysis of a M. smegmatis strain expressing secA2 K129R 
from the native chromosomal locus.  Diagram of the secA2 locus in a (A) ∆secA2 mutant 
NR116, (B) single crossover strain NR155, and (C) secA2 K129R strain NR179.  Bars below 
the line indicate where the probe hybridizes.  (D) Southern blot of BamHI digested genomic 
DNA.  BamHI restriction sites and predicted fragment sizes are indicated in A-C.  Lanes 1: 
mc2155, 2: NR116, 3: NR155, 4: NR179.  (E) Whole-cell lysates were prepared from each 
strain and equal amounts of protein were analyzed by SDS-PAGE and immunoblot with anti-
SecA1 and anti-SecA2 antibodies.  NR172, ∆secA2 mutant complemented with wild-type 
secA2 encoded by pYA810.  (F)  M. smegmatis strains were plated on Mueller Hinton agar 
plates.  Images were taken after 4 days of growth at 37˚C.
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Figure 3.4.  M. tuberculosis Walker Box mutant secA2 K115R allele fails to 
complement and exacerbates the M. smegmatis ∆secA2 mutant rich agar growth 
defect and azide hypersensitivity.  (A) M. smegmatis strains were transformed with 
empty vector, wild-type secA2 (secA2), or M. tuberculosis Walker Box mutant secA2 
(secA2 KR) plasmids and plated on 7H10 (top row) and Mueller Hinton (bottom row) 
plates and incubated at 37˚C.  (B) Sensitivity to sodium azide was measured as described 
in Methods.  Each strain was tested in triplicate.  Error bars represent standard error of the 
mean. 
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Figure 3.5.  M. smegmatis SecA2 K129R is unable to support the export of Msmeg1704-
HA and Msmeg1712-HA.  M. smegmatis strains carrying empty vector, wild-type secA2 
(secA2), or M. smegmatis Walker Box mutant secA2 (secA2 K129R) plasmids were 
transformed with vectors expressing HA-tagged Msmeg1704 or Msmeg1712.  Each strain 
was grown in 100 ml cultures of Mueller Hinton, harvested, lysed in a French pressure cell, 
and then fractionated into cell wall (CW), membrane (MEM), and soluble (SOL) fractions.  
Protein derived from an equal number of starting cells was analyzed by SDS-PAGE and 
immunoblot using anti-HA antibodies (Covance).  Goat anti-mouse secondary antibodies 
(Biorad) were used according to the manufacturer.  Blots were developed using ECL (Perkin 
Elmer) and visualized on film (Denville). 
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Figure 3.6.  M. smegmatis Walker Box mutant allele secA2 K115R fails to complement 
and exacerbates the M. smegmatis ∆secA2 mutant rich agar growth defect and azide 
hypersensitivity.  (A) M. smegmatis strains carrying empty vector, wild-type secA2 (secA2), 
or M. smegmatis Walker Box mutant secA2 (secA2 K129R) plasmids were plated onto 
Mueller Hinton agar plates.  Images were taken after 4 days of growth at 37˚C.  While not 
visible here, colonies of the ∆secA2 mutant expressing secA2 K129R will appear upon 
extended incubation.  Each strain was also tested for azide sensitivity in (B).  Note the 
exacerbated phenotype observed when secA2 K129R is expressed in wild-type M. smegmatis. 
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Figure 3.7.  SecA2 K129R is dominant negative.  Wild-type and ∆secA2 mutant M. 
smegmatis strains were transformed with pNR54 (secA2 K129R under control of an inducible 
promoter).  Transformants were grown in Mueller Hinton broth with various concentrations 
of Atc (closed circle, 0 ng/ml; open circle, 100 ng/ml; closed triangle, 200 ng/ml).  Growth of 
wild-type (A) and ∆secA2 mutant (C) was monitored by measuring OD600nm.  At 21 hours 
post inoculation, serial dilutions of the wild-type (B) and ∆secA2 mutant (D) cultures were 
plated onto Mueller Hinton plates containing 500 ng/ml Atc.  The plates were incubated at 
37˚C for 3-4 days. 
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Figure 3.8.  Model depicting SecA2 K129R interfering with the essential Sec 
pathway.  Normally, SecA2 exports proteins across the cytoplasmic membrane by 
transiently interacting with the SecYEG translocase.  Upon mutation of the Walker A 
motif, SecA2 K129R becomes permanently bound to the SecYEG translocase, 
compromising essential protein export and leading to a rich agar growth defect. 
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Figure 3.9.  Mutation of the SecA2 Walker Box changes localization of SecA2 from 
the cytoplasm to the cell envelope, while the localization of SecA1 remains 
unchanged.  Cultures of (A) wild-type, (B) ∆secA2 mutant, (C) ∆secA2 mutant 
complemented with wild-type secA2, and (D) ∆secA2 mutant carrying secA2 K129R were 
grown in Mueller Hinton until an OD600nm of 1.0.  Whole-cell lysates were used to make 
subcellular fractions as described in the Methods.  To analyze each fraction, protein 
derived from an equal number of cells was analyzed by quantitative immunoblot.  Anti-
SecA1 and anti-SecA2 antibodies were used at a 1:50,000 dilution and 1:20,000 dilution, 
respectively.  The cell wall porin MspA and cytoplasmic chaperone GroEL were used as 
quality controls for the fractionation.  Goat anti-rabbit secondary antibodies conjugated to 
alkaline phosphatase were used according to the manufacturer.  Immune complexes were 
developed using ECF and visualized using a phosphorimager.  All strains were assayed in 
triplicate.  Error bars indicate the standard error from the mean of three independent 
replicates.  Figures 3.9 A-C are the same as Figures 2.6 A-C. 
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Figure 3.10.  Spontaneous suppressors of the SecA2 KR rich agar growth defect can 
be isolated.  (A) M. smegmatis strains expressing different secA2 alleles after 4 days of 
growth on Mueller Hinton agar plates at 37˚C.  A typical suppressor is pictured at the 
right.  (B) Space-filling model of SecA2 homology model showing the location of 
identified intragenic suppressors.  The suppressors cluster in four different subdomains of 
SecA2: NBD1 (dark blue), IRA2 (cyan), IRA1 (yellow), and PPXD (pink).  Within each 
domain, the location of each suppressor mutation is indicated by different colors (orange, 
red, pink, and purple). 
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Figure 3.11.  ClustalW alignment of E. coli SecA and M. smegmatis SecA2.  
Suppressors of protein export defects in E. coli are indicated in red.  The location of the 
SecA2 K129R intragenic suppressors identified in this study is indicated in green.  The 
Walker A and Walker B ATP-binding motifs are indicated in bold.  Colored shading is the 
same as in Figure 3.10.
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Figure 3.12.  Phenotypes of representative suppressors of SecA2 K129R.  (A) Wild-
type, ∆secA2 mutant, ∆secA2 mutant complemented with secA2, and ∆secA2 mutant 
expressing secA2 K129R grown on Mueller Hinton (top) and 7H10 (bottom) plates.  (B) 
Intragenic suppressors of secA2 K129R representing the four different subdomains of 
SecA2.  (C) Two extragenic suppressors also suppress the exacerbated rich agar growth 
defect caused by SecA2 K129R.
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Figure 3.13.  A model to explain how intragenic suppressors of SecA2 K129R 
alleviate the exacerbated rich agar growth defect caused by SecA2 K129R.  As 
described in the text, one role of SecA2 might be to increase the efficiency of protein 
export through the SecYEG translocase.  SecA2 K129R becomes associated with the cell 
envelope, possibly interfering with the essential Sec pathway.  Mutations in SecA2 
K129R, particularly those that cause structural distortions, might release SecA2 K129R 
from the cell envelope.  In the resulting strain, export of proteins across the cytoplasmic 
membrane would be restored, although less efficient than in wild-type mycobacteria. 
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Figure 3.14.  Subcellular localization of SecA1 and SecA2 is altered in intragenic 
suppressors of SecA2 K129R.  Mueller Hinton-grown cultures of M. smegmatis were 
fractionated as described above.  Intragenic suppressors (PPXD, IRA2, IRA1, and NBD1) are 
indicated.  Protein derived from an equal number of cells was analyzed by SDS-PAGE and 
quantitative immunoblot with anti-SecA2 (A) or anti-SecA1 (B) antibodies.  Error bars 
represent the mean of three independent replicates of each strain.
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Figure 3.15.  Intragenic suppressor mutations of SecA2 K129R also render wild-type 
SecA2 nonfunctional.  Wild-type (mc2155) and ∆secA2 mutant (NR116) M. smegmatis 
strains were transformed with plasmids containing intragenic suppressor mutations in 
SecA2 domains (IRA1, IRA2, and NBD1) with a normal, wild-type Walker Box.  Each 
strain was assayed for sensitivity to sodium azide as described above.  Error bars represent 
the standard error from the mean of three replicates. 
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Figure 3.16.  The localization of SecA1 and SecA2 is altered in two different 
extragenic suppressors compared to wild-type M. smegmatis.  Subcellular fractions of 
M. smegmatis strains were generated and analyzed by SDS-PAGE and immunoblot for 
SecA2 (A) or SecA1 (B) as described above.  Error bars represent the standard error from 
the mean of three replicates. 
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Figure 3.17.  Msmeg1712-HA is not exported to the cell wall by two extragenic 
suppressors.  The export of Msmeg1712-HA was monitored as described above.  For 
each blot, equal proteins derived from the same number of starting cells were analyzed.  
Blots were probed with anti-HA antibodies, and the proteins were detected using ECF.  
The blots shown are representative of triplicate experiments. 
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The Sec-dependent translocation pathway that involves the essential SecA protein and 
the membrane-bound SecYEG translocon is used to export many proteins across the 
cytoplasmic membrane.  Recently, several pathogenic bacteria, including Mycobacterium 
tuberculosis, were shown to possess two SecA homologs, SecA1 and SecA2. SecA1 is 
essential for general protein export.  SecA2 is specific for a subset of exported proteins and is 
important for M. tuberculosis virulence.  The enzymatic activities of two SecA proteins from 
the same microorganism have not been defined for any bacteria.  Here, M. tuberculosis 
SecA1 and SecA2 are shown to bind ATP with high affinity, though the affinity of SecA1 for 
ATP is weaker than that of SecA2 or Escherichia coli SecA.  Amino acid substitution of 
arginine or alanine for the conserved lysine in the Walker A motif of SecA2 eliminated ATP 
binding.  We used the SecA2 (K115R) variant to show that ATP binding was necessary for 
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the SecA2 function of promoting intracellular growth of M. tuberculosis in macrophages.  
These results are the first to show the importance of ATPase activity in the function of 
accessory SecA2 proteins. 
Introduction 
Mycobacterium tuberculosis is the causative agent of the disease tuberculosis (TB).  
TB kills about 2 million people annually, and approximately one-third of the world’s 
population is currently infected with M. tuberculosis (40).  A serious problem in the 
worldwide fight against TB is the emergence of multidrug-resistant strains of M. 
tuberculosis.  To develop logical targets for new, effective drugs, the physiology of 
mycobacteria must be better understood.  
As with all bacterial pathogens, the majority of M. tuberculosis virulence factors are 
extracytoplasmic proteins exported to the bacterial cell surface or secreted further to the 
extracellular milieu (11, 21, 24).  Bacteria possess several different pathways for exporting 
proteins from the cytoplasm, including the highly conserved Sec pathway (8, 24).  The Sec 
pathway uses the SecA protein and the membrane-integrated SecYEG translocon to transport 
precursor proteins that contain a characteristic amino-terminal signal sequence across the 
cytoplasmic membrane (18).  SecA, an essential ATPase found in all bacteria, undergoes 
conformational changes upon ATP binding and hydrolysis that drive the transport of 
unfolded precursor proteins through the SecYEG translocon (36, 37).  The well-characterized 
ATPase activity of Escherichia coli SecA is absolutely required for protein export and is 
stimulated by the addition of phospholipids and by the presence of precursor protein (27, 29, 
39). 
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Most bacteria, including the model organisms E. coli and Bacillus subtilis, possess a 
single, essential SecA protein.  Recently, several microorganisms, including M. tuberculosis, 
Listeria monocytogenes, corynebacteria, and some streptococci, were found to carry two 
SecA proteins, SecA1 and SecA2 (2–5, 7, 26).  At the amino acid level, SecA1 and SecA2 of 
M. tuberculosis are about 50% similar to each other and 61% and 50% similar to E. coli 
SecA, respectively (3).  The mycobacterial SecA1 protein is essential and is thought to 
function similarly to the single SecA proteins of E. coli and B. subtilis (3, 16).  The 
mycobacterial SecA2 protein is not essential for growth in culture but is required for 
exporting a subset of proteins (3, 4, 14).  Furthermore, the ∆secA2 deletion mutant of M. 
tuberculosis is attenuated in virulence, suggesting that some of the SecA2-dependent 
exported proteins are virulence factors (4, 22).  Interestingly, the proteins exported by SecA2 
systems in different bacteria include examples with and without amino-terminal signal 
sequences (1, 2, 4, 7, 22, 25). 
The features that distinguish the function of SecA1 from that of SecA2 in a single 
bacterial species are not known, nor have the biochemical properties of each SecA been 
studied previously.  Here, we report that the SecA1 and SecA2 proteins of M. tuberculosis 
are present at comparable levels, indicating that expression levels do not explain the different 
functions of these proteins. 
Both SecA1 and SecA2 exhibit high sequence homology with other SecA proteins in 
the Walker A and B motifs commonly found in ATPases (38).  The Walker motifs are part of 
the motor domain of SecA.  In structural studies, the motor domain of M. tuberculosis SecA1 
also shows the highest similarity to that of B. subtilis SecA (32).  Using purified M. 
tuberculosis SecA1 and SecA2 proteins, we show that both proteins exhibit fully functional 
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ATPase activities.  Moreover, replacement of the conserved lysine residue in the Walker A 
motif of SecA2 to produce the SecA2 (K115R) or the SecA2 (K115A) variant eliminates 
ATP binding.  This amino acid replacement in the Walker A motif also affects the biological 
activity of SecA2, as the secA2 (K115R) variant fails to complement the intracellular growth 
defect of the M. tuberculosis ∆secA2 mutant in macrophages.  Our data present the first 
report of the characterization of the ATPase activity for any SecA2 protein and show that 
ATP binding is necessary for SecA2 function.  This work represents an important first step 
toward understanding how the two SecA proteins in mycobacteria function in protein 
translocation. 
 
Materials and Methods 
Plasmids and strains.  The E. coli SecA expression vector was a gift from Linda Randall 
(31).  The M. tuberculosis SecA1 expression vector was a gift from James Sacchettini.  The 
SecA1 plasmid was generated by PCR amplification of the secA1 gene from M. tuberculosis 
H37Rv genomic DNA into pET29a (Novagen).  A stop codon was added to the 3’ end of the 
gene to avoid addition of the C-terminal hexahistidine tag from the plasmid.  The SecA2 
expression plasmid was constructed by PCR amplification of the secA2 gene from M. 
tuberculosis H37Rv genomic DNA, using the primers 5’ 
CATTAATGGTGCCCAAGACCACCCGCGCTCA 3’ and 5’ 
TAAGCTTCAGCGGAACACCCCGGGCAGACT 3’.  The resulting PCR product was 
cloned into pET41b (Novagen) to create pNR14.  This SecA2 expression vector uses an 
internal GTG start codon located at nucleotide position 91 relative to the annotated start site 
(NCBI accession number NP_216337).  We believe this represents the true start codon.  
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Translation from this codon results in a protein whose sequence more closely resembles that 
of SecA2 from other mycobacteria, and the corresponding shorter SecA2 sequence can 
complement the ∆secA2 mutant phenotypes in Mycobacterium smegmatis and M. 
tuberculosis (data not shown).  Plasmids that overexpress SecA1 or SecA2 were transformed 
into E. coli BL21(DE3).  
The Walker A motif of M. tuberculosis SecA2 was mutated in plasmid pNR14, using 
a QuikChange site-directed mutagenesis kit (Stratagene).  The primers used to change lysine 
115 (AAG) to arginine (AGG) (underlined) were 5’ CGGTGAGGGCAGAACCCTTGCC 3’ 
and 5’ CGGCAAGGGTTCTGCCCTCACC 3’.  The resulting SecA2 (K115R) expression 
vector for E. coli is plasmid pNR24.  To create the same substitution in a mycobacterial 
expression vector, pMB162 was used as a template to create pNR7.  Plasmid pMB162 
contains the M. tuberculosis secA2 open reading frame, as annotated in the genome database, 
under control of the constitutive mycobacterial hsp60 promoter and an attachment site that 
enables stable integration into the mycobacterial genome in single copy (4).  To generate the 
SecA2 (K115A) pNR60 expression vector, site-directed mutagenesis was performed with 
pNR24 with the primers 5’ CGGTGGCGGCAGAACCCTTGCC 3’ and 5’ 
CGGCAAGGGTTCTGCCGCCACC 3’.  Sequencing was used to confirm the appropriate 
secA2 sequence in all vectors used in this study (Eton Biosciences).  
Purification of proteins.  E. coli SecA was expressed and purified as described previously 
(10).  Purification of M. tuberculosis SecA1 and SecA2 followed essentially the same 
protocol.  Freshly transformed cells were selected for the ability to overproduce each protein.  
The cultures that overproduced the SecA proteins were pooled and used for the protein 
preparation. The induced cells were suspended in 25 mM Tris (pH 7.6), 10 mM magnesium 
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acetate, and 10 mM NaCl and lysed, using a French pressure cell at 15,000 lb/in2, into a 2 
µg/ml final concentration of pepstatin A, leupeptin, and aprotinin, and 0.5 mM 
phenylmethylsulfonyl fluoride (PMSF) (Sigma).  The lysate was clarified by low-speed 
centrifugation, and the supernatants were centrifuged in a Sorvall T-865 rotor at 115,000 x g 
for 3 h to remove the cell membranes.  
For the purification of SecA1 and SecA2, the supernatant was applied to a Blue-
Sepharose CL-6B column (Pharmacia Biotech) equilibrated with 25 mM Tris at pH 7.6, 0.5 
mM EDTA, 100 µM dithiothreitol, and 0.5 mM PMSF.  The protein was eluted with a step 
gradient consisting of a low-salt (the same buffer supplemented with 10 mM NaCl), a 
medium-salt (0.4 M NaCl), and a high-salt (1.3 M NaCl) buffer.  Fractions containing SecA1 
were collected, precipitated with ammonium sulfate at 60%, and dialyzed against 10 mM 
HEPES (pH 7.6), 25 mM potassium acetate, 0.5 mM EDTA, and 100 µM tris(2-
carboxyethyl)phosphine (TCEP)-HCl (Pierce).  SecA2 was concentrated by using an Amicon 
ultrafiltration stirred cell and a membrane with a molecular weight (MW) cutoff of 30,000.  
The purified protein was stored in aliquots at -80°C.  The SecA2 (K115R) and SecA2 
(K115A) variant proteins were purified by the same method as that used for the wild-type 
(WT) SecA2.  
Quantification of the ratio of SecA2 to SecA1 in vivo.  Whole-cell lysates of exponential 
phase M. tuberculosis cultures grown in Middlebrook 7H9 medium were prepared following 
fixation in an equal volume of 10% formalin for 1 h.  Fixed cells were pelleted by 
centrifugation, resuspended in extraction buffer, and lysed by bead beating.  For quantitative 
SecA1 and SecA2 Western blot analysis, 100 µg of formalin-fixed whole-cell lysates were 
run on a 12% sodium dodecyl sulfate (SDS)-polyacrylamide gel alongside a standard curve 
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of known amounts of purified SecA1 or SecA2 protein.  Proteins were transferred to 
nitrocellulose membranes and probed with rabbit polyclonal anti-SecA1 (1:50,000 dilution) 
or anti-SecA2 (1:20,000 dilution) antibody (16).  The secondary antibody was goat anti-
rabbit conjugated to alkaline phosphatase (1:20,000 dilution), and detection of the 
fluorescence from ECF (Amersham/GE Healthcare) was done with a PhosphorImager 
(Molecular Dynamics).  The signal intensity values from six independently prepared whole-
cell lysates were quantified by comparison with standard curve values to determine the 
number of moles of SecA1 and SecA2 per mg of cellular protein.  
Circular dichroism spectra.  Circular dichroism (CD) was measured with an Applied 
Photophysics Pi-Star 180 circular dichroism spectrapolarimeter, with the cuvette maintained 
at 20°C with a circulating water bath.  A 1-cm-path-length quartz cuvette was used.  The 
protein concentration was 0.1 mg/ml in 20 mM phosphate buffer.  The slits were set at 2 nm.  
The CD spectrum was taken from 250 to 200 nm with a 1-nm step size.  The signal was 
averaged for 500,000 samples for a total of 12.5 s at each wavelength.  
Determination of melting temperature.  CD at 222 nm was used to monitor the secondary 
structure of the SecA proteins.  The protein concentration was 0.1 mg/ml.  To determine the 
melting temperature, the temperature was ramped from 8°C to 65°C with a step size of 
0.5°C.  At each temperature, the signal at 222 nm was averaged for 100,000 points, which 
required around 10 s.  The raw data were normalized (12) to show the fraction unfolded at 
each temperature.  
ATP binding assay.  Nitrocellulose membrane filtration assays were used to measure the 
ATP binding affinities of the SecA proteins as described in reference 42.  The 0.2-µM-pore-
size nitrocellulose membranes (Whatman) were incubated briefly with 0.5 N NaOH, rinsed 
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extensively with deionized H2O, and then equilibrated with binding buffer [50 mM HEPES-
NaOH (pH 7.5), 30 mM KCl, 10 mM Mg(OAc)2] for at least 1 h.  ATP stocks were prepared 
using Sigma Ultrapure ATP and GE Healthcare [α-32P]ATP.  The protein concentration in 
each assay was held between 3.7 and 4.5 µM of monomer, and increasing concentrations of 
ATP were added.  The protein-ATP mixtures were incubated on ice, which slows the ATPase 
activity to a rate undetectable by the use of the malachite green assay, as described below.  
The solutions were filtered through the nitrocellulose membrane to separate the bound ATP 
from the free ATP.  Because the apparent Kd (dissociation constant) values of E. coli SecA 
and M. tuberculosis SecA2 for ATP were lower than the protein concentrations used in the 
assays, the binding data were fitted with an equation used when there is ligand depletion (15, 
33), using the following equation: [LR] = [(Kd + [Rt] +[Lt]) - √{( Kd + [Rt] + [Lt])2 - 4[Rt][ 
Lt]}]/2, where Rt is the total protein concentration and Lt is the total ATP added.  The Kd 
value for SecA1 was obtained by fitting the data to the standard equation for binding data, 
since here the apparent Kd value was above the protein concentration used in the assay 
equation [LR] = (Rt [L]) / (Kd + [L]), where L is the free ligand.  The data were fitted with 
KaleidaGraph software (Synergy Software).  The Kd value was determined for each assay 
performed in triplicate, and the average Kd value and the standard error were determined. 
Analysis of ATPase activity.  The protocol used to measure SecA ATPase activity was a 
modification of the malachite green assay described previously (23, 27).  A reaction mixture 
contained 40 µg/ml of the SecA proteins, 1 mg/ml bovine serum albumin, and 4 mM ATP in 
reaction buffer [50 mM Tris-HCl (pH 7.0), 30 mM KCl, 30 mM NH4Cl, 1 mM dithiothreitol, 
and 5 mM Mg(OAc)2].  The assay was conducted at 25°C. Formation of inorganic phosphate 
was monitored spectrophotometrically by the increase in absorbance at 660 nm at each time 
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point.  The inorganic phosphate concentration generated in the reaction mixture with time 
was calculated using a standard curve.  Each assay was done at least four times with each 
protein.  The rate of hydrolysis was determined for each assay done in duplicate, and the 
averages and standard errors were determined.  
Macrophage infections.  Bone marrow macrophages were elicited from femurs of C57BL/6 
mice, as described previously (22, 28), and 2.5 x 105 macrophages were seeded into wells of 
8-well-chamber slides 24 h prior to infection.  The M. tuberculosis strains were grown to 
mid-exponential phase, washed with phosphate-buffered saline containing 0.05% Tween 80, 
diluted in tissue culture medium (Dulbecco’s modified Eagle’s medium supplemented with 
10% heat-inactivated fetal calf serum, 2 mM glutamine, and 1x nonessential amino acids 
[Gibco]) and added to the macrophage monolayer to achieve a multiplicity of infection of 
1.0.  Macrophage monolayers were infected with M. tuberculosis strains for 4 h at 37°C in 
5% CO2.  On days 0, 1, and 5 post infection, the contents of triplicate wells for each infection 
were washed and then lysed with 0.05% SDS.  The resulting lysates were diluted and plated 
on Middlebrook 7H10 agar to enumerate intracellular bacteria during the course of infection. 
 
Results 
SecA1 and SecA2 proteins are present in equivalent amounts in M. tuberculosis.  
The identification of bacteria that possess two SecA proteins, such as M. tuberculosis, is a 
relatively new discovery.  As a starting point to understanding the contribution of each SecA 
protein to the process of protein export in M. tuberculosis, we determined the relative 
amounts of SecA1 and SecA2 inside the bacterial cell.  Quantitative immunoblot analysis 
was performed with whole-cell lysates prepared from the virulent M. tuberculosis strain 
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H37Rv, using antibodies specific to each SecA protein.  These antibodies were raised against 
peptides specific for SecA1 or SecA2, and they recognize only the respective protein (16).  
These antibodies were used to determine the number of moles of SecA1 or SecA2 protein per 
mg of cellular protein by comparison to a standard curve for the purified M. tuberculosis 
SecA1 protein or to that of the SecA2 protein.  The results, from an evaluation of six 
independent whole-cell lysates, revealed nearly equivalent amounts of each protein.  The 
ratio of the average number of moles per mg of protein of SecA2 (2.07 x 10-11) to that of 
SecA1 (2.25 x 10-11) across these experiments was 0.93 +/- 0.12 (standard error).  This 
indicates that the differences between the functions of SecA1 and those of SecA2 in M. 
tuberculosis are not due to different levels of expression, at least under standard laboratory 
conditions.  
Purification of M. tuberculosis SecA1 and SecA2.  The two SecA proteins from any 
bacteria have not been biochemically characterized.  The SecA1 and SecA2 proteins of M. 
tuberculosis were expressed from a plasmid and purified from E. coli as soluble proteins.  
SecA1 has a predicted MW of 106,000/monomer, while SecA2 is smaller, with a predicted 
MW of 85,400/monomer (3). E. coli SecA has a MW of 101,000/monomer.  All the proteins 
were purified to >90% using Blue-Sepharose column chromatography (Fig. 1A).  SecA2 
bound less tightly to this column than SecA1 or E. coli SecA did, eluting with 0.5 M salt 
instead of 1.2 M.  This change in binding to a pseudoaffinity column for nucleotide-binding 
proteins suggested that SecA2 might have an altered affinity for nucleotides.  
We next determined if the purified M. tuberculosis SecA1 and SecA2 proteins had 
CD spectra consistent with folded secondary and tertiary structures (Fig. 1B).  Each of the 
proteins exhibited the characteristic minima at 209 and 222 nm associated with proteins with 
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significant levels of helical structure.  Tryptophan fluorescence spectra for all the proteins 
were also consistent with a native tertiary structure with emission maxima around 340 nm, 
which is typical for folded proteins (data not shown).  These results were expected for 
properly folded SecA1 and SecA2 proteins, as the three-dimensional structure of M. 
tuberculosis SecA1 is similar to that of B. subtilis SecA and E. coli SecA (17, 30, 32) and the 
sequences of the mycobacterial SecA proteins are highly homologous.  
SecA1 and SecA2 are less stable to heat denaturation than E. coli SecA.  At the 
standard temperature (37°C) used for ATP hydrolysis assays, we saw little ATPase activity 
for the M. tuberculosis SecA proteins.  Since the E. coli SecA ATPase activity is temperature 
dependent because the protein is thermolabile (27), we reasoned that the low activity levels 
of SecA1 and SecA2 proteins could be due to lower thermal stability.  To characterize the 
thermal stability of the M. tuberculosis SecA1 and SecA2 proteins, we denatured the proteins 
with heat and followed the melting transition by CD at 222 nm (Fig. 2).  The data were 
normalized to show the fraction unfolded at each temperature (12).  The melting temperature 
(Tm) for E. coli SecA was ~43°C, as shown previously (34).  Both M. tuberculosis SecA1 and 
SecA2 were less stable to heat denaturation, with Tms of ~35°C, indicating a moderate 
decrease in the stability of the M. tuberculosis SecA proteins compared to that of E. coli 
SecA.  Our data show that measurements of activity of the recombinant M. tuberculosis SecA 
proteins must be done at temperatures lower than 30°C to maintain their fully native 
structures. 
M. tuberculosis SecA1 and SecA2 bind ATP with different affinities.  To 
determine if SecA1 and SecA2 bind ATP as anticipated for proteins carrying canonical 
Walker A motifs, we used a standard nitrocellulose membrane binding assay with [α-
 155 
32P]ATP to determine the affinity of each protein for ATP (42).  The protein concentration in 
each assay was held constant, and increasing concentrations of ATP were added.  The 
solutions were filtered through a nitrocellulose membrane to separate the bound ATP from 
the free ATP.  Because the apparent Kd values of E. coli SecA and M. tuberculosis SecA2 for 
ATP were lower than the protein concentrations used in the assays, the binding data were 
fitted with an equation used when there is ligand depletion, as described in Materials and 
Methods and previously (15, 33).  The Kd value of SecA1 for ATP was obtained by fitting 
the data to the standard equation for binding data, since here the apparent Kd value was above 
the protein concentration used in the assay.  Analysis of the binding data (Fig. 3A) showed 
that E. coli SecA bound ATP with a Kd value of 0.46 +/- 0.11 µM, which is within the 
standard error for a previously published value (42).  M. tuberculosis SecA2 bound ATP with 
a somewhat weaker affinity of 1.9 +/- 0.3 µM.  M. tuberculosis SecA1 bound ATP ~10-fold 
more weakly than SecA2, with a Kd value of 21.8 +/- 4.0 µM.  
An interesting observation is that SecA2 binds more weakly to the Blue-Sepharose 
column than either E. coli SecA or SecA1, even though its Kd value for ATP binding is 
similar to that of E. coli SecA, which binds tightly to this column.  This observation suggests 
that the SecA2 binding site for the Cibacron Blue dye, presumably the ATP binding site, may 
have a different conformation than SecA1 or E. coli SecA.  
SecA1 and SecA2 exhibit ATPase activity.  To determine if M. tuberculosis SecA1 
and SecA2 hydrolyze ATP, we used a malachite green assay, which measures the amount of 
free inorganic phosphate produced over time (6, 9, 23, 29) (Fig. 3B).  Because each of the 
Tms of the M. tuberculosis SecA proteins was lower than that of E. coli SecA, all ATPase 
assays were done at 25°C.  The ATPase activity level of each protein was determined in 
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duplicate from at least four separate experiments.  While we did see some variability in the 
results of the ATPase assays, the trends were the same for all assays.  With assays done at 
25°C, each of the SecA proteins was able to hydrolyze ATP; the endogenous ATPase activity 
level of M. tuberculosis SecA1 was similar to that of E. coli SecA, while that of SecA2 was 
about threefold higher than E. coli SecA. 
Amino acid substitutions in the Walker A motif of SecA2 affect ATP binding in 
vitro.  Alignment of M. tuberculosis SecA1 and SecA2 with the SecA of E. coli and B. 
subtilis reveals high sequence identity across the characteristic Walker A motif of ATPases 
(Fig. 4A) (3).  Structural studies demonstrate that the amino acids of this motif participate in 
ATP binding (20, 37).  In previous studies, site-directed mutagenesis of the conserved lysine 
in the Walker A motif (K108 in E. coli SecA and K106 in B. subtilis SecA) has shown it to 
be important for SecA ATP binding (29, 35).  The E. coli SecA ATPase K108R mutant is 
defective in ATP binding and protein translocation in vitro, as well as biologically inactive in 
vivo as demonstrated by the inability to complement an E. coli temperature-sensitive secA 
allele (29).  The B. subtilis SecA (K106N) ATPase mutant is also unable to translocate 
precursor proteins in vivo (20).  
To determine if ATP binding and ATPase activity in M. tuberculosis SecA2 depend 
similarly on the Walker A motif, we substituted arginine or alanine for the conserved lysine 
K115 in the Walker A motif of M. tuberculosis SecA2 and purified the corresponding 
proteins as described above.  We tested the ability of the SecA (K115R) and SecA2 (K115A) 
variants to bind ATP (Fig. 4B).  Both the K115R and the K115A substitutions significantly 
decrease the ability of SecA2 to bind ATP.  We then tested the ATP hydrolysis activity of the 
SecA2 (K115R) variant, using the malachite green assay.  The endogenous ATPase activity 
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for the SecA2 (K115R) variant was somewhat higher than that for the WT SecA2.  The 
SecA2 (K115A) variant had an ATP hydrolysis rate lower than that of WT SecA2 (Fig. 4C).  
These in vitro results show that the Walker box of SecA2 is required for efficient ATP 
binding, as predicted and shown to be the case for other SecA proteins (20, 29, 35).  These 
data also indicate that a SecA2 variant in which lysine, K115, has been replaced can be used 
to assess the importance of ATP binding for the biological functions of SecA2 in M. 
tuberculosis.  
A substitution in the Walker A motif of SecA2 affects biological activity in M. 
tuberculosis.  A ∆secA2 mutant of M. tuberculosis is attenuated for growth in macrophages 
and in mice (3, 4).  The biochemical data presented above and the results of previous studies 
suggest that M. tuberculosis SecA2 functions as an ATPase to promote the export of a 
specific subset of proteins that are important to pathogenesis.  To test this idea, we asked 
whether the secA2 (K115R) allele encodes a functional protein that is able to fulfill the 
function of SecA2 in promoting the growth of M. tuberculosis in macrophages.  The secA2 
(K115R) allele was introduced into the M. tuberculosis ∆secA2 mutant in a single copy at the 
chromosomal attB site. Murine bone marrow-derived macrophages were infected in parallel 
with the parental M. tuberculosis strain H37Rv, the ∆secA2 mutant of M. tuberculosis, the 
∆secA2 mutant complemented with the wild-type secA2 gene inserted at the attB locus, or the 
∆secA2 mutant with secA2 (K115R) (Fig. 5A).  As shown previously, H37Rv and the secA2-
complemented strain grew at similar rates in macrophages over a 5-day period of infection, 
while the ∆secA2 mutant failed to grow in macrophages (22).  Unlike introduction of the WT 
secA2 gene at the attB site, which promoted M. tuberculosis growth in macrophages, the 
introduction of secA2 (K115R) in the ∆secA2 mutant failed to promote this growth.  
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Importantly, Western blot analysis confirmed that the ∆secA2 mutant strains carrying WT 
secA2 or secA2 (K115R) expressed the SecA2 protein at similar levels (Fig. 5B).  In addition, 
the growth defect of the secA2 (K115R) strain in macrophages was specific, as this strain did 
not exhibit a general growth defect when tested in 7H9 liquid medium (data not shown).  
These results indicate that replacing the conserved lysine in the Walker A motif of SecA2 
renders SecA2 inactive in its biological role of promoting M. tuberculosis growth in 
macrophages. 
 
Discussion 
Here we report the first description of ATPase activities for two SecA proteins from 
the same bacterium and the first description of the ATPase activity for any SecA2 protein.  
Based on amino acid sequence analysis, M. tuberculosis SecA1 and SecA2 possess the 
consensus Walker A and B motifs (3) that are found in ATP hydrolyzing enzymes and are 
essential to E. coli and B. subtilis SecA functions (20, 29).  However, for SecA2, which 
currently has an undefined role in protein export and differs from the well-characterized E. 
coli SecA protein in being nonessential in mycobacteria, the question of whether it can 
function as an ATPase remains unanswered (4).  
Here we demonstrated that both SecA proteins of M. tuberculosis are ATP binding 
and hydrolyzing proteins.  SecA2 bound ATP with an affinity that was somewhat weaker 
than that of E. coli SecA, and SecA1 bound ATP about 10-fold more weakly than SecA2.  
Since the ATP concentration within an M. tuberculosis cell is approximately 1 mM (13, 19), 
even with these different affinities, both SecA proteins should be fully saturated with ATP in 
vivo.  Therefore, the physiological significance of these differences in affinity is unclear.  
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The M. tuberculosis SecA proteins showed a lower melting temperature than E. coli 
SecA under our buffer conditions, suggesting that the M. tuberculosis SecA proteins are less 
thermostable than E. coli SecA.  Therefore, all of the ATP hydrolysis assays were done at a 
temperature at which the proteins maintained their native state.  At 25°C, each of the SecA 
proteins was able to hydrolyze ATP.  Although it is difficult to directly compare results of 
ATP hydrolysis activities of SecA proteins from different species because of the use of 
different experimental conditions, our results are in general agreement with the ATP 
hydrolysis rates of SecA proteins from Pseudomonas aeruginosa (41), E. coli (29), and B. 
subtilis (35).  Nevertheless, our data suggest that there may be some functional differences 
between SecA1 and SecA2 with regard to ATP affinities and hydrolysis rates.  The 
endogenous ATPase activity of M. tuberculosis SecA2 was found to be higher than that of M. 
tuberculosis SecA1 and E. coli SecA.  
The K115R substitution in the SecA2 Walker A motif clearly establishes the fact that 
ATP binding of SecA2 is vital for its function in vivo, as this substitution in SecA2 abolished 
the ability of M. tuberculosis to grow within macrophages.  In an ATP binding assay, the 
SecA2 (K115R) and SecA2 (K115A) variants exhibited significantly reduced ATP binding, 
as anticipated when the conserved lysine of Walker A motif was replaced.  However, neither 
the substitution of R for K nor A for K eliminated the endogenous ATPase activity.  The 
K115R substitution slightly increased the endogenous rate of ATP hydrolysis, while the 
SecA2 (K115A) variant showed about 60% of the activity of WT SecA2.  These results are 
consistent with those of Mitchell and Oliver (29), where the E. coli SecA (K108R) 
substitution in the Walker A motif affected biological activity and eliminated effective ATP 
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binding but did not eliminate—and even somewhat increased—the endogenous ATPase 
activity (29).  
The mycobacterial SecA proteins have been shown to be functionally dissimilar from 
one another in that SecA2 participates only in the export of a specific subset of proteins (3, 4, 
14).  The data presented here indicate that both M. tuberculosis SecA1 and SecA2 are 
ATPases.  Our data suggest that each M. tuberculosis SecA protein is likely to function in a 
manner similar to that of E. coli SecA in undergoing cycles of ATP binding and hydrolysis-
promoted conformational changes that drive protein export across the cytoplasmic 
membrane.  In addition, we show that the levels of SecA1 and SecA2 in the cell are 
equivalent.  Therefore, the functional differences between SecA1 and SecA2 may be at the 
level of the specific proteins they recognize for export or the proteins with which they 
interact to form a translocation complex.  For SecA1, we believe the protein works in concert 
with the membrane-localized SecYEG translocon.  The SecA2 protein may also work with 
SecYEG or with an as-yet unidentified translocation complex to selectively export a subset 
of proteins.  Alternatively, differences in the function of the SecA proteins might be in the 
regulation of their enzymology.  The studies here lay the groundwork for further 
investigation of the SecA2 export pathway of mycobacteria. 
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Figure 4.1.  Purification of M. tuberculosis SecA1 and SecA2.  (A) SDS gel of the purified 
SecA proteins. SecA1, SecA2, and E. coli SecA were purified as described in Materials and 
Methods. The proteins were separated on a 10% SDS polyacrylamide gel. Molecular weight 
markers (MW, in thousands) are indicated on the right side of the gel. (B) CD spectra of each 
SecA protein. The spectra were obtained as described in Materials and Methods. The protein 
concentration was 0.1 mg/ml in 20 mM phosphate buffer (pH 7.6). 
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Figure 4.2.  M. tuberculosis SecA proteins have decreased thermostability compared to 
that of E. coli SecA. To determine the melting temperatures, the SecA proteins (0.1 mg/ml) 
were ramped from 8 to 65°C. At each 0.5 °C increment in temperature, the CD at 222 nm 
was measured. The CD signal was normalized to show the fraction unfolded at each 
temperature. 
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Figure 4.3.  M. tuberculosis SecA1 and SecA2 bind and hydrolyze ATP.  (A) SecA2 binds 
ATP with high affinity. The affinity of ATP binding by SecA proteins was determined by a 
nitrocellulose membrane filtration assay. The concentrations of bound and free ATP were 
determined. The data were fitted using the binding equations described in Materials and 
Methods to determine the Kd values. Since the data were fitted using two different equations, 
the ATP concentration on the x axis is the total ATP for the E. coli SecA and SecA2 proteins 
and the free ATP for SecA1. The binding assays were repeated at least three times for each 
protein. Shown here are the averages and standard errors of the averages determined for the 
combined data. (B) Endogenous ATPase activities of the M. tuberculosis SecA proteins. The 
endogenous activity levels of the SecA proteins were determined using a malachite green 
assay for the formation of free inorganic phosphate. Each assay was done in duplicate and 
repeated at least four times to determine the average rates and standard errors of the averages. 
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Figure 4.4.  Effect of the K115R and K115A substitutions in the Walker A motif of 
SecA2 in vitro. (A) Alignment of Walker A motifs in SecA proteins. Sequence alignment of 
the highly conserved Walker A motif from mycobacterial SecA1 and SecA2 to the well-
characterized SecA proteins of E. coli and B. subtilis. The conserved lysine residue that was 
mutated to generate SecA2 (K115R) or SecA2 (K115A) is shown in bold. (B) ATP binding 
by SecA2 (K115R) (KR) and SecA2 (K115A) (KA). The ATP binding was measured as 
described in the legend to Fig. 4.3. The binding data for WT SecA2 is the same as that shown 
in Fig. 4.3. (C) Endogenous ATPase activity of SecA2 (K115R) and SecA2 (K115A). The 
average rates and standard deviations of the ATP hydrolysis by each protein were determined 
by using the malachite green assay for determination of free inorganic phosphate, as 
described in the legend to Fig. 4.3. The WT SecA2 hydrolysis rate is the same as that shown 
in Fig. 4.3. The average rates and standard deviations from all of the experiments are shown. 
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Figure 4.5. A substitution in the Walker A motif of SecA2 affects biological activity in 
M. tuberculosis.  (A) The secA2 (K115R) allele does not complement the M. tuberculosis 
∆secA2 mutant phenotype in macrophages. Murine bone marrow-derived macrophages were 
infected at a multiplicity of infection of 1.0 with the strain H37Rv, the ∆secA2 mutant, the 
∆secA2 mutant complemented by the addition of WT secA2, (∆secA2+secA2), and the 
∆secA2 mutant with secA2 (K115R) (∆secA2+secA2 KR). CFU were determined by plating 
macrophage lysates at various times post infection. The infection was performed with 
triplicate wells for each strain per time point, and the error bars represent means +/- standard 
deviations for the triplicate wells. The symbols for H37Rv and the complemented strain are 
overlapping at most time points in the graph presented. Data are representative of three 
independent experiments. *, data are statistically significantly different (P<0.05). (B) 
Expression of SecA1 and SecA2 in strains with different secA2 alleles. Equal amounts of 
formalin-fixed whole-cell lysates of the M. tuberculosis H37Rv strain carrying an empty 
vector, the M. tuberculosis secA2 mutant with an empty vector, the secA2 mutant with the 
WT secA2 integrated at the chromosomal attB site (WT), and the secA2 mutant with the 
secA2 (K115R) allele integrated at the attB site (KR) were run on SDS-polyacrylamide gels 
and subjected to Western blot analysis with anti-SecA1 or anti-SecA2 antibodies. The top 
panel shows SecA1 protein and the lower panel shows SecA2 protein. MW, molecular 
weight (in thousands). 
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Protein export is an essential process in all bacteria.  The bulk of proteins exported 
across the cytoplasmic membrane utilize the essential Sec pathway.  SecA is an essential 
ATPase that drives unfolded pre-proteins through the membrane embedded SecYEG 
translocase.  Increasingly, nonessential accessory SecA homologs are found in several 
bacterial species, including Mycobacterium smegmatis.  Unlike the essential SecA1 proteins, 
these accessory SecA2 proteins are required to export only a small subset of proteins.  
However, the mechanism behind SecA2-mediated protein export is not known.  In particular, 
it is not known if components of the essential SecA1 pathway or the accessory SecA2 
pathway work together.  To test this possibility, we examined the role of the essential SecA1 
protein in exporting SecA2-dependent protein Msmeg1712 in M. smegmatis.  Using a 
conditional SecA1 strain, we showed that depletion of SecA1 impairs the export of 
Msmeg1712 to the mycobacterial cell wall.  This is the first direct demonstration that a 
SecA2-dependent protein (Msmeg1712) requires components of the essential SecA1 pathway 
 173 
for export.  Using this approach, we can now determine if other components of the essential 
Sec pathway are involved in exporting SecA2-dependent proteins. 
 
Introduction 
 In bacteria, most exported proteins cross the cytoplasmic membrane through the 
highly conserved Sec pathway (11, 18).  The Sec pathway specifically exports unfolded 
proteins through the membrane-embedded translocase composed of the proteins SecYEG (5).  
Energy for this system is provided by ATP hydrolysis by SecA, an essential ATPase that 
interacts with both the membrane-embedded SecYEG translocase and cytosolic pre-proteins 
destined for export (15, 17, 21).  Through repeated cycles of ATP binding and hydrolysis, 
SecA undergoes conformational changes and drives export of substrate proteins across the 
cytoplasmic membrane (23). 
Recently, the existence of two SecA homologs was reported in a small subset of 
Gram positive bacteria and mycobacteria (1, 3, 4, 6, 7, 16, 22, 25).  In M. smegmatis, SecA1 
is essential for growth and it is believed to function as the “housekeeping” SecA in the 
canonical Sec pathway (3).  In contrast, SecA2 is not essential for growth and is only 
required for the export of a subset of proteins (13).  In M. smegmatis there are two cell wall 
lipoproteins identified as requiring SecA2 for their export, Msmeg1704 and Msmeg1712.  
Both of these proteins have predicted Sec signal sequences.   
The mechanism of SecA2-dependent protein export is not yet understood.  A basic 
question to be answered is whether SecA2 works with a dedicated export apparatus of its 
own or the canonical Sec pathway (SecA1/SecYEG) to export its select substrates.  The 
accessory SecA2 system in Streptococcus gordonii and S. parasanguinis includes an 
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accessory SecY2 protein for export (1, 29).  In mycobacteria, there are no accessory SecY 
homologs (8).  Without an obvious secretion apparatus or translocase, it is possible that 
SecA2 works with the canonical Sec pathway to promote export of its select subset of 
proteins.   
If SecA1 and SecYEG are involved in SecA2 export, then the export of SecA2-
dependent proteins should also be SecA1/YEG dependent.  Because secA1 is an essential 
gene, in order to test the role of SecA1 in the export of SecA2-dependent proteins a 
conditional secA1 mutant is required (14).  For this purpose we engineered a strain in which 
we can deplete SecA1 and simultaneously monitor the export of the SecA2-dependent 
protein Msmeg1712-HA to the cell wall.  Here we show that in the absence of SecA1, export 
of Msmeg1712-HA to the cell wall is severely impaired.  The export defect seen upon SecA1 
depletion is comparable to the export defect observed for Msmeg1712-HA in a ∆secA2 
mutant.  This result indicates that SecA1 is required for SecA2-dependent export of 
Msmeg1712-HA.  This is the first experimental evidence indicating a role for the canonical 
Sec pathway in the accessory SecA2 pathway of any bacteria. 
 
Materials and Methods 
Bacterial strains and culture conditions.  Middlebrook 7H9 or 7H10 medium (BD 
Biosciences), or Mueller Hinton medium (Difco, BD Biosciences) was used for growing 
mycobacteria.  Middlebrook growth medium was supplemented with 0.2% (w/v) glucose, 
0.5% (w/v) glycerol, and 0.1% (w/v) Tween 80 (Fisher).  Mueller Hinton was supplemented 
with 0.1% (w/v) Tween 80.  When needed, kanamycin (Acros Chemicals) or hygromycin 
(Roche) was added to medium at 20 µg/ml or 50 µg/ml, respectively.  For SecA1-depletion 
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experiments, saturated M. smegmatis cultures were diluted to an OD600nm of 0.1 in 100 ml of 
Mueller Hinton.  Anhydrotetracycline (Sigma) was added to 600 ng/ml and the cultures were 
grown for ~21 hours at 37˚C.  LB was used to grow Escherichia coli cultures.  When needed, 
kanamycin or hygromycin was added at 40 µg/ml or 150 µg/ml, respectively.  The identity of 
all vectors used in this study was confirmed by DNA sequencing (UNC-CH automated DNA 
sequencing facility and Eton Biosciences).  The secA1 depletion strain MSE10 and suicide 
plasmid pKIsecA1 were kind gifts from Sabine Ehrt (14).   
Construction of JM693, a M. smegmatis ∆secA2 mutant with secA1 under control of 
Pmyc1tetO.  To construct a secA1 depletion strain in a ∆secA2 mutant background, NR116 was 
transformed with the suicide plasmid pKIsecA1, and hygromycin-resistant transformants 
were selected on 7H10 plates.  Transformants were screened by Southern blot to detect 
integration of pKIsecA1 into the native secA1 locus in the chromosome.  Genomic DNA was 
isolated from M. smegmatis strains and digested with BamHI and EcoRI.  The probe used 
was a 410 bp SphI-MscI fragment from pKIsecA1.  The probe was labeled with [32P]dCTP 
using the Ready-to-Go labeling kit (Amersham). 
Construction of pNR61.  We wanted to construct a vector that encodes Msmeg1712 with a 
C-terminal HA epitope tag to monitor export of this protein.  Additionally, we also wanted 
this plasmid to encode the rev TetR repressor protein to enable regulation of genes placed 
under control of the Tet promoter.  Upon addition of anhydrotetracycline, rev TetR binds to 
Tet operator sequences in the Tet promoter, thus preventing expression of downstream genes 
(Tet OFF).  To construct pNR61, a 2.4 kb NheI fragment containing rev tetR (r1.7) was 
cloned from pTEK-4S0X (14) (gift from Sabine Ehrt) into NheI-cut pHSG85 (13).  pHSG85 
encodes Msmeg1712-HA expressed from its native promoter.   
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Subcellular fractionation.  Cell wall, membrane, and soluble fractions were prepared by 
differential ultracentrifugation as described previously (13).  Briefly, 100 ml cultures of M. 
smegmatis grown in Mueller Hinton were harvested by centrifugation at 3,000 x g.  Cell 
pellets were resuspended in 4 ml of breaking buffer (PBS, 0.6 µg/ml each of DNase and 
RNase, and a cocktail of protease inhibitors (2 µg/ml each of aprotinin, E-64, leupeptin, and 
pepstatin A and 100 µg/ml Pefabloc SC) and then lysed by five passages through a French 
pressure cell.  Unbroken cells were pelleted at 3,000 x g for 20 min to generate a clarified 
whole cell lysate, which was centrifuged at 27,000 x g for 30 min to pellet the cell wall.  The 
supernatant was centrifuged at 100,000 x g for 2 h to separate the membrane fraction from 
the soluble fraction.  The cell wall and membrane fractions were washed once and then 
resuspended in PBS.   
Immunoblot antibody conditions.  The anti-SecA2, anti-GroEL (HAT5/IT-64 from the 
World Health Organization collection), anti-MspA (gift from Michael Niederweis, (19)), and 
anti-HA (Covance) antibodies were used at 1:20,000 dilutions.  The anti-SecA1 antibody was 
used at a 1:50,000 dilution.  For most experiments, secondary antibodies conjugated to HRP 
(Bio-Rad) were used along with ECL (Perkin Elmer) and film (Denville) to visualize blots.  
For quantitative immunoblots, secondary antibodies conjugated to AP (Amersham/GE 
Healthcare) were used in conjunction with the ECF detection system.  The blots were 
visualized using a phosphorimager and quantified using ImageQuant 5.2 (Molecular 
Dynamics). 
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Results 
Construction of SecA1 depletion strains.  In order to study the potential 
contribution of SecA1 in the process of SecA2-dependent export, a conditional secA1 strain 
was required.  Recently, strain MSE10 was constructed in M. smegmatis where the 
chromosomal secA1 is under the control of a tetracycline operator/repressor system (14).  
Using the Tet OFF system, when MSE10 is grown in the presence of anhydrotetracycline 
(Atc) the amount of SecA1 is diminished as shown by western blot (data not shown) (12).  In 
previous studies, MSE10 was used to show depletion of SecA1 prevents export of the cell 
wall porin protein MspA.  MspA has a classical Sec signal sequence, and therefore its export 
was expected to depend on the canonical Sec pathway.  As expected due to the established 
essential nature of SecA1, depletion of SecA1 protein also inhibits growth of M. smegmatis.  
This strain will allow us to determine if depletion of SecA1 influences export of SecA2-
dependent proteins.     
For this study, we similarly constructed a SecA1-depletion strain in a ∆secA2 mutant 
background.  This strain will allow us to determine the combined effect of removing SecA1 
and SecA2 on export of SecA2-dependent proteins.  As shown in Figure 5.1A, pKIsecA1 
(gift from Sabine Ehrt) contains a mutant secA1 allele with a hygromycin insertion and a 
wild-type secA1 allele under control of the Tet operator (TetO).  We electroporated 
pKISecA1 into the ∆secA2 mutant strain NR116 and selected for transformants on 7H10 
plates supplemented with hygromycin (50 µg/ml).  Since pKISecA1 does not replicate in 
mycobacteria, it must integrate into the chromosome at the secA1 locus (Figure 5.1B and C).  
Successful construction of the resulting strain, JM693, was confirmed by Southern analysis 
(Figure 5.1D). 
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 With secA1 cloned behind the Tet operator in strain MSE10 and JM693, we then 
further engineered the strains so they expressed Msmeg1712-HA and the revTetR repressor.  
The revTetR binds to TetO only in the presence of the inducer molecule Atc thereby 
blocking expression of SecA1 (12).  We cloned both these elements, constitutively expressed 
revTetR and Msmeg1712-HA, onto a single mycobacteria plasmid pNR61.  MSE10 and 
JM693 were electroporated with pNR61 and transformants were recovered on 7H10 plates 
supplemented with hygromycin (50 µg/ml) and kanamycin (40 µg/ml).  Next, these 
transformants were grown in 100 ml cultures of Mueller Hinton with or without addition of 
Atc (600 µg/ml) for 21 hours.  Cells were harvested by centrifugation and lysed in a French 
pressure cell.  To monitor export of Msmeg1712-HA in these strains, we prepared subcellular 
fractions by differential ultracentrifugation and analyzed them by SDS-PAGE and 
immunoblot with anti-HA antibodies. 
Addition of Atc resulted in greater than 95% reduction of SecA1, as determined by 
densitometry (Figure 5.2).  This outcome was observed in both wild-type (Figure 5.2A) and 
∆secA2 mutant (Figure 5.2B) backgrounds.  Importantly, under the conditions we used 
depletion of SecA1 did not have any effect on the expression of control proteins GroEL or 
MspA nor was there a growth defect of the strains.  This showed our Atc treatment 
conditions were specifically influencing SecA1 depletion and not having a general effect on 
total protein levels.  As reported previously, MspA was not exported to the cell wall fraction 
of M. smegmatis when SecA1 was depleted (14).  This important control showed that 
depletion of SecA1 in our experiments had the expected effect on export of a SecA1-
dependent protein. 
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 Depletion of SecA1 inhibits export of Msmeg1712-HA to the cell wall.  The 
SecA1-depletion strains allowed us to assess the contribution of SecA1 in exporting SecA2-
dependent proteins.  Strikingly, when SecA1 was depleted from wild-type M. smegmatis, 
Msmeg1712-HA did not localize to the cell wall fraction (Figure 5.2A).  Quantification of 
our blots showed a 10-fold reduction of Msmeg1712-HA in the cell wall fraction of the 
SecA1 depleted strain MSE10 compared to the wild-type strain.  Furthermore, Msmeg1712-
HA accumulated in the soluble cytoplasmic fraction.  Accumulation of Msmeg1712-HA in 
the soluble fraction is consistent with the protein accumulating in the cytosol due to a defect 
in its export in the absence of SecA1.  As a control, we monitored the export of MspA, a 
known SecA1 substrate (14).  Upon SecA1 depletion, export of MspA to the cell wall 
fraction was abolished.  Some MspA was detected in the soluble fraction; we believe this 
corresponded to newly synthesized MspA that is awaiting export.  As a quality control check 
on our subcellular fractions, we also analyzed the localization of GroEL, a known 
cytoplasmic chaperone.  As expected, GroEL was found in the soluble cytoplasmic fraction, 
indicating that our cell wall fractions are not contaminated (Figure 5.2).  
As shown previously, in the M. smegmatis ∆secA2 mutant Msmeg1712-HA did not 
localize to the cell wall (Figure 5.2B) (13).  By comparing the ∆secA2 mutant without 
depletion (-Atc) to the wild-type strain with SecA1 depletion (+ Atc), the amount of 
Msmeg1712-HA in the cell wall of these two strains is similar (Figure 5.2C).  We also tested 
whether the Msmeg1712-HA export defect of a ∆secA2 mutant is exacerbated by depletion 
of SecA1.  Depletion of SecA1 in the ∆secA2 mutant background resulted in an export defect 
that was no greater than that seen when just ∆secA2 was deleted (i.e. in absence of Atc 
treatment) (Figure 5.2B and C).  Taken together, these results indicated that SecA1 and 
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SecA2 are both required for optimal export of Msmeg1712-HA.  On their own, neither 
SecA1 nor SecA2 are sufficient to support export of Msmeg1712-HA.  These data are the 
first to show the canonical SecA1 has a role in exporting a substrate of the accessory SecA2 
pathway. 
 
Discussion 
In this Chapter, we established a clear role for the essential SecA1 in the SecA2-
dependent process of exporting Msmeg1712-HA.  Since SecA1 is essential, this analysis 
required construction of a conditional secA1 strain (14).  When SecA1 expression was 
depleted in wild-type M. smegmatis, Msmeg1712-HA was no longer efficiently exported to 
the cell wall.  This export defect is comparable to that exhibited by a ∆secA2 mutant (13).  
Additionally, the effect of depleting SecA1 in the absence of SecA2 did not have an additive 
effect on Msmeg1712-HA export.  Msmeg1712-HA is the first example of a protein that 
requires both SecA1 and SecA2 for export from the cytoplasm. Because of the need of a 
conditional secA1 mutant to ask this question, it has remained unaddressed in any accessory 
SecA2 system until now. 
While our data showed a requirement for the canonical SecA1 in mycobacterial 
SecA2 export, the precise nature of the role of SecA1 is not clear.  We do not know if SecA1 
directly interacts with SecA2, or if the role of SecA1 is indirect.  One possibility is that 
SecA1 and SecA2 form a heterodimer.  In E. coli, SecA forms dimers, although the exact 
role of dimers in protein translocation remains in dispute (10, 20, 28).  It is possible that in 
mycobacteria, SecA2 forms heterodimers with SecA1 to export a subset of proteins like 
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Msmeg1712.  However, there is no evidence of a physical interaction between SecA1 and 
SecA2. 
In Chapter 3, we showed that SecA1 is equally distributed between cell envelope and 
cytoplasmic fractions.  This localization likely reflects the dynamic role of SecA1 reversibly 
associating with the SecYEG translocase to export proteins across the cytoplasm.  In 
contrast, SecA2 is found predominantly in the cytoplasmic fraction.  This finding could 
reveal something about the relationship between SecA1 and SecA2.  Perhaps the role of 
SecA2 is to recognize pre-protein substrates in the cytoplasm that are normally overlooked 
by SecA1.  Upon recognition, SecA2 then delivers these pre-proteins to the SecA1/SecYEG 
translocase complex.  Another possibility is that SecA2 works with SecA1 to promote export 
via a novel translocase.  To examine the potential role of the SecYEG translocase in export 
of Msmeg1712-HA, the construction of a SecY depletion strain followed by experiments to 
monitor the effect depletion has on export of SecA2-dependent proteins is planned. 
Although less likely, another formal possibility is that SecA2-dependent proteins 
cross the cytoplasmic membrane through a novel translocase that is assembled by SecA1.  
There are a few experiments suggesting SecA can be involved in the assembly of some 
domains of multi-spanning integral membrane proteins (26).  However, this role of SecA 
appears rare.  There are integral membrane proteins well-demonstrated not to require SecA 
for localization and it is the SRP GTPase that is the requisite secretion factor for membrane 
protein localization in bacteria (24, 27).  Furthermore, there is no evidence that SecA1 is 
required for assembling cytoplasmic membrane proteins in mycobacteria. 
Unlike the accessory SecA2/Y2 system in Gram positive bacteria like S. gordonii, the 
accessory SecA2 system in mycobacteria lacks an obvious translocase or an accessory SecY 
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homolog (8, 9, 22).  Without other obvious candidates, we think it is an attractive possibility 
that SecA2-dependent proteins are exported with the assistance of the SecA1/SecYEG 
translocase.  Clearly, identifying proteins that interact with SecA2 will be important for fully 
understanding the relationship between the essential SecA1/SecYEG pathway and the 
accessory SecA2 pathway. 
In mycobacteria, the features of a pre-protein substrate that dictate export via SecA2 
remain poorly understood.  In M. smegmatis, Msmeg1704 and Msmeg1712 were identified 
as being dependent on SecA2 for export from the cytoplasm (13).  Interestingly, Msmeg1704 
and Msmeg1712 are both predicted lipoproteins.  Perhaps post-translational modifications 
help direct or limit Msmeg1704 and Msmeg1712 to the accessory SecA2 pathway.  In S. 
gordonii, post-translational glycosylation is clearly an important signal for blocking GspB 
export via the canonical Sec system (2).  There is no evidence that Msmeg1704 and 
Msmeg1712 are similarly glycosylated.  However, it is interesting to speculate that the lipid 
modifications of Msmeg1704 and Msmeg1712 could be unique determinants that specify the 
need for SecA2 to export these proteins.  It is important to point out that not all lipoproteins 
are SecA2-dependent as M. tuberculosis LpqH and M. smegmatis PhoA are proven 
lipoproteins demonstrated to be exported normally in a ∆secA2 mutant of M. smegmatis (13).  
Experiments are underway to determine the elements that direct pre-proteins for export via 
SecA2.  Taken together, we propose a model where the majority of pre-proteins require 
SecA1 for export, while a small subset of proteins require both SecA1 and SecA2 for export 
(Figure 5.3).  We have pursued genetic and biochemical strategies in an attempt to identify 
SecA2-interating proteins.  Clearly, identification of SecA2-interacting proteins will be 
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critical to distinguishing between these different possible models for SecA2-mediated protein 
export in mycobacteria. 
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Figure 5.1.  A SecA1 depletion strain was constructed in a ∆secA2 mutant background.  
(A) Map of suicide plasmid pKIsecA1.  (B) Diagram of the secA1 locus in mc2155.  (C) 
Diagram of the secA1 locus upon integration of pKIsecA1.  The bar below each line indicates 
site of probe hybridization.  (D) Southern blot of genomic DNA digested with BamHI and 
EcoRI.  Restriction sites and predicted fragment sizes are indicated in B and C.  Lane 1: 
mc2155, Lane 2: JM693. 
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Figure 5.2.  Expression of both SecA1 and SecA2 is required for export of Msmeg1712-
HA.  SecA1 was depleted from cultures of (A) wild-type or (B) ∆secA2 mutant M. 
smegmatis by addition of 600 ng/ml Atc for 21 hours.  Cell wall (CW), membrane (M), and 
soluble (SOL) subcellular fractions were prepared from these cultures.  For each fraction, 
protein derived from an equal number of starting cells was analyzed by SDS-PAGE and 
western blot using the indicated antibodies.  (C) The percent localization of Msmeg1712-HA 
from (A) and (B) was quantified using a phosphorimager and is reported as the percent of 
starting WCL.  The results are the mean of three independent experiments +/- standard error. 
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Figure 5.3.  Proposed model for SecA2-mediated protein export.  SecA2 recognizes pre-
proteins in the cytoplasm, and delivers them to the SecA1/SecYEG translocase.  Upon ATP 
binding and hydrolysis, SecA2 undergoes conformational changes to initiate the export cycle.  
SecA1 finishes protein export through multiple rounds of insertion/deinsertion.  Once across 
the cytoplasmic membrane, the exported protein can fold into its mature conformation. 
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 The accessory SecA2 pathway is an example of a specialized protein export system in 
mycobacteria and some Gram positive bacteria.  The mechanism of SecA2-mediated protein 
export is not well understood.  For example, it is not known how proteins exported via SecA2 
cross the bacterial cytoplasmic membrane.  In order to clarify this process, we attempted to 
identify SecA2-interacting proteins using protein pull-down experiments.  We successfully 
expressed and purified SecA2 with a C-terminal 6xHIS tag from M. smegmatis.  To preserve 
and identify proteins that transiently interact with SecA2, we used in vivo and in vitro 
crosslinking.  Crosslinked protein complexes were analyzed by mass spectrometry.  While 
we were unable to identify SecA2-interacting proteins, we provide evidence that SecA2 
forms oligomers.  We also explored using a dominant negative mutant SecA2 protein (SecA2 
K129R) to identify SecA2-interacting proteins.  SecA2 K129R localized to the cell envelope
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fraction, and was purified upon detergent solubilization.  Taken together, our results provide 
the basis for future experiments to identify SecA2-interacting proteins. 
 
Introduction 
In mycobacteria and some Gram positive bacteria, export of a subset of proteins 
depends on an accessory SecA2 export system (1, 3, 4, 6, 7, 16, 21).  The mechanism by 
which SecA2-dependent proteins are exported from the cytoplasm is only beginning to be 
investigated.  In SecA2/Y2 systems of Gram positive organisms like Streptococcus gordonii, 
SecA2 is encoded near the secY2 and asp genes whose products are involved in SecA2-
dependent protein export (1, 20).  For example, disruption of S. gordonii secY2 prevents 
export the SecA2-dependent protein GspB (1).  SecY2 is predicted to possess transmembrane 
domains, and share sequence similarity with the essential SecY protein that is part of the 
canonical SecYEG translocase.  Asp2 (for Accessory secretory protein) also contains a 
predicted transmembrane domain.  Although Asp2 is required for GspB export, the function 
of this protein has not yet been determined (23).  Two other ORFs, asp4 and asp5, encode 
proteins with homology to SecE and SecG, respectively.  Disruption of these two genes also 
prevents GspB export (24).  By working together, SecY2 and the Asp proteins may form a 
membrane-embedded channel through which SecA2-dependent exported proteins may pass.   
In mycobacteria there is no extra SecY (8, 9).  Furthermore, the genes adjacent to 
secA2 in mycobacteria do not encode proteins with homology to the Asp proteins, and they 
do not have any known roles in SecA2-dependent protein export (20).  Three nearby genes 
are predicted to encode proteins with transmembrane domains, but the function of these 
proteins remains untested.  Without knowing the components of the mycobacterial SecA2 
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export pathway, our understanding of this important system is incomplete.  Therefore, we 
sought to identify SecA2-interacting proteins using protein pull-down assays.  To date, 
SecA2-interacting proteins have yet to be identified in any accessory SecA2 system.   
SecA2 was engineered to contain a C-terminal histidine (6xHIS) tag, and expressed in 
M. smegmatis.  As interactions with SecA2 might be transient, we used a membrane 
permeable crosslinking reagent to increase the odds of finding an interacting protein.  
Samples were crosslinked, lysed, and subject to affinity purification using nickel resin.  
SecA2-HIS crosslinked complexes were eluted and analyzed by SDS-PAGE, western blot, 
and mass spectrometry. 
These experiments demonstrated SecA2-HIS forms oligomers upon crosslinking.  
The essential SecA of Escherichia coli forms dimers, although the importance of 
dimerization for function of this protein is still a matter of debate (10, 15, 18).  This is the 
first demonstration of oligomerization of an accessory SecA2 protein from any system. 
In the above experiments, no proteins other than SecA2 were identified as being 
bound to SecA2.  Therefore, we developed an alternative strategy to identify SecA2-
interactors.  The approach involves the dominant negative SecA2 K129R protein, which we 
showed previously to become trapped at the membrane in a presumed protein complex.  We 
believe the SecA2 K129R-HIS tagged system we established will be a valuable tool for 
future efforts to indentify SecA2-interacting proteins in M. smegmatis. 
 
Materials and Methods 
Bacterial strains and growth conditions.  Middlebrook 7H9 or 7H10 medium (BD 
Biosciences) was used for growing M. smegmatis.  This growth medium was supplemented 
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with 0.2% (w/v) glucose, 0.5% (w/v) glycerol, and 0.1% (w/v) Tween 80 (Fisher).  In other 
experiments, Mueller Hinton (BD Biosciences) was used to grow M. smegmatis.  When 
needed, kanamycin (Acros Chemicals) or hygromycin (Roche) was added to the medium at 
20 µg/ml or 50 µg/ml, respectively.  Luria Bertani (LB) was used to grow E. coli cultures.  
When needed, kanamycin or hygromycin was added at 40 µg/ml or 150 µg/ml, respectively.  
The identity of all vectors used in this study was confirmed by DNA sequencing (UNC-CH 
automated DNA sequencing facility and Eton Biosciences). 
Construction of HIS-tagged SecA2.  During the course of our studies, we had reason to 
believe that the start codon of M. smegmatis SecA2 was different from the one originally 
annotated.  We constructed pHSG86 to reflect this change.  A segment of secA2 was PCR 
amplified using primers 5’-GAATCACTTCGTGCCGAAGACGTCCAGC-3’ and 5’-
GCGGAACACACCCGGGAGGCT-3’ and cloned into pCR2.1 (Invitrogen) yielding 
pHSG81.  A 1.4 kbp XmnI-NarI fragment of pHSG81 was cloned into similarly digested 
pYA810 giving plasmid pHSG86.  pHSG86 carries secA2 driven off of the constitutive 
hsp60 promoter, but now has the predicted correct start codon.  To C-terminally tag SecA2 
with 6xHIS, primers 5’-CGAATTCCTCGGCGCCGTCACCGTGT-3’ and 5’-
CGAATTCAGTGGTGGTGGTGGTGGTGGCGGAACACACCCGGCAGG-3’ were used 
to amplify a 0.9 kbp fragment of secA2 (the codons for histidine are underlined).  The 
resulting fragment was cloned into pCR2.1 yielding pHSG82.  A 0.9 kbp NarI-EcoRI 
fragment from pHSG82 was cloned into similarly cut pYA810 to yield pHSG87.  Lastly, 
pHSG87 was digested with NarI-EcoRI and the resulting 0.9 kbp fragment was cloned into 
similarly cut pHSG86, yielding plasmid pHSG93.  pHSG93 encodes SecA2-HIS using the 
predicted correct start codon and tagged at the C-terminus with 6xHIS. 
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Azide assay.  200 µl of saturated (OD600nm = 2.0) M. smegmatis culture was mixed with 3.5 
ml of molten 7H9 top agar, and then poured onto a 7H10 bottom agar plate.  After the top 
agar cooled, sterile 6 mm filter discs were placed onto the surface.  10 µl of 0.15 M sodium 
azide was then added to the disc.  The plates were inverted and incubated for 2 days at 37˚C.  
After incubation, any resulting zone of inhibition on the plate was measured.  Untreated 
plates were included as a control.  Each strain was tested in triplicate. 
Purification of SecA2-HIS from M. smegmatis.  In a previous study, the cytoplasmic 
chaperone GroEL1 was shown to bind to nickel resin by virtue of a histidine-rich C-terminus 
(17).  To avoid contamination of SecA2-HIS with GroEL1 and GroEL1-interacting proteins, 
we purified SecA2-HIS from a ∆groEL1 mutant strain (kind gift from Dr. Graham Hatfull, 
University of Pittsburgh).  The ∆groEL1 mutant was electroporated with pHSG93 to generate 
strain NR151.  100 ml cultures of NR151 grown in Muller Hinton were harvested at OD600nm 
= 1.0.  The cell pellet was resuspended in lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 
mM imidazole, pH 8.0) and lysed in a French pressure cell at 20,000 psi.  Cellular debris was 
removed by centrifugation.  The resulting lysate was mixed with Ni-NTA resin (QIAGEN) 
and mixed on a rocker at 4˚C for 1 hour.  The beads were collected in a column and washed 
three times with wash buffer (50 mM NaH2PO4, 300 mM NaCl, 30 mM imidazole, pH 8.0).  
Proteins were eluted with elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM 
imidazole, pH 8.0) and concentrated using Microcon spin columns with a 10 kDa cutoff 
(Millipore). 
Crosslinking experiments.  To crosslink SecA2-HIS with any interacting proteins, 
dithiobis(succinimidylpropionate) (DSP, Pierce) was used at a final concentration of 4 mM 
according to the manufacturer’s instructions.  DSP was added to the concentrated cell pellet 
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prior to lysis (in vivo crosslinking) or after lysis (in vitro crosslinking).  Crosslinked proteins 
were purified as described above.  To reverse the crosslinks, samples were boiled in SDS-
PAGE sample buffer containing 5% β-mercaptoethanol (BME). 
Construction and purification of SecA2 K129R-HIS.  Since SecA2 K129R is toxic to M. 
smegmatis, SecA2 K129R-HIS was placed under control of an inducible Tet promoter (Tet 
ON) (13).  Primers 5’-AGGATCCATCCGGAGGAATCACTT-3’ and 5’-
AGGATCCCTAGTGGTGGTGGTGGTGGTGGCGGAACACACCCGGCAGG-3’ were 
used to amplify SecA2 from pHSG86.  The resulting 2.4 kbp fragment was cloned into pCC1 
yielding plasmid pNR49.  A 2.4 kbp BamHI fragment was cloned from pNR49 into similarly 
cut pMP715 (gift from Dr. Martin Pavelka, University of Rochester) generating plasmid 
pNR50.  This plasmid has wild-type secA2 cloned downstream of the Tet operator (TetO).  
Additionally, pNR50 also encodes the TetR repressor.  To mutate the Walker A lysine 129 
residue to arginine, site-directed mutagenesis was performed using primers 5’-
CGGGTGAGGGCAGGACGCTGGC-3’ and 5’-GCCAGCGTCCTGCCCTCACCCG-3’to 
generate pNR54.  pNR54 was electroporated into wild-type mc2155 and ∆secA2 mutant 
NR116 to yield strains NR274 and NR275, respectively.  To induce expression of SecA2 
K129R-HIS, cultures were grown in Mueller Hinton broth at 37˚C and treated with 300 
ng/ml anhydrotetracycline for 21 hours.  Following induction, bacterial cells were harvested 
and processed into cell envelope and cytoplasmic fractions by differential ultracentrifugation 
as described previously (12).  Cell envelopes were solubilized using a panel of denaturants 
and then pooled with the soluble fraction prior to affinity purification. 
Mass spectrometric identification of proteins.  All analyses were performed by the UNC-
Duke Proteomics Core Facility at UNC-Chapel Hill. 
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Results 
SecA2-HIS is functional and highly expressed in M. smegmatis.  We generated a 
vector that overexpressed SecA2-HIS protein.  Comparison of the annotated M. smegmatis 
SecA2 sequence to other mycobacterial SecA2 proteins revealed an extension at the extreme 
N-terminus (data not shown).  We noticed a GTG codon internal to the currently annotated 
start codon that would result in a protein 15 amino acids shorter at the N-terminus.  By using 
this internal start codon and putting secA2 under control of the constitutive hsp60 promoter, 
we created pHSG93, a SecA2-HIS expression vector in M. smegmatis.  When electroporated 
into wild-type or ∆secA2 mutant M. smegmatis, pHSG93 highly expressed SecA2-HIS 
compared to SecA2 expression from the chromosome as shown by immunoblot using anti-
HIS or anti-SecA2 antibodies (Figure 6.1A).  To ensure that SecA2-HIS with the small N-
terminal truncation is still functional, we tested the ability of pHSG93 to complement the 
azide hypersensitivity of the ∆secA2 mutant.  Resistance to azide was restored to wild-type 
levels when the ∆secA2 mutant was transformed with pHSG93 (Figure 6.1B).  From these 
data, we conclude that the N-terminal extension is dispensable for normal SecA2 function 
and that SecA2-HIS is a fully functional protein in M. smegmatis. 
 
Mass spectrometric analysis of cross-linked species indicates the existence of 
SecA2-HIS multimers.  We purified SecA2-HIS from whole cell lysates using nickel-
affinity columns (Figure 6.2A).  In order to increase the chances of identifying SecA2-HIS 
interacting proteins, we employed the membrane-permeable covalent crosslinking reagent 
DSP (dithiobis(succinimidylpropionate)).  DSP is commonly used to preserve transient 
protein-protein interactions by reacting with primary amine groups on amino acids.  
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Crosslinking reagents have been successfully used to identify interactions among 
components of protein secretion systems.  We performed DSP crosslinking either before (in 
vivo) or after (in vitro) lysing M. smegmatis cells that expressed SecA2-HIS.  Cultures 
carrying an empty vector were processed in parallel as a negative control.  Crosslinked 
proteins were purified from soluble whole cell lysates using nickel-affinity columns and 
analyzed by SDS-PAGE and Coomassie staining (Figure 6.2B).  Where indicated, protein 
samples were treated with 5% BME prior to loading onto a gel; treatment with BME breaks 
the DSP crosslinks and will liberate any SecA2-HIS-interacting protein. 
SecA2-HIS is readily visible at the predicted molecular weight of 89 kDa.  We also 
observed multiple bands larger than monomeric SecA2-HIS in the crosslinked samples 
(Figure 6.2B).  DSP crosslinking yielded three SecA2-containing products, as shown by 
immunoblotting with anti-SecA2 antibody (Figure 6.2C).  We repeated this experiment with 
both in vivo and in vitro DSP crosslinking on strains that carried the SecA2-HIS expression 
plasmid or an empty vector for analysis by mass spectrometry.  In an effort to avoid false 
positives, we selected bands present in the SecA2-HIS lanes but absent in the vector control 
for further analysis (band marked with * in Figure 6.2D).  These bands were excised and 
digested with trypsin, and the resulting peptides were analyzed by MALDI-TOF MS and by 
LC-ESI-MS/MS (UNC-Duke Proteomics Core).  The data was matched to M. smegmatis 
proteins with the MASCOT search engine (19).  In all cases, SecA2 was the only protein 
identified.  This suggests the crosslinked products are SecA2 oligomers.  E. coli SecA is 
reported to dimerize although it remains controversial if SecA functions as a monomer or 
dimer during protein export (10, 15, 18).  Combined, these data argue that SecA2 is able to 
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interact with itself.  Some of the bands where SecA2 was found are much larger than the 
predicted dimer size; this could indicate that SecA2 forms much larger multimers. 
SecA2 K129R-HIS can be purified from cell envelope fractions of M. smegmatis.  
The above affinity purification of SecA2-HIS from whole cell lysates under non-denaturing 
conditions led to the apparent identification of SecA2-SecA2 interactions, but it did not 
identify other SecA2-interacting proteins.  Furthermore, any SecA2-interacting integral 
membrane proteins, including a membrane-embedded translocase, would have been missed 
because of their under representation in the whole cell lysate and because membrane 
solubilization was not performed.  In continuation of our efforts to co-purify SecA2-
interacting proteins, we decided to take advantage of the SecA2 K129R dominant negative 
protein that we found localized to the membrane in what we believe to be non-functional 
protein complexes (Chapter 3).  We proposed to purify SecA2 K129R-HIS from a membrane 
fraction in conjunction with DSP crosslinking as new approach to identify SecA2-interacting 
proteins.  Our model to explain the dominant negative phenotypes associated with SecA2 
K129R is that this mutant protein forms stable, inactive complexes with an essential 
membrane-associated protein.  The rich agar growth defect is more severe when SecA2 
K129R is expressed in a ∆secA2 mutant than in wild-type M. smegmatis; this is probably 
because some of the wild-type SecA2 molecules in this strain are still functional (Chapter 3).  
Therefore, we used expressed SecA2 K129R-HIS in the ∆secA2 mutant strain for our 
analysis.  One drawback to this approach is that GroEL1 is still expressed in the ∆secA2 
mutant; thus by using nickel-affinity columns we expected to not only purify SecA2 KR-HIS 
but GroEL1 as well.  Since SecA2 K129R is toxic to M. smegmatis, we used a system where 
expression of SecA2 K129R-HIS could be controlled by an inducible tetracycline promoter 
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(Tet ON) (13).  When induced by Atc treatment, the TetR repressor protein dissociates from 
the TetO operator and allows expression of SecA2 K129R-HIS.  SecA2 K129R-HIS can then 
be purified from cell lysates using nickel-affinity columns.  Upon subcellular fractionation, 
the inducible SecA2 K129R-HIS is predominantly localized to the cell envelope fraction, 
indicating that the C-terminal HIS tag does not affect the localization of SecA2 K129R.  
Furthermore, SecA2 K129R-HIS also causes a dominant negative phenotype on rich agar 
growth defect as expected (data not shown).   
Cell envelope proteins are relatively insoluble in non-denaturing conditions (26).  
Therefore, we resuspended cell envelope fractions in different denaturants including urea, 
Triton X-100, CHAPS, and NP-40 to solubilize the cell envelope proteins which hopefully 
include SecA2 K129R-HIS complexes (Figure 6.3).  First, SecA2 K129R expression was 
induced by adding Atc to the cultures.  After induction, the cultures were in vivo crosslinked 
by adding DSP.  The crosslinked cells were then lysed, and the resulting whole cell lysate 
was fractionated by differential ultracentrifugation to purify the cell envelope fraction.  The 
cell envelopes were solubilize using a variety of denaturants, and then purified using nickel 
resin as before.  We were able to easily purify SecA2 K129R-HIS from the cell envelope of 
M. smegmatis.  After repeated experiments using the panel of denaturants, no reproducible 
SecA2 K129R-HIS interacting protein complexes were observed, other than those likely to 
be SecA2 multimers.  Other than these SecA2 multimers, every other band in the SecA2 
K129R-HIS lanes was also found in the vector control. 
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Discussion 
One commonly used approach to understand how a protein functions is to identify 
interacting proteins by methods like coimmunoprecipitation and protein pull-down assays (2, 
5).  These methods have been successful in characterizing the components of specialized 
secretion systems, bacterial surface structures, and other multi-subunit complexes (14, 22, 
25).  We attempted to use protein pull-down experiments to identify proteins that interact 
with the accessory SecA2 protein of M. smegmatis.  Our results showed that SecA2 is able to 
form multimers.  In E. coli and B. subtilis, the single essential SecA protein has been shown 
to form dimers (11, 15, 18).  There is still controversy over whether SecA dimerization is 
required for function (10). 
The oligomeric state of accessory SecA2 proteins has not been explored in any 
bacteria that possess two SecA homologs until now.  Our results support the existence of 
SecA2  oligomers and they are an important step in understanding SecA2 function.  
However, a much more thorough biochemical analysis is required to understand how and 
why SecA2 exports only a select subset of proteins from the cytoplasm. 
During our studies, we came to appreciate the technical hurdles associated with mass 
spectrometric analysis of crosslinked proteins.  For example, not all peptides ionize equally 
well with MALDI.  Ionized peptides that are more abundant are preferentially represented in 
the mass spectra that are generated.  This could be a limitation with our analysis since 
SecA2-HIS was so highly overexpressed.  To get around this issue, we also performed liquid 
chromatography (LC)/MS/MS on the trypsinized bands.  By including the LC step, we could 
separate out the SecA2-HIS peptides from the other, less abundant peptides to aid in their 
detection.  With this method, the peptides were ionized by electrospray, which also ionizes 
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different peptides with variable efficiency.  However, even with this more sensitive approach 
we did not identify proteins other than SecA2 in our complexes.  Another issue was that we 
did not see new bands appear when the crosslinking was reversed as we would expect.  This 
might indicate that while DSP is effective at crosslinking SecA2 to itself, it is not suitable for 
crosslinking SecA2 to other proteins.  Despite our extensive efforts to identify novel SecA2 
protein interactions, we only uncovered SecA2-SecA2 multimers. 
We think the association of SecA2 K129R with the cell envelope provides a useful 
tool for identifying SecA2-interacting proteins.  As described in Chapter 3, wild-type SecA2 
localized in the cytoplasm, but the Walker box mutant SecA2 K129R protein became 
predominantly cell envelope-associated.  We think this indicates SecA2 K129R is locked in a 
complex with a membrane-embedded protein.  This finding help explain the rich agar growth 
defect associated with expression of SecA2 K129R.  It is possible that SecA2 K129R impairs 
the function of components of the essential Sec pathway.  In Chapter 5, we showed that 
SecA1 is required for the export of SecA2-dependent proteins.  Because we have been unable 
to show a direct physical interaction between SecA1 and SecA2, we think it is possible that 
SecA2 indirectly delivers pre-proteins to SecA1 or maintains them in a translocation 
competent state and thus does not need to physically associate with SecA1.  Alternatively, 
SecA2 might deliver pre-proteins directly to the SecYEG translocase.  On the other hand, 
SecA2 may work with another translocase and SecA1292 KR is locked in a complex with 
this other export machine.  Experiments are needed to distinguish between these possible 
models.  It is our hope that by further exploration of different detergents and crosslinkers 
with the inducible SecA2-K129R-HIS inducible system the important goal of identifying 
proteins that work with SecA2 in the accessory export pathway will one day be achieved.  
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Figure 6.1.  SecA2-HIS is highly expressed and fully functional in M. smegmatis.  (A) 
Whole cell extracts from wild-type and ∆secA2 mutant M. smegmatis strains expressing 
SecA2-HIS were subjected to SDS-PAGE and immunoblot with anti-HIS (lanes 1-4) or anti-
SecA2 antibodies (lanes 5-8).  Note the increased expression of SecA2-HIS (lanes 7 and 8) 
compared to SecA2 encoded on the chromosome (lane 5).  (B) SecA2-HIS restores resistance 
to azide in a ∆secA2 mutant.  Wild-type and ∆secA2 mutant were transformed with empty 
vector and pHSG93 (secA2-HIS; SecA2 with corrected translational start and a C-terminal 
6xHIS tag).  The ∆secA2 mutant was also transformed with pHSG86 (secA2; SecA2 with 
corrected translational start).  Each strain was tested in triplicate, and the data is presented as 
the mean plus standard error.
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Figure 6.2.  SecA2-HIS forms multimers.  (A) SecA2-HIS was purified from M. smegmatis 
whole cell lysates (WCL) using nickel-affinity columns.  Flow through (FT), wash (W1 and 
W2), and elution (E1 and E2) fractions were analyzed by SDS-PAGE and Coomassie 
staining.  (B) Coomassie stained gel of DSP crosslinking experiment.  DSP crosslinking was 
performed where indicated.  (C) Anti-SecA2 immunoblot shows formation of high molecular 
weight SecA2-reactive complexes upon DSP crosslinking.  (D) Crosslinked proteins for 
analysis by mass spectrometry.  Bands marked with * were isolated from the Coomassie 
stained gel, digested by trypsin, and subjected to peptide mass fingerprinting.  For some 
samples, crosslinking was reversed by treatment with 5% BME prior to gel analysis. 
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Figure 6.3.  SecA2 K129R-HIS can be purified from cell envelope fractions of M. 
smegmatis.  SecA2 K129R-HIS was purified from M. smegmatis cell envelope fractions and 
crosslinked with DSP where indicated.  Crosslinking was reversed by treatment with 5% 
BME where indicated.  Several different denaturants were used for solubilization and showed 
similar results; shown is a representative Coomassie stained gel of protein samples 
solubilized with 8M urea.  The position of SecA2 KR-HIS and GroEL are indicated by the 
arrows. 
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 Chapter 7 
CONCLUSION 
 
The global burden of tuberculosis (TB) is staggering – worldwide, 2 billion people 
are believed to be infected with Mycobacterium tuberculosis, the causative agent of TB (65).  
On average, each person with an active case of TB infects 10-15 people per year.  While 
antibiotic treatment for TB exists, the drug regimen is lengthy (up to 6 months).  Full patient 
compliance is essential to prevent treatment failure.  Furthermore, misuse of antibiotics 
contributes to drug resistance.  The emergence of multi-drug resistant (MDR) and 
extensively drug resistant (XDR) TB strains represents a major problem for disease treatment 
(43, 65).  It is therefore critically important that new therapies be designed to combat TB.  
Understanding the physiology of M. tuberculosis could aid in the discovery of novel drug 
targets.  To that end, we study mycobacterial protein export pathways and how they 
contribute to the success of M. tuberculosis as a pathogen of global importance (38). 
Specialized protein export and secretion pathways are often used by bacterial 
pathogens to initiate and establish infection (24).  Gram negative bacteria possess a wide 
variety of specialized secretion systems, including the well-characterized Type III secretion 
system (T3SS) (32).  Organisms like Yersinia pestis and Salmonella typhimurium use a T3SS 
to directly inject virulence factors into the host cell cytoplasm.  Gram negative bacteria have 
multiple specialized secretion systems (Type I-VI) (25). 
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There are comparatively few specialized secretion systems in Gram positive and 
mycobacteria.  The ESX-1 system is one example of specialized secretion in Gram positive 
and mycobacteria (1).  This system was initially described as being required for M. 
tuberculosis virulence (41).  Subsequently, ESX-1 systems have been discovered in 
Staphylococcus aureus and Listeria monocytogenes (1, 57).  In M. tuberculosis, ESX-1 is 
required for the export of two small protein virulence factors, ESAT-6 and CFP-10 (9). 
All bacteria use the essential canonical Sec pathway to transport the bulk of exported 
proteins across the bacterial cytoplasmic membrane (17, 45).  SecA is an ATPase that powers 
the export of unfolded pre-proteins through the membrane-embedded SecYEG translocase 
(44).  Through repeated cycles of ATP binding and hydrolysis, SecA undergoes 
conformational changes and ratchets pre-proteins across the central channel formed by 
SecYEG (18, 19).  SecA is an essential protein in all tested cases.  A small subset of Gram 
positive bacteria and mycobacteria contain a second accessory SecA protein (3, 6, 7, 13, 14, 
40, 49, 54).  Recent studies lead to the identification of accessory SecA2 pathways as new 
specialized protein export systems.  In the cases of bacteria with two SecAs, the general trend 
is that SecA1 is the essential, housekeeping secretion factor.  SecA2 is the accessory 
secretion factor that is only required to export a small subset of proteins.  SecA2 is not 
essential for growth.  Accessory SecA2 homologs exist in all species of mycobacteria, and 
are found in some Gram positive bacteria including Streptococcus gordonii and Listeria 
monocytogenes (49). 
In mycobacteria, the accessory SecA2 system is required for exporting a subset of 
proteins (7, 26, 31).  However, almost nothing is known about the mechanism of SecA2-
mediated protein export in mycobacteria.  The work described in this dissertation represents 
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the first attempts to define how SecA2 functions to export proteins in mycobacteria.  Our 
studies started by asking basic questions.  In the process, we uncovered structural and 
functional differences between SecA1 and SecA2.  We also developed genetic and 
biochemical tools that will enable further study and identification of other important 
components of the accessory SecA2 protein export system.  Through the course of our 
experiments, we also provided evidence that M. smegmatis is a legitimate model system for 
studying the mycobacterial SecA2 protein export pathway. 
 
Similarities and differences exist between SecA1 and SecA2. 
Sequence alignments show M. tuberculosis SecA1 and SecA2 are 50% similar to 
each other (Chapter 2).  This similarity is spread throughout much of the two proteins, even 
though SecA1 is 20 kDa larger than SecA2.  Both SecA1 and SecA2 possess Walker Box 
motifs which are the site of ATP binding for many ATPases (6, 49).  The difference in size is 
attributed to two deletions within the SecA2 sequence.  To better understand the differences 
between SecA1 and SecA2, we created a computer-generated homology model of SecA2 
based on the experimentally determined crystal structure of SecA1.  We found that the 
deletions in SecA2 occur in two different subdomains: the Gram negative loop and 
HWD/CTL (Helix wing domain/C-terminal linker) (17).  The Gram negative loop protrudes 
from a subdomain called IRA2 (Intramolecular regulator of ATPase).  As defined in E. coli 
SecA, IRA2 forms part of the ATPase motor domain along with NBD1 (Nucleotide binding 
domain) (46, 62).  Interestingly, the Gram negative loop is also absent in Gram positive SecA 
proteins, but is present in Gram negative SecA proteins (27).  The function of this Gram 
negative loop is unknown.  Perhaps this loop confers substrate specificity to SecA1 versus 
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SecA2.  Mutagenesis of the Gram negative loop in SecA1 will help to understand the 
function of this substructure. 
The other SecA2 deletion is in HWD/CTL.  The function of the HWD is not 
understood, even in the well-studied SecA of E. coli (17).  Activities that map to the CTL of 
E. coli include binding to phospholipids, binding to the chaperone protein SecB, and binding 
to a Zn2+ ion (8, 21, 22, 29).  It is worth noting that the corresponding CTL region of SecA1 
in mycobacteria does not contain residues for a Zn2+ binding motif.  In E. coli, the Zn2+ 
binding site is also part of the SecB binding site.  There are no SecB homologs in 
mycobacteria, so the absence of a SecB binding site is not surprising (15).  The functional 
significance of the missing subdomains in SecA2 is not clear.  Perhaps these subdomains are 
involved in recognizing pre-proteins that are compatible with SecA1 versus SecA2.  
Alternatively, these domains could be important for specifying interactions with different 
translocases.  We think that the SecA2 homology model will be a useful tool for designing 
mutations to characterize the functional subdomains of SecA1 and SecA2. 
SecA1 and SecA2 have unique functions; the two proteins are not functionally 
redundant.  This is shown in M. smegmatis where overexpression of SecA1 does not 
compensate for the absence of SecA2 and vice versa (6).  However, it is not obvious how 
these similar proteins play different roles inside the cell.  To begin our analysis, we 
determined that both in M. tuberculosis and M. smegmatis, SecA1 and SecA2 are expressed 
at the same level, at least under standard laboratory growth conditions (Chapter 2).  This 
shows that the difference between SecA1 and SecA2 is not due to expression level.  Rather, 
the difference between SecA1 and SecA2 is more likely due to different functions and/or 
different proteins with which they interact. 
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Since components of bacterial protein export systems are found in different 
subcellular compartments(10, 25, 52), we performed experiments to determine where SecA1 
and SecA2 function in the mycobacterial cell.  E. coli SecA cycles between the cell envelope 
and the cytoplasm (12, 18, 19).  This dynamic localization reflects the ability of SecA to 
interact with newly synthesized pre-proteins as well as the membrane-embedded SecYEG 
translocase (29, 47).  In Chapter 2, we performed subcellular localization of M. smegmatis to 
determine which subcellular fractions contain SecA1 and SecA2.  Similar to E. coli SecA, we 
found that SecA1 is equally represented in the cytoplasm and the cell envelope.  This is not 
surprising since SecA1 is the essential SecA of mycobacteria (6, 28, 51).  In contrast, we 
found SecA2 enriched in the cytosolic fraction.  We suspect this difference between SecA1 
and SecA2 is functionally significant.  The cytoplasmic localization of SecA2 might indicate 
that the accessory SecA plays a supportive role in protein export, perhaps functioning as a 
chaperone analogous to the role of SecB in E. coli.  Of note, SecB is only required for the 
export of a subset of proteins in E. coli and there are no SecB homologs in mycobacteria (15, 
16). 
While SecA1 and SecA2 certainly have distinct roles inside the cell, we also wanted 
to explore whether SecA1 and SecA2 work together in protein export.  The absence of SecA2 
only affects a subset of exported proteins (7, 26).  We wanted to determine if SecA1 plays a 
role in exporting SecA2-dependent proteins.  Using a tetracycline repressible system (28), we 
depleted SecA1 from M. smegmatis and followed the export of the SecA2-dependent 
lipoprotein Msmeg1712-HA to the mycobacterial cell wall.  This experiment showed 
depletion of SecA1 prevents Msmeg1712-HA from reaching the cell wall; furthermore, 
Msmeg1712-HA accumulated in the cytoplasm in the absence of its export.  This export 
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defect revealed that the effect of SecA1 depletion on Msmeg1712-HA export is comparable 
to the defect exhibited by the ∆secA2 mutant.  This is the first demonstration of the canonical 
SecA1 being involved in exporting substrates that require the accessory SecA2.  In the other 
accessory SecA2 systems being studied, this exact question has yet to be asked. 
We do not yet understand the nature of the relationship between SecA1 and SecA2.  
SecA2 could directly interact with SecA1 or other Sec components to export Msmeg1712-
HA.  In this model, discussed again below, the role of SecA2 may be to deliver pre-proteins 
to the SecYEG translocase that are normally overlooked by the general Sec apparatus.  To 
further explore this idea, we can test whether depletion of other Sec components will impair 
Msmeg1712-HA export.  It is also possible that SecA1 works with SecA2 in conjunction 
with a novel translocase.  As noted in Chapter 1, there are several putative transmembrane 
proteins encoded by genes that neighbor secA2 (49).  In S. gordonii and S. parasanguinis, the 
genes that neighbor secA2 are involved in accessory SecA2 export (3, 14, 58-60, 66).  It is 
worth exploring the functions of the genes that neighbor secA2 in mycobacteria in case they 
comprise a unique SecA2-dependent translocase.  Although less likely, a final possibility is 
that SecA1 assembles a novel translocase used by SecA2 to export Msmeg1712-HA.  
However, it is only in rare cases that E. coli SecA influences integral membrane protein 
assembly and there is no evidence SecA1 does this in mycobacteria (52, 61, 64).  The 
identification of SecA2-interacting proteins will be critical to defining the role of 
SecA1/SecYEG in the process of SecA2 export.   
 
ATP binding is required for normal SecA2 function in M. tuberculosis and M. 
smegmatis. 
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The single, essential SecA protein of E. coli and B. subtilis binds and hydrolyzes ATP 
(42, 44).  This ATPase activity is absolutely required for SecA function.  Sequence 
alignments show that M. tuberculosis SecA1 and SecA2 both have predicted Walker Box 
motifs.  We hypothesized that SecA1 and SecA2 could bind ATP.  In Chapter 4, we showed 
that M. tuberculosis SecA1 and SecA2 proteins both bind and hydrolyze ATP in vitro.  This 
was the first demonstration of ATPase activity for an accessory SecA2 protein from any 
bacterial species.  In support of this finding, we also showed that mutating a conserved lysine 
residue in the Walker A motif of SecA2 prevents ATP binding in vitro. 
 We assessed the biological importance of ATP binding for SecA2 function by testing 
the ability of Walker Box mutant secA2 alleles to complement ∆secA2 mutant phenotypes 
(Chapter 3).  M. tuberculosis is an intracellular pathogen and as such is able to grow inside 
macrophages (30).  However, the M. tuberculosis ∆secA2 mutant is unable to grow inside 
macrophages, indicating that SecA2 is an important virulence factor (39).  This macrophage 
growth defect can be overcome by expressing wild-type secA2 from a plasmid in the ∆secA2 
mutant.  We transformed the ∆secA2 mutant with a plasmid carrying secA2 K115R, and 
showed the resulting transformants are unable to grow inside macrophages.  This indicates 
that the Walker Box residue K115 is required for normal SecA2 function during intracellular 
growth. 
We also tested the ability of Walker Box mutant secA2 alleles to complement the 
smooth colony morphology of the M. tuberculosis ∆secA2 mutant (37).  Expression of SecA2 
K115R in the ∆secA2 mutant does not complement the colony morphology.  Furthermore, 
expression of SecA2 K115R in wild-type H37Rv causes the colonies to appear smooth.  This 
was our first indication that SecA2 K115R was dominant negative.  Taken together, these 
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results confirm that ATP binding is absolutely required for normal SecA2 function in M. 
tuberculosis. 
We also tested Walker Box mutant secA2 alleles in M. smegmatis.  The M. smegmatis 
∆secA2 mutant has a rich agar growth defect and is hypersensitive to sodium azide (6).  As 
described in Chapter 3, Walker Box mutant secA2 alleles from M. tuberculosis (secA2 
K115R and secA2 D216N) and M. smegmatis (secA2 K129R) failed to complement these 
phenotypes.  In fact, we found that these alleles actually exacerbated the ∆secA2 mutant 
phenotypes.  Furthermore, when the secA2 K129R allele is expressed in wild-type M. 
smegmatis, the resulting strain had a rich agar growth defect equivalent to a ∆secA2 null 
mutant.  This result also indicated SecA2 K129R is dominant negative. 
 
SecA2 K129R is dominant negative. 
Dominant negative mutants have a wide history of use as a tool to understand 
biological processes, including protein export pathways (50).  In fact, the Walker Box mutant 
SecA K108R of E. coli has dominant negative effects on Sec-dependent protein export in 
vitro (44).  Other Walker Box mutants also have dominant negative effects (11, 50, 53).  
Dominant negative phenotypes are often dosage dependent (2, 55, 56).  We confirmed that 
SecA2 K129R was dominant negative by showing that the phenotype associated with this 
protein is dosage dependent; increased expression of SecA2 K129R correlates with a 
worsened rich agar growth defect in wild-type M. smegmatis (Chapter 3).  By discovering 
this dominant negative phenotype, we now have another tool to dissect the mechanism of the 
accessory SecA2 pathway. 
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We think SecA2 K129R is dominant negative because it is locked in a non-functional 
complex with SecA2-interacting proteins.  This interaction appears to disable components of 
a process that is essential for normal cell growth, as shown by the growth inhibitory effects 
of high level expression of SecA2 K129R.  Therefore, we consider essential Sec components 
strong candidates for being the proteins affected by SecA2 K129R.  As already mentioned, 
we think it is a strong possibility that the role for SecA2 is to work with SecA1 to enable 
efficient export of a particular subset of proteins via the canonical Sec pathway.  In a ∆secA2 
mutant, this subset of proteins might still be exported, but much less efficiently if at all.  We 
believe some of these exported proteins might be important for metabolizing certain nutrients 
or for resisting stress on the cell envelope.  This would explain why the ∆secA2 mutant has a 
growth defect on rich agar and high salt agar plates.  When the only SecA2 molecule inside 
the cell contains the K129R mutation, the plate phenotypes are greatly exacerbated. 
  
SecA2 K129R is a tool to identity residues critical for normal SecA2 function. 
During our studies, we isolated spontaneous intragenic and extragenic suppressors of 
the exacerbated rich agar growth defect of the M. smegmatis ∆secA2/secA2 K129R strain.  As 
discussed in Chapter 3, the intragenic suppressors mapped to different subdomains of SecA2, 
including surface exposed regions of the NBD1, IRA2, IRA1, and PPXD subdomains.  
Together, NBD1 and IRA2 constitute the N-domain while IRA1 and PPXD are components 
of the C-domain (17, 62).  If SecA2 normally interacts with a membrane-embedded 
translocase, and SecA2 K129R irreversibly associates with this translocase, then suppressors 
could alleviate the dominant negative phenotype by disrupting interactions with the 
translocase.  A recent structural study showed that the IRA1 and PPXD subdomains are 
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important for interactions between SecA and SecY in Thermotoga maritima (20, 67).  Thus, 
we predicted that suppressor mutations in IRA1 and PPXD could alter how SecA2 K129R 
interacts with other proteins.  To test this hypothesis, we localized SecA2 K129R in the 
intragenic suppressor strains.  We found that the mutations in IRA1 and PPXD released 
SecA2 from the cell envelope.  This finding was important because it provides support for 
our model of why SecA2 K129R is dominant negative, and how suppressor mutations 
alleviate this phenotype.  
Additionally, by isolating these intragenic suppressor mutants we uncovered residues 
of SecA2 that are important for function.  When the suppressor mutations are recreated in 
SecA2 with a normal, wild-type Walker Box, the resulting proteins are unable to complement 
the ∆secA2 mutant phenotypes.  Said another way, the recreated suppressors were equivalent 
to secA2 null alleles.  We think these results are particularly exciting since to date, no 
mutational analysis has been performed on accessory SecA2 proteins in any bacteria.  
Furthermore, the residues that we found important for SecA2 function have not been 
identified in previous mutational analyses of the essential E. coli SecA protein (23, 33-36, 
63). 
 
Extragenic suppressors of SecA2 K129R can be used to identify SecA2-interacting 
proteins. 
In addition to the intragenic suppressors, we also collected extragenic suppressors of 
SecA2 K129R.  Suppressor analysis has been successfully used to identify interactions 
between proteins that function in the same pathway (2).  Indeed, components of the E. coli 
Sec pathway were identified by suppressor analysis (4, 5).  We think using these extragenic 
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suppressors represents an excellent opportunity to identify components that interact with 
SecA2 during protein export.  SecA2 K129R is released from the cell envelope in two 
extragenic suppressors we tested.  This result makes us think that these suppressor mutations 
function by preventing formation of inactive complexes with SecA2 K129R.  Therefore the 
suppressor mutation must be in a protein that normally interacts with SecA2.  We have not 
yet identified where the suppressor mutations are in these strains, but we are currently 
pursuing several strategies to do so.  First, we have started to sequence the genomes of two 
representative suppressors.  The cost of whole genome sequencing is rapidly decreasing, 
making this approach a feasible option.  Second, we are attempting a more traditional library 
approach to clone the suppressor mutation.  Until recently, we were unable to pursue this 
strategy due to technical limitations.  However, using genomic libraries in a newly created 
cosmid vector this is also now a valid option.  We believe that one of these strategies will 
enable us to identify the extragenic suppressor mutations in our strains. 
 
A model for SecA2-dependent protein export in mycobacteria that involves components 
of the canonical Sec pathway. 
We propose that SecA2-mediated protein export involves some or all of the 
components of the canonical Sec pathway.  We favor this model over others that invoke the 
existence of a completely novel set of translocase components because several results point 
in this direction.  First, mycobacteria do not have an accessory SecY2 homolog (15).  
Perhaps SecA2 is capable of functioning with the essential SecY, so the presence of an 
accessory SecY2 protein is not necessary. 
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Second, SecA2 K129R is dominant negative and has a negative impact on growth of 
wild-type and ∆secA2 M. smegmatis strains.  This implies that SecA2 K129R inactivates an 
essential process.  It is consistent with SecA2 K129R disrupting the canonical Sec pathway 
through formation of nonfunctional SecA2 K129R/SecYEG complexes.  We showed that the 
K129R substitution changes the localization of SecA2 from the cytoplasm to the cell 
envelope (Chapter 3).  This is consistent with SecA2 K129R becoming irreversibly 
associated with a membrane-embedded complex such as the Sec translocase.   
Third, in some of our suppressors of SecA2 K129R phenotypes the localization of 
SecA1 changed.  Even though the suppressor mutations are not in secA1 in these strains, we 
think this altered localization indicates that the suppressor mutation is in another component 
of the canonical Sec pathway which in turn influences the localization of SecA1.   
Fourth, we showed that SecA1 is required for the export of the SecA2-dependent 
protein Msmeg1712-HA (Chapter 5).  Although it is not yet possible to rule out indirect roles 
for SecA1 in Msmeg1712-HA export, this result is consistent with the proposal that SecA2 
works with SecA1 to export a subset of proteins across the membrane.  The fact that SecA in 
E. coli is known to dimerize suggested to us that SecA1 and SecA2 may work together as a 
heterodimer.  However, we have been unable to demonstrate a physical interaction between 
SecA1 and SecA2.  Another possibility is that SecA2 binds to components of the Sec 
pathway other than SecA1. 
Fifth, there are synthetic phenotypes that link SecA1 and SecA2.  Overexpression of 
SecA1 in wild-type M. smegmatis has no detrimental effect, but overexpression of SecA1 in 
a ∆secA2 mutant exacerbates the rich agar growth defect and azide hypersensitivity 
phenotypes (6).  Perhaps an overabundance of SecA1 and the dearth of SecA2 in a ∆secA2 
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mutant alter the normal stoichiometry of and interaction with the canonical Sec pathway.  
Although the explanation for this synthetic phenotype remains a mystery, this synthetic 
phenotype is further evidence of a relationship between SecA1 and SecA2. 
The above results are all consistent with there being a functional relationship between 
SecA2 and the canonical Sec pathway.  We think that in mycobacteria, the primary role of 
SecA2 is to recognize and/or deliver a subset of pre-proteins to the essential SecYEG 
translocase (Figure 7.1).  ATPase activity is required for SecA2 function.  Perhaps energy 
derived from the hydrolysis of ATP allows SecA2 to initially engage pre-proteins with the 
SecYEG channel, but SecA1 is required for subsequent cycles of export.  However, more 
studies are obviously needed to definitively demonstrate a role for SecA1 and/or SecYEG in 
the mechanism of SecA2-dependent export.  The identification of SecA2-interacting proteins 
will be a critical step in proving the mechanism of SecA2-mediated protein export. 
 
M. smegmatis is a valid model for studying cellular processes of mycobacteria. 
 Most of our studies of the SecA2-dependent pathway used M. smegmatis.  Fast 
growing, nonpathogenic M. smegmatis is much more amenable to genetic and biochemical 
analyses than slow growing, pathogenic M. tuberculosis (48).  During the course of our 
studies, we performed several experiments to show that M. smegmatis is a valid model 
system to study processes that are conserved in M. tuberculosis.  Using cross-species 
complementation experiments, we showed that M. smegmatis secA2 can complement the 
macrophage growth defect and the smooth colony phenotypes of the M. tuberculosis ∆secA2 
mutant.  It is also possible to complement phenotypes of the M. smegmatis ∆secA2 mutant by 
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expressing M. tuberculosis secA2.  These findings clearly demonstrate functional 
conservation of SecA2 between the two mycobacterial species. 
Our studies also identified several other similarities between M. tuberculosis and M. 
smegmatis.  Expression of SecA1 and SecA2 is the same in both organisms.  Our analysis 
also showed ATP binding is required for function of SecA2 in M. tuberculosis and M. 
smegmatis.  We also showed that expression of secA2 Walker Box mutant alleles was 
dominant negative in both species.  One discrepancy is that all the known SecA2-dependent 
proteins of M. tuberculosis lack signal sequences, while all the known SecA2-dependent 
protein of M. smegmatis contain signal sequences.  This could indicate a slight difference in 
how pre-proteins are recognized between these two mycobacteria.  It is also possible that we 
have not yet identified SecA2 substrates in M. tuberculosis that possess signal sequences, or 
SecA2 substrates in M. smegmatis that lack signal sequences.  It will be important to identify 
more SecA2-dependent proteins to fully understand this difference.  Taken together, we think 
our results provide a rationale for continued studies of the accessory SecA2 pathway of M. 
smegmatis as a key to understanding how specialized secretion systems contribute to 
pathogenesis of M. tuberculosis. 
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Figure 7.1.  Proposed model for SecA2-mediated protein export.  SecA2 recognizes pre-
proteins in the cytoplasm, and delivers them to the SecA1/SecYEG translocase.  Upon ATP 
binding and hydrolysis, SecA2 undergoes conformational changes to initiate the export cycle.  
SecA1 finishes protein export through multiple rounds of insertion/deinsertion.  Once across 
the cytoplasmic membrane, the exported protein can fold into its mature conformation. 
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